In vivo analysis of RNA polymerase I elongation and termination in Saccharomyces cerevisiae by Reiter, Alarich
  
 
 
 
In vivo analysis of RNA polymerase I elongation 
and termination in Saccharomyces cerevisiae 
 
 
 
 
 
 
 
DISSERTATION ZUR ERLANGUNG DES DOKTORGRADES DER NATURWISSENSCHAFTEN 
(DR. RER. NAT.) DER FAKULTÄT FÜR BIOLOGIE UND VORKLINISCHE MEDIZIN DER 
UNIVERSITÄT REGENSBURG 
 
 
 
 
vorgelegt von 
Alarich Reiter 
 
aus  
Temeschburg 
 
im Juni 2011 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Promotionsgesuch eingereicht am:    15. Juni 2011 
 
Die Arbeit wurde angeleitet von:    Prof. Dr. Herbert Tschochner 
 
 
Prüfungsausschuss: 
 
 Vorsitzender:   Prof. Dr. Reinhard Wirth 
         1. Prüfer:   Prof. Dr. Herbert Tschochner 
         2. Prüfer:   Prof. Dr. Michael Thomm 
         3. Prüfer:   Prof. Dr. Reinhard Sterner 
 
 
Tag der mündlichen Prüfung:    26. Juli 2011 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
Die vorliegende Arbeit wurde in der Zeit von April 2007 bis Juni 2011 am Lehrstuhl 
Biochemie III des Instituts für Biochemie, Genetik und Mikrobiologie der 
Naturwissenschaftlichen Fakultät III der Universität Regensburg unter Anleitung von  
Prof. Dr. Herbert Tschochner angefertigt. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Ich erkläre hiermit, dass ich diese Arbeit selbst verfasst und keine anderen als die 
angegebenen Quellen und Hilfsmittel verwendet habe. 
Diese Arbeit war bisher noch nicht Bestandteil eines Prüfungsverfahrens. 
Andere Promotionsversuche wurden nicht unternommen. 
 
 
 
Regensburg, den 15. Juni 2011 
 
 
 
Alarich Reiter 
  
 
 
 
 
 
Table of Contents 
I 
Table of Contents 
 
 
1 INTRODUCTION   ......................................................................................... 1
1.1 RNA polymerases   ....................................................................................................... 1
1.2 RNA polymerase I transcription   ................................................................................ 2
1.2.1 Cellular localization and structure of ribosomal RNA genes   .......................................... 2
1.2.2 RNA polymerase I structure and subunit composition   .................................................... 5
1.2.3 Assembly of RNA polymerase I   ................................................................................................. 9
1.2.4 The RNA polymerase I transcription cycle   .......................................................................... 10
1.2.5 Pre-rRNA processing and maturation of ribosomes  ........................................................ 15
1.2.6 Regulation of Pol I transcription and ribosome biogenesis   ......................................... 17
1.2.7 Posttranslational modifications of RNA polymerase I   .................................................... 20
1.3 Objectives   ................................................................................................................. 21
 
2 RESULTS   ................................................................................................... 23
2.1 In vivo analysis for RNA polymerase I mutants   ...................................................... 23
2.1.1 Functional analysis of RNA polymerase I phosphomutants   ......................................... 23
2.1.2 Characterization of a putative A43-Rrn3 interaction mutant   ...................................... 27
2.1.3 Analysis of the Pol I synthetic lethal mutant rpa190 S685D / Δrpa12   ....................... 30
2.1.4 Characterization of a dominant negative A12.2 mutation   ........................................... 36
2.2 Regulation of ribosome synthesis upon environmental changes   ........................ 43
2.3 Establishment of an in vivo system to study Pol I elongation   ............................... 50
2.4 In vivo characterization of Pol I termination   .......................................................... 57
2.4.1 Identification of Ydr026c as yeast Pol I termination factor   ........................................... 57
2.4.2 Pol I accumulates in front of an artificially introduced termination site   .................. 60
2.4.3 Ydr026c binding is sufficient to terminate at an artificially introduced  
 termination site   ............................................................................................................................ 62
2.4.4 Characterization of the DNA element required for termination   ................................. 64
2.4.5 Effects of premature termination on rRNA processing   .................................................. 66
2.4.6 Ydr026c is a bona fide Pol I transcription termination factor   ....................................... 68
2.4.7 Deletion of YDR026c is viable and causes rDNA repeat expansion   ............................ 70
 
 
Table of Contents 
II 
3 DISCUSSION   ............................................................................................. 73
3.1 Possible roles of Pol I phosphorylation   .................................................................. 73
3.2 Formation of Pol I-Rrn3 complexes   ........................................................................ 74
3.3 Uncoupling transcription and pre-rRNA processing after short-term TOR 
 inactivation   ............................................................................................................... 75
3.4 The importance of correct Pol I assembly and possible roles of phosphorylation 
 in this process   ........................................................................................................... 78
3.5 A12.2, a Pol I specific subunit involved in many processes   .................................. 79
3.6 In vivo Pol I elongation assay   .................................................................................. 81
3.7 `Torpedo termination` or not?   ................................................................................ 83
 
4 SUMMARY – ZUSAMMENFASSUNG   ....................................................... 85
4.1 Summary   ................................................................................................................... 85
4.2 Zusammenfassung   ................................................................................................... 87
 
5 MATERIAL AND METHODS   ..................................................................... 89
5.1 Material   ..................................................................................................................... 89
5.1.1 Saccharomyces cerevisiae strains   ............................................................................................ 89
5.1.2 Escherichia coli strains   ................................................................................................................ 93
5.1.3 Plasmids   .......................................................................................................................................... 93
5.1.4 Oligonucleotides   ......................................................................................................................... 97
5.1.5 Southern Probes   ....................................................................................................................... 102
5.1.6 Northern probes   ....................................................................................................................... 103
5.1.7 Antibodies   ................................................................................................................................... 103
5.1.8 Enzymes   ....................................................................................................................................... 104
5.1.9 Kits   ................................................................................................................................................. 104
5.1.10 Media   ............................................................................................................................................ 104
5.1.11 Buffers   ........................................................................................................................................... 106
5.1.12 Chemicals   .................................................................................................................................... 109
5.1.13 Other materials   .......................................................................................................................... 109
5.1.14 Equipment   .................................................................................................................................. 110
5.1.15 Software   ....................................................................................................................................... 111
 
 
 
 
Table of Contents 
III 
5.2 Methods   .................................................................................................................. 112
5.2.1 Work with Saccharomyces cerevisiae   .................................................................................. 112
5.2.2 Work with Escherichia coli   ...................................................................................................... 114
5.2.3 Work with DNA   .......................................................................................................................... 116
5.2.4 Work with RNA   .......................................................................................................................... 120
5.2.5 Work with proteins  ................................................................................................................... 122
5.2.6 I-TRAQ analyses (semi-quantitative MALDI mass spectrometry)   ............................. 125
5.2.7 Additional biochemical methods   ....................................................................................... 126
 
6 REFERENCES   .......................................................................................... 131
 
7 PUBLICATIONS   ...................................................................................... 151
 
8 ABBREVIATIONS   .................................................................................... 153
 
Acknowledgments   ...................................................................................... 157
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
INTRODUCTION 
1 
1 INTRODUCTION 
 
 
1.1 RNA polymerases 
 
In 1960, Sam Weiss, Audrey Stevens, and Jerard Hurwitz independently discovered a RNA 
polymerase. One year before the Nobel Prize in Medicine had been awarded to Severo Ochoa 
and Arthur Kornberg for their discovery of the mechanisms in the biological synthesis of RNA 
and DNA by the identification of a DNA polymerase. Interestingly, another Nobel Prize was 
awarded to the polymerase research field in 2006, emphasizing general importance of these 
kind of enzymes. Roger Kornberg, Arthur Kornberg`s son, was awarded for describing the 
molecular mechanism of elongating RNA polymerase II.  
The DNA-dependent RNA polymerase (RNAP) is an enzyme which catalyzes the synthesis of 
ribonucleic acids (RNAs) in a process called transcription. RNAP is a nucleotidyl transferase that 
polymerizes ribonucleotides in a 5´-3´-direction on a DNA gene template.  
In general, RNA polymerases can initiate transcription at specific DNA sequences known as 
promoters. It then produces an RNA chain which is complementary to the template DNA 
strand. The process of adding nucleotides to the RNA strand is called elongation. The release of 
its RNA transcript at specific DNA sequences, encoded at the end of genes is known as 
termination.  
RNAPs are essential for growth and are found in all organisms and many viruses.  
Most information on viral RNA polymerases is available from the RNAP of the bacteriophage 
T7. The single-subunit T7 RNA polymerase is related to that found in mitochondria and 
chloroplasts (Hedtke et al., 1997), and shares considerable homology to DNA polymerases. It is 
suggested that most viral polymerases therefore evolved from a DNA polymerase and are not 
directly related to the multi-subunit RNA polymerases.  
In bacteria, one RNA polymerase catalyzes the synthesis of the three major RNAs (rRNA, mRNA, 
and tRNA). The core enzyme consists of 5 subunits whereas the complete holoenzyme 
contains 6 subunits: α2ββ'σω (~480 kDa). The sigma factor (σ) greatly reduces the affinity of 
RNAP for nonspecific DNA while increasing specificity for certain promoter regions to assure 
correct transcription initiation.  
Archaea also have a single RNAP that synthesizes all three major RNAs. However, it is closely 
related in structure and function to the three main eukaryotic RNA polymerases (Hirata et al., 
2008). Thus, it has been speculated that the archaeal RNA polymerase and the three 
specialized eukaryotic RNA polymerases evolved from a common ancestor. 
Initially only one single RNA polymerase had been characterized in extracts from different 
eukaryotic organisms varying from mammals to yeast (Weiss, 1960). A decade later the 
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purification of the polymerase over an anion exchange column resulted in three different 
fractions, namely RNA polymerase I, II, and III (Roeder and Rutter, 1969). RNAPI synthesizes the 
precursor of ribosomal RNA (rRNA). RNAPII synthesizes precursors of mRNAs, most small 
nuclear RNAs (snRNA), and microRNAs (Lee et al., 2004). RNAPIII synthesizes tRNAs, 5S rRNA 
and other small RNAs found in the nucleus and cytosol (Willis, 1993). In plants, two additional 
RNAPs were identified. RNAPIV and RNAPV are related to siRNA metabolism (Herr et al., 2005; 
Wierzbicki et al., 2009). Other RNAPs exist in mitochondria and chloroplasts. 
Additionally, RNA-dependent RNA polymerases are involved in RNA interference (Makeyev and 
Bamford, 2002). 
It is unclear yet, why a specialization of RNA synthesis occured during evolution and what are 
the molecular basics of this specialization. One of the features of this specialization in RNA 
production is the association of the different RNAPs with different nuclear sub-domains. This 
correlation may suggest that spatial separation of the transcription apparatuses in the nucleus 
provides an advantage for eukaryotic cells.  
An example of a complex interplay between all three nuclear RNAPs is the synthesis of 
ribosomes. All nuclear RNAPs are involved to assure that ribosomal components are available 
in stoichiometric amounts. This process needs to be well adapted to the proliferation state of a 
cell, and it was suggested that the RNA polymerases need to be tightly coregulated       
(Warner, 1999). 
 
 
1.2 RNA polymerase I transcription 
 
1.2.1 Cellular localization and structure of ribosomal RNA genes 
 
Ribosomal RNA genes are localized in the nucleolus, which is the major site of RNA  
polymerase I transcription in eukaryotic cells. The nucleolus denotes a specialized                   
sub-compartment of the nucleus. In yeast, only one single nucleolus is found. Under the 
electron microscope (EM), three morphologically different regions of the nucleolus can be 
distinguished, namely fibrillar centers (FC), a dense fibrillar component (DFC), and a granular 
component (GC) (Figure 1). Fibrillar centers are detected near the nuclear envelope and 
contain the rDNA (Schwarzacher and Wachtler, 1993). These fibrillar centers are surrounded by 
a dense fibrillar component, where the nascent rRNA transcripts accumulate (Cmarko et al., 
2000). Transcripts extend as a network throughout the nucleolar volume and contain the Pol I 
transcription machinery. This arrangement of rDNA in the FCs and nascent transcript in the 
DFC suggests a model, where rRNA transcription from the rDNA occurs just at the interface 
between FC and DFC. The granular component is dispersed throughout the rest of the 
nucleolus and contains the maturing pre-ribosomes (Léger-Silvestre et al., 1999).  
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Figure 1. Nucleolar structure of Saccharomyces cerevisiae 
Electron micrograph of a yeast nucleus. Nuclear pore complexes are marked (*). The nucleolus (Nu) can be seen as an 
electron dense structure next to the nuclear envelope (EN). The nucleolus is sub-structured into 3 sub-compartments 
visible in EM: the fibrillar center (FC), the dense fibrillar component (DFC) and the granular component (GC). Scale bar is 
0.2μm. (from Léger-Silvestre et al., 1999) 
 
In S. cerevisiae the rRNA genes are located on the right arm of Chromosome XII and consist of 
about 150-200 transcription units arranged in a tandem array (Schweizer and Halvorson, 1969; 
Petes, 1979). Each rDNA copy has a size of 9.1-kilobase pairs (kb) (Figure 2). The number of 
repeats is dynamic and can vary due to unequal meiotic and mitotic recombination events 
(Warner, 1989). Each of the repeated rDNA units is composed of the Pol I transcribed 35S rRNA 
gene and the gene for the 5S rRNA, which is transcribed in the opposite direction by Pol III 
(Philippsen et al., 1978). The presence of the 5S rRNA gene within the rDNA unit in S. cerevisiae 
is different from the situation in other eukaryotes where the 5S rRNA repeats are separated 
from the nucleolar rRNA repeats (Rubin and Sulston, 1973; Drouin and de Sá, 1995; Geiduschek 
and Kassavetis, 2001). The 35S rRNA is transcribed as a precursor which is processed into the 
mature 18S, 5.8S, and 25S rRNAs. Different elements important for the regulation of rDNA 
transcription have been identified within the 35S rRNA gene (Kulkens et al., 1991; Musters et 
al., 1989). The upstream element (UE) and the core element (CE) are located on the 5´ end of 
the 35S rDNA within the intergenic spacer region 2 (IGS2). These elements span about 170 bp 
and constitute the 35S rDNA promoter.  
A third element, called enhancer (ENH), is located at the 3´ end of the 35S transcription unit. 
This element has been shown to exhibit a stimulatory effect on RNA synthesis by Pol I, using 
Pol I reporter templates, either in vitro or in vivo (Elion and Warner, 1984, 1986). The ENH region 
also contains two terminators for 35S rDNA transcription (Reeder et al., 1999).  
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Figure 2. Schematic representation of the rDNA locus in S. cerevisiae 
The position of the rDNA repeat cluster on chromosome XII with respect to the centromere (CEN) and telomeres (Tel) is 
shown. Each rDNA repeat consists of the Pol I transcribed 35S rRNA gene (precursor for the 18S, 5.8S, and 25S rRNAs), the 
RNA Pol III transcribed 5S rRNA gene and two intergenic spacer regions IGS 1 and 2. Arrows mark the transcription start 
sites and direction. The positions of several DNA elements like the 5` and 3` external transcribed spacers (ETS), the 
internal transcribed spacers (ITS) 1 and 2, as well as the Reb1 binding site (Reb1), the RNAse III (Rnt1) cleavage site, and 
the replication fork barrier (RFB) are indicated. The upstream element (UE) and core element (CE) constitute the Pol I 
promoter (P). Termination occurs at the Reb1 binding site which is located within a region called enhancer (ENH). Sites of 
autonomous replication sequence (ARS) and a region required for repeat expansion (EXP), harboring a bidirectional Pol II 
promoter, are depicted. 
 
Several other cis-regulatory elements unrelated to 35S rDNA transcription are located within 
IGS1 and IGS2. During S-phase, bidirectional replication is initiated at the ribosomal 
autonomous sequence (rARS) (Linskens and Huberman, 1988). A replication fork barrier (RFB) 
site is located near the enhancer element and allows the progression of the replication fork in 
the direction of 35S rDNA transcription but not in the opposite direction (Brewer and 
Fangman, 1988; Brewer et al., 1992; Fangman and Brewer, 1992; Kobayashi et al., 1992). The 
replication fork blocking protein (Fob1) binds to the RFB and is required for this activity 
(Kobayashi and Horiuchi, 1996). In addition, Fob1 is required for expansion and contraction of 
rDNA repeats (Kobayashi et al., 1998). These repeat expansion and contraction events require 
recombination which is triggered by double strand breaks introduced into the rDNA by     
Fob1-dependent pausing of the DNA replication machinery at RFB sites (Burkhalter and Sogo, 
2004; Kobayashi et al., 1998, 2004). In addition to the RFB, the adjacent region (EXP) has also 
been shown to be required for repeat expansion (Kobayashi et al., 2001). This region harbors a 
bidirectional Pol II promoter which drives the transcription of non-coding RNAs (Ganley et al., 
2005; Houseley et al., 2007). 
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1.2.2 RNA polymerase I structure and subunit composition 
 
The yeast enzyme RNA polymerase I is a multi-protein complex consisting of 14 different 
subunits as revealed by the analyses of Pol I complexes purified by diverse methods (Keener et 
al., 1998; Carles et al., 1991; Kuhn et al., 2007; Paule, 1999). Their designation in the common 
Pol I nomenclature is composed of the letter A, B and/or C indicating the appearance of the 
subunit in RNA polymerase I, II and/or III, respectively, and of a number denoting the 
respective molecular weight in kDa as determined by SDS-PAGE (Table 1). All but four of the 
Pol I subunits are essential proteins (Mémet et al., 1988; Yano and Nomura, 1991; Thuriaux et 
al., 1995; Mann et al., 1987; Woychik et al., 1990; Dequard-Chablat et al., 1991;                        
Treich et al., 1992). 
 
Table 1. Subunit composition of RNA polymerases 
 Eukaryotes  Archaea Bacteria Subunit type 
Pol I Pol II Pol III    
A190 Rpb1 C160 A´+A´´ β´ core/homolog 
A135 Rpb2 C128 B (B´+B´´) β core/homolog 
AC40 Rpb3 AC40 D α core/homolog 
AC19 Rpb11 AC19 L α core/homolog 
ABC27 ABC27 (Rpb5) ABC27 H ω core/common 
ABC23 ABC23 (Rpb6) ABC23 K - common 
ABC14.5 ABC14.5 (Rpb8) ABC14.5 - - common 
ABC10α ABC10α (Rpb10) ABC10α N - common 
ABC10β ABC10β (Rpb12) ABC10β P - common 
A12.2* Rpb9 C11 X - homolog 
A14* Rpb4 C17 F - counterpart 
A43 Rpb7 C25 E - counterpart 
A49* - C37 - - Pol I/III specific 
A34.5* - C53 - - Pol I/III specific 
- - C82 - - Pol III specific 
- - C34 - - Pol III specific 
- - C31 - - Pol III specific 
                     Non-essential Pol I subunits are marked with a * 
 
Molecular details of multisubunit RNA polymerases have been revealed by the crystal 
structures of the bacterial RNA polymerase from Thermus aquaticus (Zhang et al., 1999; 
Vassylyev et al., 2002). To date most progress in structural studies for eukaryotic polymerases 
was achieved for RNA polymerase II, culminating in the atomic structure of the 10-subunit core 
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enzyme (Cramer et al., 2001) and the complete 12-subunit enzyme structure (Armache et al., 
2005). As suggested by the high degree of conservation between the polymerase subunits, it 
resembles the general architecture of multisubunit RNA polymerases (Bischler et al., 2002; 
Cramer, 2002; Kuhn et al., 2007). 
The Pol I structure has been intensively investigated by EM, immuno-EM and cryo-EM analyses 
(Schultz et al., 1993; Klinger et al., 1996; Bischler et al., 2002; De Carlo et al., 2003; Kuhn et al., 
2007). The Pol II crystal structure could be fitted into the Pol I cryo-EM maps (Bischler et al., 
2002; Kuhn et al., 2007). Based on the structural similarities, sequence alignments and a new 
crystal structure of the Pol I subunits A43 and A14, it was only possible to construct a 12 
subunit Pol I homology model (Kuhn et al., 2007) with the absence of A49 and A34.5 as their 
counterparts in Pol II are missing in the model. However, their position in the complex could be 
derived from the difference between cryo-EM maps of the complete Pol I and of a variant 
lacking the A34.5/A49 heterodimer (Huet et al., 1975; Kuhn et al., 2007) (Figure 3). 
 
 
Figure 3. RNA polymerase I structure 
Hybrid structure and functional architecture of Pol I. The EM envelope is shown as a blue line, the Pol I core ribbon model 
in gray with Rpb9 (A12.2) highlighted in orange, and the A14/43 crystal structure in red/blue. The position of the 
A49/34.5 heterodimer is indicated in green. The window shows a cut-away view of the active center containing a 
modeled DNA-RNA hybrid. Red dashes indicate the RNA 3′ end extruded into the pore. (from Kuhn et al., 2007) 
 
The two large Pol I subunits A190 and A135 form the central mass of the RNA polymerase I 
complex and are localized on the opposite sites of the cleft (Bischler et al., 2002). Derived from 
homology studies with the respective Pol II counterparts Rpb1 and Rpb2 (Mémet et al., 1988) 
they comprise the active center, coordinating a Mg2+ ion required for the enzymatic 
mechanism of the enzyme. 
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The two subunits AC40 and AC19 are common in Pol I and Pol III and share homologies with 
Rpb3 and Rpb11, the corresponding subunits of RNA polymerase II (Lalo et al., 1993). These 
two subunits are the counterparts of the two identical α-subunits of the bacterial enzyme and 
play a role in the first steps of RNA polymerase assembly (Ishihama, 1981). 
The subunits ABC27, ABC23, ABC14.5, ABC10β, and ABC10α are identical in all three nuclear 
polymerases (Carles et al., 1991). Interestingly, ABC23 is the only common subunit with a 
homolog in the bacterial RNA polymerase. In Pol I it forms the main interaction interphase 
between the core polymerase and the two `stalk` subunits (A43, A14) and therefore plays a role 
in polymerase assembly (Smid et al., 1995; Lanzendörfer et al., 1997).  
The subunits A14 and A43 form a heterodimer constituting the protruding `stalk`, which is 
distantly related to Rpb4/Rpb7 in Pol II and Rpc17/Rpc25 in Pol III (Peyroche et al., 2002; Geiger 
et al., 2008). The structure of these subcomplexes within the three nuclear RNA polymerases 
has been solved with high resolution (Armache et al., 2003; Jasiak et al., 2006; Geiger et al., 
2008). Structures of A43 and its counterparts Rpb7, C25, and the archaeal RpoE can be 
separated into two distinct domains: the N-terminal part, involved in the binding to ABC23 
(called ‘tip domain’), and the C-terminal half, forming the most outer part of the stalk        
(called ‘OB-domain’) (Kuhn et al., 2007). A43 plays an important role in transcription initiation 
through contact formation with the respective basal transcription factor Rrn3 (Peyroche et al., 
2000). However, the molecular details of this A43-Rrn3 complex formation and regulatory 
mechanisms controlling this interaction are still unclear and under current investigation. 
Subunit A12.2 is homologous to subunit Rpb9 in Pol II and C11 in Pol III. It is non-essential 
under normal growth conditions, but required for growth at elevated temperatures (Nogi et 
al., 1993). This is consistent with its Pol II homolog Rpb9 (Woychik et al., 1991), while the 
homologous Pol III subunit C11 is an essential protein (Chédin et al., 1998). The A12.2                
C-terminal domain contains a highly conserved motif (Q.RSADE..T.F; only Rpb9 contains 
variations), which is also present in the Pol II elongation factor TFIIS (Figure 4). Thus, A12.2, 
Rpb9, C11, and the archaeal factor TFS are sometimes referred to as TFIIS-like RNA polymerase 
subunits and are linked to transcript elongation (see section 1.2.4.2). However, this homology 
is limited to the C-terminal domain of A12.2 and the C-terminal zinc binding domain of the 
much larger Pol II transcript cleavage factor TFIIS (Mullem et al., 2002; Chédin et al., 1998). 
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Figure 4. Homology of A12.2, Rpb9, C11, TFIIS, and TFS 
Top: Sequence alignment of S. cerevisiae A12.2, Rpb9, C11, TFIIS, and of the archeal TFS factor (Sulfolobus acidocaldarius). 
Alignments were made using a BLOSUM 62 matrix. Stars indicate the invariant amino acids. The black bar denotes the 
invariant Q.RSADE..T.F motif shared by these polypeptides except Rpb9. 
Bottom: Sequence alignment of S. cerevisiae, S. pombe, and Homo sapiens A12.2 homologues. Stars indicate the invariant 
amino acids shared by all three polypeptides. (modified from Mullem et al., 2002) 
 
The TFIIS-like polymerase subunits are also involved in the transcription termination processes 
(Chédin et al., 1998; Landrieux et al., 2006; Prescott et al., 2004). Yeast strains lacking RPA12  
(the gene encoding A12.2) were shown to accumulate Pol I molecules in the IGS regions of the 
rDNA locus (Prescott et al., 2004). In the case of Pol III, C11 was identified as a termination 
factor, but the associated intrinsic RNA cleavage activity does not seem to be necessary 
(Landrieux et al., 2006). 
The analysis of deletion mutants lacking either the N-terminal (A12.2 ΔN) or C-terminal half of 
the protein (A12.2 ΔC) revealed, that the ΔN-mutant is not able to bind to the polymerase, and 
thus was phenotypically indistinguishable from a strain with a full RPA12 knock-out (Mullem et 
al., 2002). In the obtained Pol I structure A12.2 binds to the jaw region of the largest subunit 
(Figure 3). In contrast yeast strains expressing the A12.2 ΔC mutant, lacking the highly 
conserved domain, do not show the temperature sensitive (ts) phenotype and grow like     
wild-type arguing for a non-essential function of this domain. Most probably, the binding of 
the N-terminal half of A12.2 is required to assure the correct conformation of A190 (Mullem et 
al., 2002). As depicted above, A12.2 seems to play a role in several transcription processes. 
However, some discrepancy between in vitro and in vivo data concerning e.g. transcript 
cleavage and termination can be observed. 
No counterparts in other polymerases have been found for subunits A49 and A34.5 (Gadal et 
al., 1997; Liljelund et al., 1992). However, local homologies were detected between these two 
proteins and the Pol II-associated factors TFIIF and TFIIE, respectively. It was shown in vitro that 
these subunits form a TFIIF-like heterodimer which could provide a built-in elongation factor 
for RNA polymerase I (Kuhn et al., 2007; Geiger et al., 2010). Whether this described function 
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can also be applied in vivo is still unclear. Genetic analyses of the deletion strains for each of 
the two subunits revealed synthetic lethal effects with deletions of RPA14. Furthermore 
synthetic growth defects of Δrpa34 with the deletion of DNA Topoisomerase I (TOP1) and 
HMO1 (Gadal et al., 1997; Berger et al., 2007) and of Δrpa49 with deletions of DNA 
Topoisomerase III (TOP3) and HMO1 were found (Gadal et al., 1997; Berger et al., 2007). 
Recently it was reported that these two subunits control the binding and release of Rrn3 
during transcription and play a role in initiation and polymerase loading rate (Beckouet et al., 
2008; Albert et al., 2011). 
 
1.2.3 Assembly of RNA polymerase I 
 
The assembly of single subunits into a RNA polymerase complex is best studied for the five 
subunit RNA polymerase of E. coli. Assembly of the polymerase core of eukaryotic enzymes 
seems to follow the same mechanism. The homodimerization of the bacterial α-subunits is the 
first step in the assembly of the RNA polymerase in E. coli, followed by the subsequent binding 
of the β- and β’-subunit (A135 and A190 Pol I counterparts, see Table 1) (Ishihama, 1981). The 
heterodimerization of AC40 and AC19, the α-subunit counterparts in Pol I and Pol III, has been 
demonstrated in vivo (Lalo et al., 1993; Flores et al., 1999). ABC23 (Rpb6) is the eukaryotic 
counterpart of the bacterial RNAP ω-subunit (Minakhin et al., 2001) whose function seems to 
be related to the assembly of the enzyme (Nouraini et al., 1996; Minakhin et al., 2001). In the 
proposed mechanism ABC23 latches the C-terminus of the largest polymerase subunit to a 
more N-terminal region of the protein, thus inducing a conformational change, which 
promotes the binding to the α2β-like intermediate complex (Minakhin et al., 2001; 
Lanzendörfer et al., 1997; Ghosh et al., 2001). Furthermore it forms the main interaction 
interphase between the core polymerase and the A14/A43 heterodimer in Pol I (Peyroche et 
al., 2002). Additionally the subunits ABC10α, ABC10β seem to be crucial for the assembly of the 
eukaryotic enzyme (Gadal et al., 1999; Rubbi et al., 1999). They form a subcomplex with the     
α-like polymerase subunits and seem to be involved in interactions with the large subunits 
(Cramer et al., 2000). The binding of the N-terminal half of A12.2 is required to assure the 
correct conformation and assembly of A190, increasing polymerase stability                      
(Mullem et al., 2002). 
This is consistent with the observation, that the ts-phenotype of a Δrpa12 strain can be 
suppressed by overexpression of A190 (Nogi et al., 1993). 
It is not easy to distinguish between effects due to the lacking activity of A12.2 or an incorrect 
folding of A190. For instance the 6AU-sensitivity described for RPA12 deletion strains could 
also be suppressed by the overexpression of A190 (Mullem et al., 2002). The instability of A190 
is probably also the cause for an observed synthetic lethal defect of Δrpa12 when combined 
with either Δrpa14 (Gadal et al., 1997) or Δhmo1 (Berger et al., 2007). 
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Figure 5. Interaction diagram for the Pol I subunits 
The scheme was derived from interaction diagrams of the 10 subunit Pol II (Cramer et al., 2000, 2001) and represents the 
top view. Approximate positions of Pol I specific subunits A49, A34.5, A43, and A14 are indicated using information 
described by (Bischler et al., 2002). Downstream DNA bound in the cleft is also shown. (from Gerber, 2008)  
 
 
1.2.4 The RNA polymerase I transcription cycle 
1.2.4.1 Initiation 
Pol I requires four major transcription factors to transcribe its substrate. These transcription 
factors are TBP, Rrn3 and two protein complexes, termed UAF for upstream activating factor 
and CF for core factor. The latter bind to two promoter sequences, the upstream element (UE) 
and the core element (CE), respectively. The UE is situated from -146 to -51 bp with respect to 
the transcription start site (Kulkens et al., 1991; Musters et al., 1989) and is bound by the UAF 
protein complex (Keys et al., 1996) which consists of the six subunits Rrn5, Rrn9, Rrn10, Uaf30, 
and the histones H3 and H4 (Keener et al., 1997; Keys et al., 1996; Siddiqi et al., 2001). Uaf30 
was demonstrated to be important for UAF recruitment to the UE (Hontz et al., 2009), whereas 
the functions of the other factors, besides mediating specific protein-protein interactions 
(Steffan et al., 1996), are still unknown. The histones H3 and H4 are targets for multiple 
posttranslational modifications (Pazin and Kadonaga, 1997; Li et al., 2007a). However, it is not 
known if they are modified in the context of UAF. Further proximal to and including the 
transcription start site locates the CE at position -28 to +8 bp (Kulkens et al., 1991; Musters et 
al., 1989), targeted by the core factor (Keys et al., 1994; Lalo et al., 1996). CF consists of three 
proteins, namely Rrn6, Rrn7, and Rrn11 (Keys et al., 1994; Lalo et al., 1996). The TATA-binding 
protein (TBP) participates in Pol I initiation by bridgeing between UAF and CF through 
interaction with both complexes (Steffan et al., 1998). Rrn3 interacts directly with Pol I forming 
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an active Pol I-Rrn3 complex via interaction with the A43 subunit (Yamamoto et al., 1996; 
Peyroche et al., 2000). Less than 2% of Pol I is associated with Rrn3 in whole cell extracts, which 
is the fraction competent for initiation (Milkereit and Tschochner, 1998). In addition, Rrn3 binds 
to the CF subunit Rrn6 suggesting that Rrn3 may act as a bridge between CF and Pol I 
(Peyroche et al., 2000). Promoter assembly studies draw the current picture as follows: UAF is 
first recruited to the UE. TBP binds to the UAF and recruits / stabilizes the CF onto the CE. UAF 
and CF form a stable complex. This assembly onto the yeast ribosomal DNA (rDNA) promoter 
forms the pre-initiation complex (PIC), to which the initiation competent, Rrn3-associated, Pol I 
is recruited.  
The two Pol I subunits A49 and A34.5 also seem to influence interaction properties between 
Rrn3 and Pol I and are essential for nucleolar assembly and for the high polymerase loading 
rate associated with frequent contact between adjacent enzymes (Beckouet et al., 2008;   
Albert et al., 2011). 
 
 
Figue 6. The Pol I pre-initiation complex (PIC) 
Yeast PIC. The six subunit containing upstream activating factor (green) binds the upstream element (UE). The core factor 
(composed of Rrn6, Rrn7, and Rrn11) binds the core element (`core`). The two complexes are bridged via the               
TATA-binding protein (TBP). Initiation competent Pol I, associated with Rrn3, interacts with the Rrn6 subunit of the core 
factor. (from Moss, 2004) 
 
After transcription initiation Rrn3 dissociates from the template during or immediately after 
Pol I switched from initiation to elongation (Bier et al., 2004). The mechanism of this transition 
is not completely understood yet, since dissociation of Rrn3 from Pol I does not seem to be 
vital in a strain expressing an A43-Rrn3 fusion protein (Laferté et al., 2006).  
It is likely that (de-)phosphorylation of Pol I subunits is involved in the regulation of this 
transition step, since it was shown that Rrn3 bound Pol I exhibits a different phosphorylation 
pattern than the bulk of Pol I (Fath et al., 2001).  
 
INTRODUCTION 
12 
1.2.4.2 Elongation  
Most knowledge about RNA elongation comes from studies with RNA Pol II (Shilatifard, 2004; 
Reinberg and Sims, 2006; Svejstrup, 2007) and bacterial polymerases (Borukhov and        
Nudler, 2008).  
Eukaryotic or bacterial elongation factors like TFIIS or GreA/GreB, respectively, allow the 
transcription complex to pass through physical barriers (Reines and Mote, 1993; Toulmé et al., 
2000). TFIIS induces the hydrolytic cleavage of the nascent RNA chain from the 3` end of a 
backtracked Pol II after encountering a transcriptional block (Fish and Kane, 2002; Sigurdsson 
et al., 2010). The two acidic residues (DE) in the conserved C-terminal motif were shown to be 
crucial for the mechanism of TFIIS-induced RNA cleavage (Jeon et al., 1994; Kettenberger et al., 
2003). Other factors like FACT and Elongator facilitate transcription from chromatin templates 
(Reinberg and Sims, 2006). However, it is unclear how these factors contribute to efficient 
transcription through chromatin in vivo, especially since many of them (like TFIIS, Elongin, Paf1) 
are dispensable for cell viability under physiological conditions (Archambault et al., 1992; 
Yamazaki et al., 2003). Our understanding about elongation in the Pol I cycle is rather low 
compared to the regulation of initiation events since RNA Pol I elongation has only been 
marginally investigated in vitro (Stefanovsky et al., 2006; Schneider et al., 2007). In fact, there is 
a need to establish a system for in vivo analysis of Pol I elongation.  
The recently reported interactions of Pol I with transcription elongation factors previously 
described to be involved in Pol II transcription like Spt4/5 and Paf1 (Schneider et al., 2006; 
Zhang et al., 2009, 2010; Anderson et al., 2011; Viktorovskaya et al., 2011) suggests common 
principles in RNA chain elongation. As in the case for Pol II it is concluded that it is not the 
elongation rate (nucleotide addition per minute) that is increased by Spt4/Spt5, but rather the 
processivity of the polymerase (nucleotide addition per initiation event) (Mason and         
Struhl, 2005).  
Moreover, it was shown in bacteria that trailing RNA Pols transcribing the same gene have  
anti-arrest and anti-pause effects due to forward translocation of leading complexes. This 
effect could also be transferred to the Pol I system where several polymerases, approximately 
one polymerase every 70 bp, are transcribing one rDNA gene as seen in Miller chromatin 
spreads (Figure 7). The cooperation of RNA Pols may explain why elongation can still be fast 
and processive in vivo even without anti-arrest factors (Epshtein and Nudler, 2003;          
Epshtein et al., 2003). 
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Figure 7. Miller chromatin spread of yeast rDNA 
Electron microscopic image of a Miller chromatin spread of yeast strain y1599 (WT) with a 20000 fold magnification, 
obtained from Dr. Isabelle Léger-Silvestre, University of Toulouse. The tandemly repeated and transcriptionally active 
rRNA genes are especially noticeable in the chromatin mass due to their relatively dark appearance, which is due to 
multiple nascent RNA transcripts extending from the DNA backbone. 
 
No specific Pol I elongation factors are known so far. However, the idea of a A49/A34.5 
heterodimer acting as a ‘built-in’ Pol I elongation factor, derived from in vitro studies, exists 
(Kuhn et al., 2007; Geiger et al., 2010). Furthermore the function of the Pol I subunit A12.2 is 
linked to transcription elongation (Mullem et al., 2002). It has only been shown in vitro, that   
Pol I exhibits an intrinsic RNA cleavage activity which is dependent on the C-terminal domain 
of A12.2, capable of shortening the RNA from the 3` end in an artificially stalled ternary 
complex (Kuhn et al., 2007). Similar to TFIIS deletion mutants, yeast strains lacking the gene 
coding for A12.2 are sensitive to the NTP-pool depleting drug 6-azauracil (6AU), a phenotype 
often associated with defects in transcription elongation (Archambault et al., 1992; Exinger and 
Lacroute, 1992; Hampsey, 1997; Mullem et al., 2002). 
 
1.2.4.3 Termination 
Transcription termination requires specific DNA sites which are recognized by the respective 
RNA polymerase machinery. Termination of transcription shows common features in all 
nuclear transcription machineries (Richard and Manley, 2009). It depends on pausing of the 
RNA polymerase at a specific site and is followed by destabilization and dissociation of the 
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stalled polymerase. Two terminators for 35S rDNA transcription reside within the ENH region of 
yeast (Reeder et al., 1999). Approximately 90% of all transcripts terminate at a T1 site located 
93 nucleotides downstream of the 3` end of mature 25S rRNA. The remaining transcripts 
terminate at a T2 failsafe termination site composed of a thymine-rich DNA stretch located 250 
nucleotides downstream of the 3` end of the mature 25S rRNA (Reeder et al., 1999). The T1 
terminator site contains two elements: one binding site for the Pol I enhancer binding protein 
Reb1 and an upstream T-rich element that encodes the last 10-12 nucleotides of the 
terminated transcript (Reeder and Lang, 1997). There are some similarities to the mouse 
terminator, where the Reb1 homolog TTF-I cooperates with PTRF, a transcript release factor, in 
combination with a T-rich upstream DNA sequence to terminate and dissociate Pol I and the 
nascent transcript from the template DNA (Kuhn et al., 1990; Jansa and Grummt, 1999). 
Homologies within the terminator structure as well as in the amino acid sequences of the  
Myb-like DNA binding domains at the C-terminal regions of the terminator proteins, suggest a 
high conservation of the mechanism of Pol I termination throughout eukaryotes (Jeong et al., 
1995). However, two models of termination are currently discussed due to a discrepancy of     
in vitro and in vivo data. These are a) Termination of transcription by `pause and release` 
mechanism or b) a `torpedo-like` model, similar to Pol II termination. 
Ad a) In vitro reconstitution of termination from purified yeast factors revealed that Reb1 both 
pauses Pol I and supports the release of the generated transcripts at the T1 site (Lang and 
Reeder, 1993). In addition, a T-rich DNA element at this site supports termination by 
destabilizing the pausing Pol I through a resulting A-U heteroduplex (Lang and Reeder, 1995). 
In vivo studies on ribosomal minigenes using S1 nuclease protection analysis strongly support 
this in vitro data (Reeder et al., 1999). However, Reb1 binding in vivo can only be detected at its 
binding site near the Pol I promoter but not at the terminator and a fourfold reduction of Reb1 
in vivo had no effect on termination (Kawauchi et al., 2008). Non-terminated transcripts are 
extended either to a `failsafe` terminator (T2), which resides about 250 nt downstream of the 
25S 3` end (Prescott et al., 2004; Reeder et al., 1999) or to the replication fork barrier (RFB), 
which is located about 300 bp downstreams (El Hage et al., 2008). Fob1, a protein which blocks 
DNA replication forks binds to RFB (Huang et al., 2006; Takeuchi et al., 2003) and was 
suggested to be involved in efficient termination (El Hage et al., 2008).  
Ad b) For efficient Pol I termination, accoding to the `torpedo`-model (Kawauchi et al., 2008;    
El Hage et al., 2008), cleavage of the nascent pre-rRNA by the RNase III-like endonuclease Rnt1, 
which acts across a stem-loop structure within the 3` ETS, is required (Kufel et al., 1999; Henras 
et al., 2004; Prescott et al., 2004). The generated 5` end of the cleaved transcript then serves as 
a substrate for the exonuclease Rat1 which progressivly degrades the Pol I-bound transcripts 
with the help of the helicase Sen1 and, thus, finally releases Pol I from the template by 
destabilization of the transcription complex. This model is based on in vivo analyses of yeast 
mutants deficient in the endonuclease Rnt1, resulting in accumulated transcripts beyond the 
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T1 termination site (Prescott et al., 2004; Reeder et al., 1999). Additionally, inactivation of the 
nuclear exonuclease Rat1 and the RNA helicase Sen1 leads to accumulation of extended      
pre-rRNAs and increased Pol I occupancy in the region downstream of the T1 terminator 
(Kawauchi et al., 2008; El Hage et al., 2008). Very recent studies introduce the RNA/DNA kinase 
Grc3, which is proposed to control the phosphorylation status of the downstream Rnt1 
cleavage product and thereby regulates its accessibility to the torpedo Rat1, in Pol I 
termination (Braglia et al., 2010a). Interestingly, inactivation of Rat1 alone is insufficient to 
display a full termination defect (Kawauchi et al., 2008). ChIP analyses of a Δfob1 strain showed 
increased Pol I occupancy 3` of the RFB when Rat1 is depleted. This is pointing towards an 
additional role of the RFB as an extra barrier for Pol I transcription and a Fob1-dependent 
terminator to avoid collisions of Pol I complexes with rDNA replication forks moving in 
opposite direction (El Hage et al., 2008). In an approach by Braglia et al. from 2010 the effects 
of Rnt1 deletion, already leading to slow growth, on termination were observed in vivo on a 
plasmid based Pol I minigene. In their analysis a torpedo-like termination mechanism was 
suggested to function even in the absence of the Rnt1-dependent cleavage. In cells carrying 
Pol I minigenes, which lack the Rnt1-cleavage site, a second - `failsafe` - cleavage site at the     
T-rich region of T1 by a not yet identified endonuclease was proposed. Alternative cleavage at 
the T-rich element and the presence of an intact Reb1 binding site are crucial for efficient 
transcription termination. Cleavage at this site should allow co-transcriptional recruitment of 
the exonuclease Rat1 (Braglia et al., 2010b). Additionally the Pol I subunit A12.2 seems to play a 
role in termination (Prescott et al., 2004). 
Taken together, there is a discrepancy between the rather conclusive in vitro data about Reb1 
and the in vivo termination analyses. Furthermore, it is difficult to distinguish between 
transcription termination and processing events at the proposed second - `failsafe` - cleavage 
site at the T-rich region since 5` and 3` ends of the resulting transcripts were not mapped.  
To clarify these controversies, the establishment of an in vivo system consisting of several DNA 
cis-elements will help to study termination in more detail. 
 
1.2.5 Pre-rRNA processing and maturation of ribosomes 
 
Three of the four ribosomal RNA species in yeast (18S, 5.8S, and 25S) are transcribed by RNA 
polymerase I as a single polycistronic precursor, the 35S pre-rRNA. This precursor is 
subsequently matured in a complex series of co- and post-transcriptional processing steps to 
yield the mature RNAs. In yeast, a subset of ribosomal proteins and ribosomal biogenesis 
factors along with diverse small nucleolar ribonucleoprotein particles (snoRNPs) assemble to 
the precursor rRNA in the course of transcription to establish the initial 90S pre-ribosomal 
particle. The first detectable pre-rRNA transcript (35S) is thought to be co-transcriptionally 
cleaved at site B0 (Henras et al., 2004). U3 snoRNP dependent endonucleolytic cleavages at 
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sites A0, A1, and A2 occur next. These processing events are strongly coupled and involve base 
pairing of U3 snoRNA with ETS1 and 18S rRNA sequences (Hughes and Ares, 1991; Beltrame 
and Tollervey, 1992). Processing at site A2 finally leads to separation of the pre-40S and pre-60S 
particle containing either the 20S or the 27SA2 pre-rRNA species, respectively. The pre-40S 
particle is exported to the cytoplasm where it is converted into the mature small ribosomal 
subunit by cleavage of the 20S pre-rRNA at site D, producing the 18S rRNA. Further, processing 
of the 27SA2 pre-rRNA into the mature 5.8S and 25S rRNAs through several exo- and 
endonucleolytic digestion steps occurs by two alternative pathways (Figure 8). For 
comprehensive and detailed description of each processing step see (Nazar, 2004; Henras et 
al., 2008) and references therein.  
 
 
Figure 8. Pre-rRNA processing scheme in Saccharomyces cerevisiae 
The upper panel shows a schematic drawing of the 35S pre-rRNA transcript with the locations of the respective 
processing sites. The central panel depicts the successive processing steps from the 35S to the 32S pre-rRNA within the 
pre-90S particle. An endonucleolytic cleavage event separates the processing pathways of the pre-40S and the pre-60S 
particle, both of which are illustrated in the two lower panels. Subsequent conversion of the 20S pre-rRNA and the 27SA2 
pre-rRNA into the mature rRNA species is shown. The intermediate rRNA species and the implications of diverse exo- and 
endonucleolytic cleavage activities are depicted, as are the cell compartments where the respective processing steps 
occur. (from Henras et al., 2008) 
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Contrary to the pre-40S particle, all rRNA species of the pre-60S particle are matured completely 
before the particle is exported to the cytoplasm (Figure 8) (Venema and Tollervey, 1995; 
Tschochner and Hurt, 2003; Fromont-Racine et al., 2003; Henras et al., 2008). Although there are 
differences in the pre-rRNA processing and modification pathways between yeast and mammals, 
the overall sequence of maturation events in eukaryotes seems very related, since trans-acting 
factors involved in ribosome biogenesis are highly conserved (Henras et al., 2008). The 
modifications like cytosine-methylation or pseudouridylation are most probably important for 
ribosome function, rather than for ribosome biogenesis. However, the modifications could be 
structural checkpoints, since the binding sites for some r-proteins of biogenesis factors might 
be formed only if the modification mark is set (Song and Nazar, 2002). 
Importantly, continuous availability of ribosomal proteins in at least stoichiometric amounts with 
the rRNA is crucial for proper maturation of ribosomal subunits. Reduced production of individual 
ribosomal proteins due to conditional depletion or r-protein gene haploinsufficiency rapidly leads 
to severe pre-rRNA processing defects (Lucioli et al., 1988; Song et al., 1996; Deutschbauer et al., 
2005; Ferreira-Cerca et al., 2005; Pöll et al., 2009). 
Although RNA polymerase I transcription proceeds in some cases unabated until the 3` ETS is 
synthesized, the nascent transcript could also be modified and cleaved co-transcriptionally in the 
ITS1, thereby immediately releasing a pre-40S particle without prior pre-90S particle formation 
(Osheim et al., 2004; Kos and Tollervey, 2010). Indeed, accurate transcription elongation by RNA  
Pol I is a prerequisite for efficient pre-rRNA processing and pre-ribosome assembly             
(Schneider et al., 2007). Similarly, two independent studies revealed a subset of early assembling 
non-ribosomal proteins to be implicated not only in accurate pre-rRNA processing but also in 
efficient rDNA transcription (Gallagher et al., 2004; Prieto and McStay, 2007). Additionally, depletion 
of the Pol II elongation factor Spt4, which is similarly involved in the Pol I system, results in           
pre-rRNA processing defects (Schneider et al., 2006). These observations indicate that efficient 
rRNA elongation and rRNA processing are closely linked and therefore have to be tightly regulated 
(Granneman and Baserga, 2005). 
 
1.2.6 Regulation of Pol I transcription and ribosome biogenesis 
 
Survival of a cell critically relies on its ability to respond to environmental signals. 
Consequently, living organisms sense and react to the availability of nutrients. Ribosome 
biogenesis is an energetically very costly process in the cell that has to be tightly regulated in 
response to nutrient and energy conditions. Prokaryotic cells mainly regulate ribosome 
synthesis at the level of rDNA transcription and translational feedback mechanisms (Wagner, 
2002; Magnusson et al., 2005; Suthers et al., 2007). Each prokaryotic cell has to deal with fast 
changing environmental conditions. Nutrient depletion, in particular amino acid starvation 
triggers the so-called `stringent response` on ribosome biogenesis. 
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The common pathway in eukaryotes of sensing nutrient availability and other environmental 
conditions, is mediated by the TOR (target of rapamycin) kinase (Powers and Walter, 1999; 
Lempiäinen and Shore, 2009). TOR kinase is found in two structural and functional diverse 
complexes termed TORC1 and TORC2 (TOR kinase complex 1 or 2). The TORC1 is sensitive to 
stress and lack of nutrients (mimicked by the drug rapamycin). The main functions of TORC2 
are the regulation of the cytoskeleton dynamics and the AGC kinase family                         
(protein kinase A, G, C) (Cybulski and Hall, 2009).  
TOR signaling has been shown to affect the complex process of ribosome biogenesis on the 
levels of transcriptional regulation of the polymerases, translation initiation, RNA processing, 
and internuclear and nucleo-cytoplasmic transport processes. 
For example, nutrient deprivation or rapamycin treatment of eukaryotic cells results in a rapid 
decrease in Pol I transcription rates (Grummt et al., 1976; Zaragoza et al., 1998; Powers and 
Walter, 1999). Therefore, the activity of RNA polymerase I and thus ribosome biogenesis is 
apparently strictly regulated in a TOR-dependent manner. In yeast cells following      
rapamycin-induced TOR inactivation, the amount of Pol I-Rrn3 complexes is decreased as is the 
association of Pol I with both the promoter and the transcribed region of the rDNA locus, 
nicely resembling the situation in stationary phase (Claypool et al., 2004; Philippi et al., 2010). 
This suggests that in yeast the rate of Pol I transcription is strongly dependent on the 
formation of Pol I-Rrn3 complexes.  
Since in yeast Rrn3 as well as Pol I are described to be phosphorylated in vivo (Bell et al., 1976; 
Buhler et al., 1976a; Bréant et al., 1983; Fath et al., 2001), TOR signaling was speculated to 
influence the formation of Pol I-Rrn3 complexes via phosphorylation-dephosphorylation 
cascades in a growth-dependent manner. Indeed, in vitro experiments suggest that Pol I needs 
to be phosphorylated for binding to Rrn3, whereas the latter is able to bind to Pol I in its 
unphosphorylated form (Fath et al., 2001). The level of Rrn3 was recently reported to gradually 
decrease in rapamycin treated yeast cells due to the combination of proteasome-dependent 
degradation and a reduction in the neo-synthesis rate of this factor (Philippi et al., 2010). The 
decrease in Pol I occupancy at the rDNA locus following rapamycin treatment could be further 
attenuated in a mutant strain expressing an A43-Rrn3 fusion protein, thereby preventing not 
only the degradation of Rrn3 but also its dissociation from Pol I. This strain termed CARA for 
Constitutive Association of Rrn3 and RPA43, was largely insensitive to rapamycin treatment 
and TORC1 inhibition. Concomitantly, the decline in 35S pre-rRNA synthesis is also significantly 
retarded in these cells (Laferté et al., 2006). Although all these observations suggest distinct 
roles for Rrn3-levels and for the phosphorylation status of both Rrn3 and Pol I in the regulation 
of Pol I-Rrn3 complex formation and thus Pol I transcription, little is known about the 
underlying regulatory mechansims.  
However, TOR inactivation affects ribosome biogenesis in yeast not only at the level of Pol I 
transcription initiation but also the elongation rate of the polymerase seems to be regulated in 
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a growth-dependent manner (Zhang et al., 2009, 2010). It is suggested that the elongation 
factor Paf1C plays a TOR-dependent role in the modulation of rRNA production. Besides Pol I 
transcription, TOR inactivation was also shown to specifically and rapidly down-regulate the 
RNA polymerase II-dependent transcription of ribosomal protein (RP) genes (Powers and 
Walter, 1999; Cardenas et al., 1999). Transcription by Pol II is similarly decreased following 
impaired TOR signaling in the Ribi-regulon consisting of the ribosome biogenesis (Ribi) genes 
coding for auxiliary ribosome biogenesis factors (Jorgensen et al., 2002, 2004). Consecutive 
analysis revealed several transcription regulators and transcription factors such as Sch9, Sfp1, 
Fhl1, and Ifh1 whose activity or binding to RP and Ribi gene promoters, respectively, is 
controlled by TOR signaling via alterations in their cellular localization or abundance 
(Jorgensen et al., 2004; Marion et al., 2004; Schawalder et al., 2004; Rudra et al., 2005). Another 
factor which may be directly involved in downregulation of RNA Pol I and RNA Pol III 
transcription following rapamycin treatment is TORC1 itself. A nuclear fraction of TORC1 
associates with the rRNA gene promoter and the 5S rRNA gene locus under normal growth 
conditions but leaves the nucleus in the presence of rapamycin or upon nutrient deprivation 
(Li et al., 2006). TOR inactivation obviously mediates the transcriptional downregulation of all 
components required for ribosome biogenesis. However, the activity of RNA polymerase I 
seems to play a superior role in this process, since the artificial stabilization of Pol I 
transcription in rapamycin-treated CARA mutant cells attenuates the decrease in the level of 
both r-protein mRNAs and 5S rRNAs produced by Pol II and Pol III, respectively (Laferté et al., 
2006). In addition to transcription, general translation is also severely compromised upon TOR 
inactivation due to the impaired function of various translation factors (Barbet et al., 1996). 
One downstream consequence of rapamycin treatment is the activation of Gcn2 kinase which, 
in turn, phosphorylates the α-subunit of eukaryotic initiation factor 2 (eIF2α), thus inhibiting 
translation initiation (Cherkasova and Hinnebusch, 2003). TOR inactivation further affects 
translation initiation by the degradation of elF4G, an essential protein required for mRNA 
translation via the 5` cap-dependent pathway in yeast (Berset et al., 1998). 
Strikingly, it was shown that not only Pol I transcription is repressed following rapamycin 
treatment, but also 35S pre-rRNA processing is severely and rapidly affected, thereby nearly 
abolishing the production of mature ribosomal RNAs (Powers and Walter, 1999). This could be 
due to direct TOR-dependent inactivation of ribosome biogenesis factors and/or to the 
transcriptional downregulation of genes controlled by the Ribi regulon, leading to rapid 
depletion of protein factors involved in rRNA maturation. Another example for TOR-mediated 
effects on RNA metabolism is the specific inhibition of r-protein mRNA splicing, induced by 
amino acid starvation (Pleiss et al., 2007). Finally, evidence exists suggesting that TOR signaling 
is involved in the control of pre-ribosomal transport processes. TOR inactivation leads to a 
rapid nucleolar entrapment of various ribosome biogenesis factors, thereby causing cessation 
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of late rRNA maturation steps and defects in the nuclear-cytoplasmic translocation of            
pre-ribosomal particles (Honma et al., 2006; Vanrobays et al., 2008). 
During eukaryotic ribosome biogenesis, misfolded or misassembled precursors are detected, 
polyadenylated by the TRAMP (Trf4p-Air1/2p-Mtr4p polyadenylation) complex and 
subsequently degraded by the exosome (Dez et al., 2006; Schneider et al., 2007; Wery et al., 
2009). The absence of the non-essential nuclear exosome component Rrp6 conferres RNA 
stabilization and leads to hyperadenylation (Dez et al., 2006). 
 
1.2.7 Posttranslational modifications of RNA polymerase I 
 
Protein phosphorylation-dephosphorylation is often seen as as a mechanism of modulating 
the activity of enzymes (Fischer and Krebs, 1955; Cohen, 2002). The importance of this 
reversible posttranslational modification as a common regulatory concept emerged already in 
the early 1970s (Holzer and Duntze, 1971). 
In 1976, two research groups identified, independently from one another, five RNA  
polymerase I subunits (A190, A43, A34.5, ABC23 and ABC19) as in vivo phosphorylated proteins 
(Bell et al., 1976; Buhler et al., 1976b). Considerable in vitro data argue for a regulatory role of 
Pol I phosphorylation by modulating the enzyme at the different stages of the transcription 
cycle (Fath et al., 2001, 2004; Bier et al., 2004).  
Since Pol I is phosphorylated in vivo, TOR signaling was speculated to influence the Pol I-Rrn3 
complexe formation via phosphorylation-dephosphorylation. 
Up to date, detailed analyses of phosphorylation sites and their function in eukaryotic RNA 
polymerases have been largely limited to the carboxy-terminal domain (CTD) of the largest Pol 
II subunit, which was subject to many investigations due to its importance for Pol II 
transcription (Phatnani and Greenleaf, 2006). Recently Jochen Gerber identified 13 RNA 
polymerase I specific phosphorylation sites through chemical derivatization of 
phosphopeptides and mass spectrometry (Gerber et al., 2008). Furthermore, additional Pol I 
phosphosites are described in the proteome-wide approaches by Ficarro et al. (2002) and         
Li et al. (2007). These findings served as a starting point for the mutant-analysis of these 
phosphosites to investigate their role in regulation. A list of all identified phosphosites is 
shown in Table 2.  
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Table 2. Identified RNA polymerase I phosphorylation sites 
Subunit Phosphosite Reference 
A190 S354 (Gerber et al., 2008) 
 S685 (Gerber et al., 2008) 
 S936 or S941 (Gerber et al., 2008) 
 S1413 or S1415 or S1417 (Ficarro et al., 2002) 
 S1636 (Li et al., 2007b) 
A43 S208 (Gerber et al., 2008) 
 S220 (Gerber et al., 2008) 
 S262 or S263 (Gerber et al., 2008) 
 S285 (Gerber et al., 2008) 
A34.5 S10 or S12 or S14 (Li et al., 2007b) 
ABC23 S102 (Gerber et al., 2008) 
AC19 T33 (Gerber et al., 2008) 
 T51 or T54 or T55 (Li et al., 2007b) 
 
Additionally to the posttranslational modification by phosphorylation, A190 was shown to be a 
substrate for sumoylation in yeast (Panse et al., 2004). 
The largest Pol II subunit Rpb1 was found to be a substrate for the E3 ubiquitin-protein ligase 
Rsp5 (Huibregtse et al., 1997; Crews, 2003). The mapped ubiquitination-sites are conserved in 
A190 (Somesh et al., 2005; Kuhn et al., 2007), but as Rpb1 ubiquitination seems to depend on 
the CTD-domain (Huibregtse et al., 1997; Somesh et al., 2007) it is unclear whether a similar 
mechanism exists for Pol I. 
 
 
1.3 Objectives 
 
Several objectives covering the Pol I transcription cycle and its regulation have been set. 
First, it is difficult to distinguish between primary and secondary effects after inactivation of the 
TOR pathway in eukaryotic cells since the multiple processes leading to mature ribosomes 
appear to be intimately linked. Following rapamycin treatment or nutrient deprivation, 
transcription by all three RNA polymerases, general translation, as well as pre-rRNA processing 
are substantially down-regulated or exhibit severe defects (see 1.2.6). In order to timely resolve 
the response of transcription and pre-rRNA processing to rapamycin treatment, we 
investigated effects on both processes shortly after TOR inactivation (after 15 min).  
Second, our laboratory data suggested that the phosphorylation pattern of Pol I is crucial for 
association and dissociation of the Pol I-Rrn3 complex (Fath et al., 2001, 2004). However, all 
phosphorylation sites identified so far in Pol I and Rrn3 turned out not to be required for this 
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process (Gerber et al., 2008). To elucidate common principles and specific features in 
eukaryotic transcription, the further characterization of the created phosphosite mutants, the 
identification and functional analysis of additional Pol I mutants, namely the synthetic lethal 
mutant (rpa190 S685D / Δrpa12), the putative A43-Rrn3 interaction mutant (A43 S141/143D) as 
well as the lethal mutant of the non essential Pol I subunit A12.2 (A12.2 DE/AA), in vivo and      
in vitro should be tackled in this work. 
Third, most knowledge about RNA elongation comes from studies with RNA Pol II and bacterial 
polymerases (Stefanovsky et al., 2006; Schneider et al., 2007). Specific elongation factors, first 
described for Pol II, allow the transcription complex to pass physical barriers. Other factors 
facilitate transcription from chromatin templates in vitro. Furthermore, the termination factor 
Reb1 which was described to bind to the terminator in vitro does not bind to the terminator    
in vivo. It is unclear yet how and if these factors contribute to efficient Pol I transcription in vivo. 
Therefore an in vivo system should be established which should allow to analyse elongation 
and termination of RNA polymerase I in more detail.  
Furthermore, a major aim of this work was to set up an in vivo screen to identify and 
characterize Pol I specific elongation- and termination factors. The established in vivo screen 
should be suitable to further characterize the Pol I mutants mentioned above with the focus on 
elongation and termination. In the long term this system should help both to determine the 
requirements for transcription elongation and termination and to screen for putative Pol I 
specific elongation and termination factors. 
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2 RESULTS 
 
 
2.1 In vivo analysis for RNA polymerase I mutants 
 
2.1.1 Functional analysis of RNA polymerase I phosphomutants 
 
The functions of the many Pol I phosphosites are unknown. Primary analysis of single 
mutations of the Pol I phosphosites to either alanin or aspartic acid, to mimic constitutively 
dephosphorylated or phosphorylated states, showed no apparent impact on the growth 
behavior in vivo (Gerber, 2008). Creating clusters of Pol I phosphomutants or looking for 
genetic interaction partners of these phosphomutants in a synthetic lethal screen are 
strategies to further investigate the in vivo role of these phosphosites and to obtain more 
information about their contribution in the regulation of Pol I. Furthermore, additional Pol I 
phosphorylation sites might still exist since it is possible that only the constitutive, but not the 
transient phosphosites were detected in Jochen Gerber´s approach. 
For further analysis of the Pol I phosphomutants, Johannes Felixberger and I continued the 
mutagenesis to generate strains with several mutated Pol I phosphosites. A list of the created 
Pol I phosphomutants is shown in Table 3.  
The mutant yeast strains were obtained by introducing the vectors with the mutated genes 
into the corresponding plasmid-shuffle strain for the respective five Pol I subunit genes, using 
either canavanine- or 5-FOA-counterselection (depending on the genotype of the strain) 
(Sikorski and Boeke, 1991). Since A34.5 is a non-essential protein, the vectors containing 
mutant alleles of this gene were simply transformed into a Δrpa34 strain.  
Several to all phosphosites of one subunit were mutated and tested for complementation of 
the wild-type subunit (for A190 mutants see Felixberger, 2009). A43 phosphomutants were 
generated by splicing by overlap extension-PCR (SOE-PCR) (Horton et al., 1989; Pogulis et al., 
1996) (see Figure 45 for schematic mutagenesis strategy). 
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Table 3. RNA polymerase I phosphorylation site mutations 
Pol I subunit Mutation 
A190 S354A 
 S354D 
 S685A 
 S685D 
 S936/941A 
 S936/941D 
 S936D 
 S941D 
 S936E 
 S941E 
 S1413/1415/1417A 
 S1413/1415/1417D 
 S1636A 
 S1636D 
 S936/941A S1413/1415/1417A 
 S354A S936/941A S1413/1415/1417A 
 S354A S685A S936/941A S1413/1415/1417A 
 S354A S685A S936/941A S1413/1415/1417A S1636A 
 S354D S685D 
 S1413/1415/1417D S1636D 
 S936/941D S1413/1415/1417D S1636D 
 S354D S685D S936/941D S1413/1415/1417D S1636D 
A43 S208A 
 S208D 
 S220A 
 S220D 
 S208/220A 
 S208/220D 
 S262A 
 S262D 
 S263D 
 S262/263/265A 
 S262/263D 
 S285A 
 S285D 
 S208A S220A S262/263A 
 S208A S220A S262/263A S285A 
 S220D S262/263D 
 S208D S220D S262/263D  
 S208D S220D S262/263D S285D 
A34.5 S10/12/14A 
ABC23 S102A 
 S102D 
AC19 T33A 
 
RESULTS 
25 
The capability of the Pol I A43 phosphosite mutants to complement the loss of their wild-type 
subunits was checked in the plasmid-shuffle strains on full media YPD agar plates at 16°C, 24°C, 
30°C, and 37°C (Figure 9). Plasmid-shuffling was controlled on appropriate synthetic media 
plates to check for the presence of the mutant copy vector, the loss of the wild-type vector, 
and the maintenance of the original RPA-gene deletion. Isogenic wild-type strains carrying the 
same plasmid without mutations of the respective RPA-gene served as a control in each case. 
All A43 mutants fully complement the loss of the wild-type subunit and show no significant 
growth phenotype (Figure 9).  
 
 
Figure 9. Single and combined mutations of the phosphorylated amino acids of A43 have no effect on growth 
Experiments were performed with the strain D101-I2 transformed with the respective phosphosite mutation vectors. 
Plasmid-shuffling and maintenance of the chromosomal deletion was controlled via the respective auxotrophic markers. 
The 5-FOA-shuffle system was used for the creation of the Pol I phosphosite mutants of A43. Strains were spotted in serial 
dilutions on YPD plates and grown at different temperatures for 2-3 days before pictures were taken. Growth on YPD 
plates at 30°C is shown as an example. (A) Single and (B) combined RPA43 mutations.  
 
Additionally, Johannes Felixberger created A190 mutant strains with all A190 phosphosites 
either mutated to alanin or aspartic acid using a variation of the site-specific            
mutagenesis-strategy by Muhlrad (Muhlrad et al., 1992). All of the created mutants could 
complement the wild-type A190 subunit and showed no significant growth defect on 6AU 
plates (Felixberger, 2009). 6AU, which lowers the free pool of UTP and GTP by interfering with 
their biosynthesis pathways, is commonly used to test for defects in transcription elongation 
(Hampsey, 1997; Schneider et al., 2007).  
 
RESULTS 
26 
Furthermore, the sensitivity of phosphomutant strains to DNA damaging agents such as 
methyl methanesulfonat (MMS), causing double stranded DNA breaks, and ultraviolet (UV) 
radiation, causing thymine dimers in DNA (Ide et al., 2010), was addressed. Using different 
concentrations of MMS (from 0% to 0,01%) and different UV doses (from 0 J/m2 to 400 J/m2) no 
significant growth-phenotype of the phosphomutants compared to wild-type cells was 
detected by spotting serial dilutions of the cultures on YPD (MMS)- or YPD-plates prior to      
UV-treatment, respectively (data not shown). 
Interestingly, the mutation rpa190 S685D was found to be synthetic lethal (SL) with a deletion 
of the non-essential Pol I subunit A12.2 (Reiter, 2007). In a continuative approach the newly 
created mutations of A43 phosphoserines to aspartic acid were tested for genetic interaction 
with selected non essential yeast genes (see Reiter, 2007 for detailed description of the 
synthetic lethal (SL) screen). Results of the small-scale SL screen are depicted in Table 4.  
 
Table 4. No phenotype was detected in a small-scale SL screen for mutations of A43 phosphoserines to aspartic 
acid in combination with selected gene deletions (blue field indicates the absence of a growth phenotype) 
 
 
Since no synthetic lethal phenotype was detected, a large scale screen for genetic interactions 
of the A43 phosphosite/A or phosphosite/D mutants (all phosphosites are mutated either to 
alanin or aspartic acid) with a library of all non-essential yeast genes according to the slightly 
modified GIM-method (Genetic Interaction Mapping) (Decourty et al., 2008) was carried out. 
This screen was performed by Johannes Felixberger in collaboration with Christophe Normand 
from the lab of Olivier Gadal in Toulouse in the course of the PICS program. No genetic 
interaction partner of the A43 phosphomutants could be identified in this approach 
(Felixberger, 2009).  
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Thus, it appears that the so far identified phosphosites do not primarily contribute to the 
regulation of Pol I since no phenotype was detected yet. 
 
2.1.2 Characterization of a putative A43-Rrn3 interaction mutant 
 
It is possible that transient phosphorylation is required for the regulation of Pol I. Such 
regulatory transient phosphosites are often found within the contact surface of interacting 
proteins. Mutant analysis of A43 revealed a highly conserved region in A43 which is probably 
important for the interaction with Rrn3 (Peyroche et al., 2000). Furthermore, the structural data 
of the A14/A43 subcomplex could show that most of the conserved amino acids are located on 
the upstream surface region of A43 (Kuhn et al., 2007; Geiger et al., 2008). These data suggests 
the presence of a putative A43-Rrn3 interaction surface. Therefore, selected serine residues 
within or nearby the conserved surface region, which could be putative phosphorylation sites, 
were mutated to alanin and aspartic acid, respectively. Mutagenesis was done by SOE-PCR on 
the plasmid pRS314-RPA43 (pGP5). A list of the mutated residues and the location of the 
chosen residues in the A43 structure can be seen in Figure 10A-C.  
Complementation of the loss of the wild-type protein by the mutated Pol I subunit was 
checked in the RPA43 plasmid-shuffle strain. Wild-type strains carrying the same vector 
without mutations of the RPA43 gene as well as strains carrying an empty vector served as 
controls. Interestingly, only cells with the rpa43 S141/143D but not the rpa43 S141/143A 
mutation are unable to grow because they cannot complement the loss of the wild-type 
subunit, resulting in a lethal phenotype (Figure 10D). 
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Figure 10. A mutation in the putative A43-Rrn3 interaction site leads to a lethal phenotype  
(A) Mutated serines in the putative A43-Rrn3 interaction site. (B) Sequence alignment of the conserved domain between 
orthologues of the A43 subunit. S.c., Saccharomyces cerevisiae; C.a., Candida albicans; S.p., Schizosaccharomyces pombe; 
M.m., Mus musculus; H.s., Homo sapiens. Black boxes indicate the residues identical in at least three sequences. The black 
line localizes a 15 residue motif highly conserved from yeast to human. The asterisks indicate the three residues mutated 
in the protein encoded by the rpa43-6 allele. The red dots indicate the mutated S48, S141, S143 and S156 residues within 
the conserved A43 domain. (from Peyroche et al., 2000) (C) Left: Surface representation of the A14/43 complex. Residues 
conserved among eight selected Saccharomycotinae are colored in green, orange, and yellow, according to decreasing 
conservation. Residues affected by the A43-6 mutations (Peyroche et al., 2000) are in red. (from Kuhn et al., 2007)       
Right: Position of the mutated serines on the surface representation of the A14/43 complex. Mutated serines as well as 
the mutated Q140, K63 residues in the A43-6 mutant are shown in yellow. (D) Growth of RPA43 shuffle strain D101-I2 
transformed with an empty vector as well as wild-type (WT) vector and mutated RPA43 vectors is shown on SDC + 5-FOA 
plates incubated at 30°C. Plasmid shuffling and maintenance of the chromosomal deletion was controlled via the 
respective auxotrophic markers. Strains were grown at different temperatures for 2-3 days before pictures were taken.  
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In vitro and in vivo experiments were carried out to further analyse this A43 mutant with regard 
to A43-Rrn3 complex formation or Pol I recruitment to the promoter.  
For in vitro analyses the serine residues 141/143 were mutated either to alanin or aspartic acid 
in the expression-vector pET21b A14/A43, kindly provided by Sebastian Geiger from the 
laboratory of Patrick Cramer. Protein expression and purification from E. coli BL21 (DE3) cells, 
except for the thrombin-cleavage step, were performed as described (Kuhn et al., 2007).            
A silver-stained SDS-gel of the purified A14/A43 heterodimers (A43 WT, A43 S141/143A,           
A43 A141/143D) is shown in Figure 11. 
 
Figure 11. Silver-stained SDS-gel of purified recombinant yeast A14/A43 heterodimers containing either           
wild-type A43 (WT) or the A43 mutants (S141/143A and S141/143D)  
Expression of recombinant proteins and purification via a Ni-NTA column was performed as described in (Geiger et al., 
2008) from the expression vector pET21b A14/A43. An internal ribosomal entry site was introduced before A43 to enable 
bicistronic expression.1μg of total protein of each preparation was loaded and separated on a NuPAGE® 4-12% gradient 
gel. The corresponding bands for A14 and A43 on the silver-stained gel are marked with a star. 
 
Initial experiments to test the recombinant A14/A43 (WT/A/D) heterodimer for Rrn3 complex 
formation with immunopurified Rrn3 from yeast were carried out but could not give any 
conclusive results (data not shown). 
Parallel to these studies with recombinant proteins, in vivo studies with wild-type and mutant 
A43 were performed (Felixberger, 2009). Therefore C- and N-terminally FLAG-tagged as well as 
untagged versions of A43 wild-type, A43 S141/143A and A43 S141/143D were cloned in the 
YCplac22-pGAL vector. Plasmids were transformed in RPA43 shuffle-strains D101-I2, D101-I2 
A135-TEV-ProtA and D101-I2 Rrn3-TEV-ProtA. A wild-type version of A43 is co-expressed in 
these strains. Incorporation of the mutated subunits in the polymerase as well as interaction of 
the mutants with Rrn3 was checked by co-immunoprecipitation. The Co-IP experiments of the 
mutant A43 subunits and the polymerase performed with ANTI-FLAG M2 beads show that the 
mutated A43 subunits are incorporated into the polymerase to the same extent as the         
wild-type subunit (Felixberger, 2009). This result excludes that the lethal phenotype of the            
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A43 S141/143D mutation originates from incorrect assembly of the subunit to the polymerase. 
Occupancy of the mutated Pol I at the rDNA promoter and throughout the rDNA was analysed 
by ChIP in which the FLAG-tagged A43 subunit (wild-type and mutants) was                                
co-immunoprecipitated with rDNA chromatin. One could emphasize that the mutant 
polymerase co-precipitates only about 40-50% of rDNA chromatin at the promoter and that 
general Pol I occupancy throughout the rDNA gene is lowered compared to wild-type 
(Felixberger, 2009). Whether this is due to a disturbance in A43-Rrn3 interaction still remains 
unclear. The detailed findings of this work are summarized in the diploma thesis of Johannes 
Felixberger (Felixberger, 2009).  
Taken together, it should be noted that conclusive statements on the interaction of the 
mutated A43 subunits with Rrn3 could not be drawn since, in the performed experiments, the 
co-expressed untagged A43 wild-type version from the constitutive endogenous promoter is 
in direct competition with the FLAG tagged A43 versions for Pol I incorporation and Rrn3 
interaction. Furthermore it remains unclear whether the mutated serine residues are in vivo 
phosphorylated. In vivo and in vitro experiments to further characterize these lethal mutations 
should be carried out. 
 
2.1.3 Analysis of the Pol I synthetic lethal mutant rpa190 S685D / Δrpa12 
 
As mentioned earlier (see 2.2), one phosphosite mutant showed a synthetic lethal phenotype 
in combination with the deletion of the non-essential Pol I subunit A12.2 (Gerber et al., 2008). 
Deletion of RPA12 alone leads to a temperature-sensitive growth phenotype. It is suggested 
that in the absence of A12.2, the assembly of A190 into a stable Pol I structure is partially 
defective and the free A190 subunit is subject to proteolytic degradation (Nogi et al., 1993). 
Increased synthesis of A190 increases the amount of Pol I containing A190 to some extent, 
leading to partial suppression of growth defects at higher temperatures.  
For further analysis of the rpa190 S685D / Δrpa12 SL-mutant, conditional yeast strains were 
established revealing the SL phenotype after shifting the cells from galactose to glucose. 
Therefore vectors were constructed containing the genes for RPA190 wild-type or                  
S685 mutants (S/A or S/D), respectively, as well as the gene for RPA12 expressed from a       
galactose-inducible promoter. Vectors were transformed in the A190 shuffle strain deleted in 
RPA12 and cells were grown in YPG medium after plasmid-shuffling. Shuffling was controlled 
on different synthetic media to check for presence of the mutant vector, the loss of the       
wild-type plasmid, and the maintenance of the original RPA-gene deletion. A schematic view 
of the established yeast strains and serial dilutions of conditional strains with A190 wild type, 
A190 S685A and A190 S685D mutations on YPG and YPD plates at 30°C are shown in         
Figure 12A. An isogenic wild-type strain carrying the same vector with a wild-type copy of 
RPA190 served as a control. All, wild-type and mutated Pol I subunits, could complement the 
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loss of the wild-type protein on YPG plates where A12.2 is expressed. However, shift of the cells 
to glucose, which results in a depletion of A12.2, leads to a severe growth phenotype of the 
strain expressing the A190 S685D mutant which can be seen in Figure 12B. 
 
 
Figure 12. Combination of rpa190 S685D and Δrpa12 mutations is synthetic lethal 
(A) Schematic view of established conditional strains exemplified for an rpa190 mutant. Endogenous RPA190 and RPA12 
are deleted by URA3- or KanMX4-genes, respectively. Cells of the A190-shuffle strain (NOY222 Δrpa12) grow on galactose 
containing media by expressing the wild-type RPA12 from a galactose-inducible promoter and wild-type or mutant A190 
subunit, respectively, from the same low copy plasmid. Shifting of cells from galactose- to glucose containing media 
leads to a depletion of A12.2 and subsequently emerges the SL-phenotype of the rpa190 S685D/Δrpa12 mutations.        
(B) Serial dilutions of the respective wild-type (y1600) and mutant strains (y1601 (S685A), y1602 (S685D)) on galactose 
and glucose-plates at 30°C are shown as an example. Strains were grown at different temperatures for 2-3 days before 
pictures were taken. 
 
In growth curves an effect of the SL mutations can be detected 14-16h after shift to glucose 
(data not shown). Since both mutations are in Pol I, we wanted to confirm that the                    
SL-phenotype is due to impaired Pol I activity. Thus, we performed pulse experiments in which 
logarithmically growing yeast cells were pulsed with [3H]-uracil for 30 min before shifting to 
glucose as well as 8h, 10h, 12h, 14h, and 16h after the shift, respectively. RNA was extracted 
and seperated on a denaturing TBE/urea/acrylamide gel to distinguish the small 5.8S from the 
5S rRNAs. Since the 5.8S rRNA derives from the Pol I transcribed 35S rRNA precursor and the 5S 
rRNA is transcribed by Pol III, changes in transcription activity of the two polymerases in the 
mutants can be directly compared after the shift to glucose (Figure 13A). After 12-14h the 
signals for the processed Pol I transcripts 25S, 18S, and 5.8S rRNA get weaker compared to the 
signal of the Pol III transcribed 5S rRNA in the rpa190 S685D / Δrpa12 mutant in comparison to 
the wild-type. This indicates that the two mutations lead to a non-functional Pol I. As a 
consequence of this, cell growth is heavily impaired leading to the synthetic lethal phenotype. 
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Figure 13. Pol I but not Pol III transcription is impaired in the conditional SL mutant rpa190 S685D / Δrpa12 after 
shift to glucose for 12-14h 
Experiments were performed in yeast strains y1600 (WT), y1601 (S685A) and y1602 (S685D). (A) [3H]-uracil metabolic 
labeling of newly synthesized RNA. Cells were pulsed for 30 minutes at 30°C before and at the indicated times after shift 
to glucose containing media. Total RNA was extracted and separated by gel electrophoresis. RNA was blotted on a 
positively charged nylon membrane and a [3H]-imaging-screen (FUJI) was applied for 2 days before signals were detected 
with the FLA-3000 imaging system (FUJI). Signals for 25S-, 18S-, 5.8S-, and 5S rRNA as well as for smaller tRNAs are 
indicated. Pol III transcripts are marked by an asterisk. Ethidium bromide (EtBr) staining of RNA serves as a loading 
control. (B) Quantification of the 5.8S/5S ratio at the indicated times after shift to glucose in the three analysed strains 
normalized to the ratio of the corresponding non-shifted strain which was arbitrarily set to 1. Signal intensities for 
quantification of the obtained 5.8S and 5S signals were determined with the MultiGauge software (FUJI). 
 
Keeping the temperature-sensitive phenotype of the RPA12 deletion in mind, which is 
probably caused by partially defective assembly of the A190 subunit into a stable polymerase 
(Nogi et al., 1993), one could imagine that the rpa190 S685D phosphosite mutation could 
enhance this ts-phenotype. Since Van Mullem and co-workers reported that the N-terminal 
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zinc domain is sufficient to cure the ts-phenotype (Mullem et al., 2002), we created a 
conditional system for the expression of wild-type A12.2 as well as for N-terminally (aa69-125) 
and C-terminally (aa1-69) truncated A12.2 variants to verify if the presence of the N-terminal 
domain of A12.2 rescues the SL-phenotype. For this purpose the Tet-Off expression system was 
used. The Tet-system was originally developed for mammalian cells (Gossen and Bujard, 1992) 
and is based on a tetracycline-controlled transactivator protein (tTA), which is composed of the 
Tet repressor DNA binding protein (TetR) from E. coli fused to the strong transactivating 
domain of VP16 from Herpes simplex virus. It regulates expression of a target gene that is 
under transcriptional control of a tetracycline-responsive promoter element (TRE). The TRE is 
made up of Tet operator (tetO) sequence concatemers fused to a minimal promoter. In the 
absence of tetracycline (Tc) or its analogon doxycyclin (Dox), tTA binds to the TRE and activates 
transcription of the target gene. In the presence of Tc or Dox, tTA can not bind to the TRE, and 
expression from the target gene remains inactive (Baron and Bujard, 2000). One advantage of 
this expression system is that expression can be precisely regulated via the concentration of Tc 
or Dox in the media. In S. cerevisiae this system is mainly used to characterize essential proteins, 
which can be done either by using yeast-specific expression vectors, containing the tTA-gene 
and the tetO-promoter, or by direct integration of these two elements into the yeast genome 
through homologous recombination. In our case we used a slightly modified version of the 
pCM182 yeast expression vector (Garí et al., 1997) in which the TRP1 marker was replaced by a 
LEU2 marker from YCplac111 to make it compatible with the markers used in the analysed 
yeast strain. RPA12 wild-type, rpa12-ΔC (aa1-69), and rpa12-ΔN (aa69-125) were PCR-amplified 
and cloned into the MCS of the modified pCM182-LEU2. The obtained vectors and an empty 
vector control were transformed in the wild-type and mutant strains, and serial dilutions were 
spotted on GAL, GLC, GAL + Dox and GLC + Dox plates (final Dox concentration 10 μg/ml).        
A schematic overview of the used strains and expected results exemplified for the N-terminally 
truncated A12.2 version as well as the results from the serial dilutions are depicted in         
Figure 14B-C. This data shows that the N-terminal domain of A12.2 alone is sufficient to rescue 
the SL phenotype which could argue for a destabilized Pol I as the main reason for the growth 
inhibition. 
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Figure 14. Expression of the A12.2 N-terminus rescues the SL phenotype of the rpa190 S685D / Δrpa12 mutant 
(A) Partial deletions of A12.2. Growth pattern: strain SL9-6b (Δrpa12) was transformed with pCM185 derivatives bearing 
wild type or partly deleted RPA12 mutants. Cells were spotted and incubated at 25°C and 34°C for 4–5 days. A12.2 
fragments are symbolized by open boxes. The black boxes denote invariant cysteines (from Mullem et al., 2002).              
(B) Schematic representation of the conditional yeast strain with galactose-dependent expression of wild-type A12.2 and 
an N-terminally truncated A12.2 (69-125) version expressed from a doxycyclin (Dox)-repressed promoter, when Dox is 
missing. Expected survival on different growth conditions for the N-terminally truncated A12.2 (aa69-125) version is 
shown to the right. (C) Experiments were performed in yeast strains y1600 (WT), y1601 (S685A) and y1602 (S685D). Spots 
of respective strains transformed with the indicated Tet-Off vectors (left) on different SC-leu plates (GAL, GLC, GAL + Dox, 
GLC + Dox) are shown. Plates were incubated for 3-4 days at 24°C before pictures were taken, to exclude possible             
ts-effects caused by A12.2 variants. 
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To confirm that the mutations cause a Pol I assembly phenotype we wanted to compare the 
amount of co-precipitated Pol I subunits in wild-type and mutant strains (Pilsl, 2010).                  
A semi-quantitative mass spectrometry approach (iTRAQ®, Applied Biosystems) was used. 16h 
after shift to glucose, the polymerases were purified via the TEV-ProtA-tagged A135 subunit in 
the corresponding yeast strains. The associated proteins were digested with trypsin, labeled 
with the iTRAQ reagents, and analysed by mass spectrometry (MALDI TOF/TOF). A135 is the 
second largest Pol I subunit and part of the core polymerase. Early Pol I assembly defects 
should be detected by different subunit stoichiometry of the co-purified Pol I complexes. 
Indeed, these preliminary results indicate that subunit assembly is affected in the SL mutant, 
since A190 and associated subunits like A43, ABC27, ABC23, and A14 seem to be partially 
depleted from the complex (Figure 15), arguing for an impaired assembly of A190 and 
subsequently associated subunits in the SL mutant polymerase (Nogi et al., 1993; Lanzendörfer 
et al., 1997). However, this experiment should be repeated to confirm these results. 
 
 
Figure 15. The synthetic lethal phenotype is probably caused by impaired assembly of A190 and subsequently 
associated subunits  
Semi-quantitative mass spectrometric comparison of co-purified Pol I subunits from mutant and WT cells shifted to 
glucose (left panel) as well as mutant cells overexpressing A12.2 and WT cells (right panel). Experiments were performed 
in yeast strains y2043 (WT), y2044 (S685A) and y2045 (S685D). RNA polymerase I was purified via its TEV-ProtA tag on 
subunit A135 from cell lysates of both, wild-type strain and respective mutant strains depleted for RPA12, as well as for a 
control strain y2045 not depleted for RPA12. For a detailed description of iTRAQ labeling see 5.2.6. The relative iTRAQ 
ratio of purified Pol I subunits for both, shifted SL-mutant (S685D) and shifted corresponding wild-type (WT), indicating 
an enrichment or depletion of co-purified subunits is shown in the left panel. The relative iTRAQ ratio of purified Pol I 
subunits for both, non-shifted SL-mutant (S685D) and shifted corresponding wild-type (WT) showing the depletion of 
A12.2 is depicted in the right panel. A mean value, with the corresponding standard deviation of all identified peptides of 
a single protein is depicted. The name of the respective yeast protein is given below each bar followed by the number of 
identified peptides in parentheses.  
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2.1.4 Characterization of a dominant negative A12.2 mutation 
 
The Pol I subunit A12.2 seems to be not only involved in Pol I assembly and complex stability 
but was also reported to play a role in RNA cleavage, transcript elongation and termination 
(Kuhn et al., 2007; Mullem et al., 2002; Prescott et al., 2004). Although deletion of the                  
C-terminal domain does not lead to a temperature-sensitive phenotype as found for the          
N-terminus, it contains a highly conserved motif (Q.RSADE..T.F), which is also present in the   
Pol II elongation factor TFIIS (see 1.2.2). 
The two acidic residues (DE) in the conserved motif were shown to be crucial for the 
mechanism of TFIIS-induced RNA cleavage (Jeon et al., 1994; Kettenberger et al., 2003). 
Mutation of the same residues in C11 (the Pol III counterpart) is lethal (Chédin et al., 1998). An 
intrinsic RNA cleavage activity which was shown to be dependent on the C-terminal domain of 
A12.2 is responsible for shortening the RNA from the 3` end in an artificially stalled ternary 
complex in vitro (Kuhn et al., 2007).  
In collaboration with the laboratory of Patrick Cramer, Jochen Gerber created a mutant of the 
Pol I subunit A12.2 to investigate the role of this subunit in the intrinsic Pol I RNA cleavage 
activity. The two above mentioned acidic residues in the conserved C-terminal motif were 
replaced by alanines in A12.2, resulting in the mutant rpa12 D105A E106A (A12.2 DE/AA) 
(Gerber, 2008). Paradoxically, the mutation of these two amino acids in a dispensable part of a 
non-essential protein leads to a lethal phenotype. To further investigate this phenomenon, 
plasmids were constructed in which the genes for the wild-type A12.2 and the mutant A12.2 
DE/AA are expressed from a galactose-inducible promoter. Under the repressing glucose 
conditions all strains behaved like the RPA12 deletion strain showing the described                    
ts-phenotype (Nogi et al., 1993). On galactose plates, the knock-out was complemented by the 
wild-type A12.2 as judged by the ability to grow at 37°C. In contrast, after induction of A12.2 
DE/AA mutant-expression, no colonies were formed at any incubation temperature (Figure16), 
confirming the observation that this mutation apparently results in a lethal phenotype.  
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Figure 16. Overexpression of the mutated Pol I subunit A12.2 D105A E106A, containing the mutations in the 
highly conserved C-terminal motif (Q.RSADE..T.F), is lethal 
Experiments were performed with the strain y601 (BY4741 Δrpa12) transformed with the vectors YCplac111-pGAL, 
YCplac111-pGAL-RPA12, or YCplac111-pGAL-rpa12 DE/AA. Strains were spotted on plates containing either glucose           
(no expression) or galactose (expression) and grown at different temperatures for 2-3 days before pictures were taken. 
(from Gerber, 2008) 
 
The phenotype of the rpa12 DE/AA mutation is suppressed at higher temperatures. The 
constructed plasmids (YCplac111-pGAL, YCplac111-pGAL-RPA12 or YCplac111-pGAL-rpa12 
DE/AA) were transformed in the EUROSCARF wild-type strain BY4741 and A12.2 versions were            
co-expressed with endogenous A12.2 wild-type. Serial dilutions of the corresponding strains 
were spotted on glucose- and galactose containing plates, respectively (Figure 17). 
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Figure 17. The dominant negative phenotype of the rpa12 DE/AA mutation is suppressed at higher temperatures 
in wild-type strains 
Experiments were performed with the strain y206 (BY4741) transformed with the vectors YCplac111-pGAL,           
YCplac111-pGAL-RPA12, or YCplac111-pGAL-rpa12 DE/AA. Strains were spotted in serial dilutions on plates containing 
either glucose (no expression) or galactose (expression) and grown at different temperatures for 2-3 days before pictures 
were taken.  
 
Note that the phenotype of the rpa12 DE/AA mutation is attenuated in strains endogenously 
expressing wild-type A12.2 at low temperatures and disappears at higher temperatures.  
Interestingly, the N-terminal FLAG-tag on A12.2 shows no effect on the lethal phenotype of the 
DE/AA mutation, whereas the C-terminal FLAG-tag suppresses the lethal phenotype and 
additionally rescues the Δrpa12 ts-phenotype at 37°C (Figure 18), indicating, that the lethal 
phenotype is suppressed most probably by sterical hindrance introduced by the C-terminal 
FLAG-tag. 
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Figure 18. C-Terminal FLAG-tag rescues the lethal phenotype induced by the A12.2 DE/AA mutant 
Experiments were performed with the strain y601 (BY4741 Δrpa12) transformed with the vectors YCplac111-pGAL, 
YCplac111-pGAL-RPA12, YCplac111-pGAL-rpa12 DE/AA, YCplac111-pGAL-FLAG, YCplac111-pGAL-FLAG-RPA12, or      
YCplac111-pGAL-FLAG-rpa12 DE/AA) (A) and with the vectors YCplac111-pGAL, YCplac111-pGAL-RPA12,                    
YCplac111-pGAL-rpa12 DE/AA, YCplac111-pGAL-RPA12-FLAG, or YCplac111-pGAL-rpa12 DE/AA-FLAG) (B). Strains were 
spotted in serial dilutions on plates containing either glucose (no expression) or galactose (expression) and grown at 
different temperatures for 2-3 days before pictures were taken. 
 
To investigate whether these mutations impair Pol I transcription and do not induce general 
toxicity, we performed RNA pulse labeling experiments in BY4741 Δrpa12 (y601) transformed 
with YCplac111-pGAL, YCplac111-pGAL-RPA12, or YCplac111-pGAL-rpa12 DE/AA before, as 
well as 2h, 4h, and 8h after shifting the cells to galactose. Logarithmically growing yeast cells 
were pulsed with [3H]-uracil for 15 min. RNA was extracted and separated by denaturing 
agarose gel electrophoresis to resolve the larger rRNAs as well as on a denaturing 
TBE/urea/acrylamide gel to resolve the smaller 5.8S rRNA and the Pol III transcribed 5S rRNA. 
An autoradiograph of the blotted RNA is shown in Figure 19. 
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Figure 19. The lethal A12.2 DE/AA mutant affects primarily Pol I transcription 
Experiments were performed with the strain y601 (BY4741 Δrpa12) transformed with the vectors YCplac111-pGAL, 
YCplac111-pGAL-RPA12, or YCplac111-pGAL-rpa12 DE/AA. Cells were grown overnight in selective media containing 
glucose before shift to YPG to induce expression of A12.2 variants. One OD600 of cells was withdrawn at the indicated 
times for [3H]-uracil metabolic labeling of newly synthesized RNA. Cells were pulsed for 15 min at 30°C. Total RNA was 
extracted and separated by gel electrophoresis. Radio-labeled RNA was visualized by fluorography. 
 
It appears that Pol I transcription, but not pre-rRNA processing is severely affected after shift to 
galactose for 8h since no signal accumulation of a rRNA precursor over the mature rRNA is 
detected. Signal intensity and thus transcription is generally reduced in the mutant compared 
to wild-type (Figure 19, compare lane 12 to lane 11). It is also apparent that Pol I transcription is 
primarily affected compared to Pol III transcription (Figure 19, compare 5.8S rRNA to 5S rRNA in 
lanes 10-12). The signal intensity for the Pol III transcribed 5S rRNA also declines 8h after the 
shift. This is probably due to secondary effects of the lethal phenotype. By creating single 
mutants of the acidic residues D105 and E106 to alanin via SOE-PCR we tried to dissect the 
lethal mutation. Vectors were transformed in BY4741 Δrpa12 (y601) and corresponding strains 
were spotted in serial dilutions on glucose- and galactose containing plates (Figure 20). The 
single mutations alone also generate a severe growth phenotype (D105A more severe than 
E106A) but no lethality. 
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Figure 20. Overexpression of the single mutants A12.2 D105A and A12.2 E106A exhibits a severe growth 
phenotype but is not lethal 
Experiments were performed with the strain y601 (BY4741 Δrpa12) transformed with the vectors YCplac111-pGAL, 
YCplac111-pGAL-RPA12, YCplac111-pGAL-rpa12 D105A, YCplac111-pGAL-rpa12 E106A, or YCplac111-pGAL-rpa12 DE/AA. 
Strains were spotted in serial dilutions on plates containing either glucose (no expression) or galactose (expression) and 
grown at different temperatures for 2-3 days before pictures were taken.  
 
In RNA pulse labeling experiments, effects on Pol I transcription compared to Pol III 
transcription are evident in all mutant strains (Figure 21, compare 5.8S rRNA to 5S rRNA). Only 
slight differences are detectable among the mutants (Figure 21, compare lane 6, 8, and 10) 
after 8h of induction.  
As the control strain with the transformed empty vector also shows comparable defects after 
shift to galactose, it seems that the EUROSCARF yeast strain BY4741 Δrpa12 (y601) generally 
acts sensitive upon shift to galactose.  
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Figure 21. The single mutants A12.2 D105A, A12.2 E106A and the double mutant A12.2 DE/AA impair Pol I but not 
Pol III transcription 
Experiments were performed with the strain y601 (BY4741 Δrpa12) transformed with the vectors YCplac111-pGAL, 
YCplac111-pGAL-RPA12, YCplac111-pGAL-rpa12 D105A, YCplac111-pGAL-rpa12 E106A, or YCplac111-pGAL-rpa12 DE/AA. 
Cells were grown overnight in selective media containing glucose before shift to YPG for expression of A12.2 variants. 
One OD600 of cells was withdrawn at the indicated times for [
3H]-uracil metabolic labeling of newly synthesized RNA. Cells 
were pulsed for 15 min at 30°C. Total RNA was extracted and separated by gel electrophoresis. Radio-labeled RNA was 
visualized by fluorography.  
 
Therefore all following experiments were carried out in the yeast strain background W303-1a, 
which is commonly used in shift experiments. Vectors were transformed in W303-1a and 
W303-1a Δrpa12 (y1597) to test for the above described phenotypes after shift to galactose in 
the new strain backgrounds by spotting serial dilutions of the corresponding strains on 
glucose and galactose containing plates. 
The growth phenotype of the rpa12 D105A, E106A and DE/AA mutations is attenuated in 
strains endogenously expressing wild-type A12.2 at low temperatures and disappears at 
higher temperatures whereas the lethal effect prevails in the Δrpa12 genetic background (data 
not shown). Occurring phenotypes are as described in the BY4741 and BY4741 Δrpa12 (y601) 
strain background.  
To investigate correct subunit incorporation of the wild-type and mutated A12.2 subunits into 
the polymerase, the A135 subunit was TEV-ProtA-tagged as described in (Knop et al., 1999). 
Since no antibody detecting the A12.2 subunit is available in the lab, N-terminal FLAG-tagged 
versions of the A12.2 wild-type and mutants were cloned. Vectors were transformed in     
W303-1a Δrpa12 RPA135-TEV-ProtA to test for the presence of the described phenotypes after 
shift to galactose by spotting serial dilutions of the corresponding strains on glucose and 
galactose containing plates. A135-TEV-ProtA-tagging and N-terminal FLAG-tagging of A12.2 
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wild-type and mutants did not affect the described phenotypes (data not shown).                        
A co-immunoprecipitation of the FLAG tagged A12.2 mutants in the Pol I complex via               
IgG-coupled magnetic beads immunoprecipitating the A135 subunit was performed to 
analyse assembly of the mutant subunits to the enzyme. However, correct integration could 
not be clearly shown in this preliminary experiment (Pilsl, 2010). Yet, it can be assumed that a 
correct incorporation takes place since strains carrying the N-terminal FLAG-tag show the same 
phenotype as untagged strains. For example, the galactose induced expression of tagged 
A12.2 rescues the ts-phenotype of a deletion strain at 37°C. Furthermore, Michael Pilsl used 
chromatin-immunoprecipitation (ChIP) experiments to determine whether the association of 
the polymerase with the rDNA varies in the different mutants. First indications that Pol I is less 
associated to rDNA in the mutants, pointing to problems in Pol I initiation or early elongation, 
could be detected. For more detailed information see (Pilsl, 2010). Nevertheless, these 
experiments should be repeated to reproduce the obtained results. 
 
Taken together, in the performed Pol I mutant analyses no phenotype could be detected in the 
investigated Pol I phosphomutants. Furthermore a putative Pol I-Rrn3 interaction mutant 
could be generated and initially characterized. Analysis of the described Pol I synthetic lethal 
mutant (Reiter, 2007) could give indications for the possible role of the A190 S685 phosphosite 
in enzyme assembly, and the characterization of a lethal A12.2 mutant could reveal the 
possible role of the A12.2 C-terminus in transcript cleavage and/or early elongation. However, 
to elucidate at which exact stages the mutations affect the Pol I transcription process further  
in vivo analyses of the mutant enzymes are necessary. 
 
 
2.2 Regulation of ribosome synthesis upon environmental changes 
 
The activity of RNA polymerase I and thus ribosome biogenesis is apparently strictly regulated 
in a TOR-dependent manner. As a cause of rapamycin-induced TOR inactivation, the amount of 
Pol I-Rrn3 complexes is decreased as is the association of Pol I with both the promoter and the 
transcribed region of the rDNA locus (Claypool et al., 2004; Philippi et al., 2010). This suggests 
that in yeast the rate of Pol I transcription is strongly dependent on the formation of Pol I-Rrn3 
complexes.  
Since in yeast Rrn3 as well as Pol I is described to be phosphorylated in vivo (Bell et al., 1976; 
Buhler et al., 1976a; Bréant et al., 1983; Fath et al., 2001), TOR signaling was speculated to 
influence the formation of Pol I-Rrn3 complexes via phosphorylation-dephosphorylation 
cascades in a growth-dependent manner.  
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However, the dramatic reduction of rRNA synthesis in the immediate cellular response to 
impaired TOR signalling cannot be explained by the simple down-regulation of Rrn3 and       
Pol I–Rrn3 levels (Philippi et al., 2010).  
As indicated in the introduction (1.2.6) TOR inhibition appears to affect ribosome biogenesis 
on many different levels: (a) transcriptional regulation of all three polymerases, (b) translation 
initiation, (c) RNA processing, and (d) internuclear and nucleo-cytoplasmatic transport 
processes.  
It has become increasingly difficult to distinguish between primary and secondary effects on 
ribosome biogenesis in the yeast Saccharomyces cerevisiae since the multiple processes 
leading to mature ribosomes appear to be intimately linked. To determine the target 
mediating the fast response to TOR inactivation we performed an in-depth analysis of yeast 
cellular phenotypes after 15 min of rapamycin treatment. Rapamycin treatment mimics 
nutrient starvation of cells by specifically inactivating the kinase activity of TORC1. Since the 
inhibition of translation by cycloheximide treatment leads to very similar pre-rRNA processing 
defects (de Kloet, 1966; Udem and Warner, 1972; Warner and Udem, 1972), this drug can be 
used as a tool to directly compare the effects of short-term rapamycin treatment and 
cycloheximide treatment on rRNA neo-synthesis in pulse-chase experiments. Therefore, yeast 
strains RRN3-TAP-A43-3xHA (y658), and a wild-type BY4741 (y206) were grown in YPD at 30°C 
to mid-log phase before cultures were split in three parts and further cultivated in YPD either 
in the absence or in the presence of rapamycin or cycloheximide, respectively. After 15 min of 
treatment, same amounts of cells were pulsed for 5 min with [3H]-uracil and chased with an 
excess of unlabeled uracil for 4 min, 8 min, and 16 min. Total RNA was isolated and analysed by 
denaturing agarose gel electrophoresis with subsequent Northern blotting and 
autoradiography (Figure 22A-B). To exclude effects of rapamycin or cycloheximide on the 
cellular [3H]-uracil uptake, experiments were performed after pulse labeling where samples 
were taken twice for untreated cells (black) and three times after 15 min treatment (gray) 
(Figure 22C). Note, that the [3H]-uracil uptake was only moderately affected after 15 min 
rapamycin or cycloheximide treatment. 
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Figure 22. Short-term rapamycin or cycloheximide treatment lead to severe pre-rRNA processing defects while 
[3H]-uptake is only moderately affected after 15 min treatment 
Experiments were performed with yeast strains y658 (A), and y206 (B). Strains y658 (expressing 3xHA-tagged Pol I 
subunit A43 and TAP-tagged Rrn3), and y206 (BY4741) were grown in YPD at 30°C to mid-log phase before the cultures 
were split in three parts and further cultivated in YPD either in the absence or in the presence of rapamycin (200 ng/ml) 
or cycloheximide (100 μg/ml) for 15 min. Pulse labeling with [3H]-uracil was performed for 5 min followed by a chase with 
an excess of unlabeled uracil (final concentration 1 mg/ml) for the times indicated above the panel. RNA was isolated, 
separated in a denaturing agarose gel, and transferred to a positively charged nylon membrane. The autoradiogram 
shown was obtained after exposure of the membrane treated with EN3HANCE solution. Positions of the different rRNA 
processing products are indicated on the left. (C) Data for y685 is depicted as an example. Quantitative analysis of        
[3H]-uracil incorporation into 25S rRNA (top) was determined by excision of the 25S rRNA bands from an identical blot 
and analysis by liquid scintillation counting. The values obtained were normalized to the value after 5 min pulse (0) of the 
culture grown for 15 min in YPD, which was arbitrarily set to 1, and plotted against the time of the chase. Cellular          
[3H]-uracil uptake moderately decreases upon rapamycin and cycloheximide treatment for 15 min (bottom). 
Exponentially growing yeast strains were cultured in the absence (YPD) or presence of rapamycin (200 ng/ml) or 
cycloheximide (100 μg/ml) for the times indicated. Pulse-labeling with [3H]-uracil was performed for 5 min. The              
cell-associated [3H]-label was determined. The values obtained were normalized to the value after 5 min pulse (0 min) of 
the culture grown in YPD, which was arbitrarily set to 1. The experiment was performed twice for untreated cells        
(black bars) and in triplicate for cells after 15 min treatment (gray bars).  
 
Untreated cells showed wild-type levels of newly synthesized 35S pre-rRNA, which was 
subsequently processed to the intermediate 27S and 20S rRNA and finally to the mature 25S 
and 18S rRNA (Figure 22A-B, lanes 1-4). Strikingly, in both rapamycin and cycloheximide 
treated cells, strong maturation defects could be detected resulting in the relative 
accumulation of labeled 35S pre-rRNA. Although the initial 35S pre-rRNA levels were 
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comparable to those observed in untreated cells, the amounts of intermediate rRNA and 
mature rRNA were strongly reduced in rapamycin-treated cells and almost completely lost in 
cycloheximide-treated cells (Figure 22A-B, lanes 5-12). Furthermore, the incorporation of          
[3H]-uracil into the mature 25S rRNA was quantified for all strains as a measure of ribosome 
neo-production (Figure 22C). 15 min of TOR inactivation were sufficient to decrease the        
neo-synthesis of 25S rRNA to less than 10%, whereas the effect in cells inhibited in translation 
for the same time was even stronger. These results suggest that inhibition of translation by 
cycloheximide for 15 min leads to severe defects in pre-rRNA maturation comparable to those 
observed after short-term TOR inactivation by rapamycin.  
Since the pool of “free” ribosomal proteins is limited due to their fast turnover rate and rapid 
assembly into pre-ribosomal particles (Gorenstein and Warner, 1977; Kruiswijk et al., 1978; 
Wittekind et al., 1990) and since ribosome biogenesis defects are observed after conditional 
shutdown of individual r-proteins (Ferreira-Cerca et al., 2005, 2007; Pöll et al., 2009), we 
compared neosynthesis of r-proteins upon short-term rapamycin treatment and treatment 
with different concentrations of cycloheximide. Experiments were performed by Robert 
Steinbauer. To this end, yeast strains were cultured in either the absence or presence of 
rapamycin or cycloheximide for 15 min prior to pulse-labeling of proteins with                          
[35S] methionine-cysteine. After extraction, [35S]-incorporation into total protein was 
determined. Proteins were separated in 16% urea gels and analysed by Coomassie staining 
and autoradiography. 
Total protein production decreased to around 50% to 60% of the value in the untreated 
sample after 15 min of rapamycin treatment (Figure 23B). Downregulation of protein synthesis 
was virtually identical when cells were treated with 0.1 μg/ml cycloheximide, the lowest 
concentration used in the experiment (Figure 23B). However, when we analysed                    
[35S]-incorporation into specific polypeptides after urea gel electrophoresis and 
autoradiography, we found that neosynthesis of a group of small proteins was specifically 
affected upon the addition of rapamycin but not in the presence of 0.1 μg/ml cycloheximide 
(Figure 23C, compare lanes 8 and 9 in top panels; the region of interest is marked by a black 
bar on the left side of the autoradiogram, enlarged in the bottom panels). Most of these 
proteins migrated with the same velocity as r-proteins derived from an affinity-purified 80S 
ribosome (Figure 23C, bottom panels, compare lane 1 with lanes 2 and 8). We focused on the 
apparent level of neosynthesized proteins in two prominent bands (Figure 23C, bottom 
panels, asterisks), for which we unambiguously identified further r-proteins as major 
components by mass spectrometry. We found that production of these proteins was only 
moderately affected in the presence of 0.1 μg/ml cycloheximide, whereas they were no longer 
detectable in the rapamycin-treated sample (Figure 23C, lanes 8 to 10 in the bottom panels). 
[35S]-labeling of these proteins was similar, however, in cells treated with concentrations of 1 to 
10 μg/ml cycloheximide (Figure 23C, bottom panels; compare lanes 9, 11, and 12). 
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Figure 23. The defect in ribosomal subunit synthesis upon TOR inactivation correlates with shutdown of r-protein 
production (experiments performed by Robert Steinbauer) 
(A to C) r-protein production is severely and specifically affected shortly after rapamycin treatment. Panel (A) shows a 
flow chart of the experiment presented in panel (C). Two wild-type yeast strains (y6 (W303-1a) and y207 (BY4742)) were 
grown to exponential phase (OD600 of 0.5) at 30°C in SCD medium lacking methionine and cysteine (SCD-Met-Cys). Each 
culture was split in six parts, and rapamycin (200 ng/ml; RAPA), or cycloheximide (0.1, 1, 10 or 100 μg /ml; CHX) was 
added, with one of the samples remaining untreated. After another 15 min at 30°C, pulse-labeling with                              
[35S] methionine-cysteine was performed for 5 min. (B) Protein was isolated, and relative [35S]-incorporation was 
determined. Values were normalized to the value obtained for the untreated cells growing in SCD-Met-Cys medium. The 
average and standard deviation of two independent biological replicates of strain y6 are shown. (C) Protein from the 
different samples described above, as well from affinity-purified 80S ribosome (80S), was separated in a 16% 
polyacrylamide urea gel. Total protein was detected with Coomassie blue, whereas neosynthesized proteins were 
detected after autoradiography of the gel. The position of a subset of proteins whose neosynthesis is specifically 
inhibited in the presence of rapamycin is marked by a bar on the left side of the autoradiogram. This area is enlarged for 
lanes 1 and 2 and 8 to 12 in the lower panels. Two asterisks mark protein bands whose major components have been 
unambiguously identified as r-proteins by mass spectrometry. The experiment shown is from an analysis of strain y6. 
Identical results were obtained for strain y207 (modified from Reiter et al., 2011). 
 
Thus, upon rapamycin treatment the production of r-proteins is specifically inhibited, which 
might be caused by the combination of downregulation of general translation (Barbet et al., 
1996) and the strong reduction in r-protein mRNA levels (Powers and Walter, 1999; Warner and 
Gorenstein, 1978). 
It was recently postulated that the transcriptional activity of RNA polymerase I is a key 
determinant for the level of all ribosome components (Laferté et al., 2006). A yeast mutant 
strain was described whose RNA polymerase I molecules remain constitutively competent for 
initiation of transcription under stress conditions due to the expression of an A43-Rrn3 fusion 
protein (Laferté et al., 2006). In this CARA mutant, the downregulation of Pol I transcription 
upon rapamycin treatment is attenuated, resulting concomitantly in a derepression of Pol II 
transcription that is restricted to the genes encoding ribosomal proteins. To estimate the 
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influence of the described CARA phenotype and to analyse whether this attenuated decrease 
in the mRNA levels of ribosomal proteins leads to increased neo-synthesis of these proteins, 
[35S]-pulse experiments including the corresponding wild-type strain YPH500 as an appropriate 
control were performed under the same rapamycin and cycloheximide conditions by Robert 
Steinbauer (Steinbauer, 2010). In both cases the same reduction in the expression levels of 
ribosomal proteins was detected as observed for strain y6 (W303-1a) and y207 (BY4742) 
(Steinbauer, 2010). To directly correlate the reduction in r-protein production with the 
reduction in ribosome production, pulse-chase experiments with [3H]-uracil were performed in 
the same strains used for the protein analysis (Figure 24).  
 
Figure 24. Neosynthesis of r-proteins correlates with production of mature rRNAs 
(A) Experiments were performed in strains y6 (W303-1a), y207 (BY4742), y2172 (YPH500), and y2171 (CARA). For           
[3H]-uracil pulse-chase experiments strains were grown in YPD at 30°C to mid-log phase before the cultures were split in 
six parts and further cultivated in YPD either in the absence or in the presence of rapamycin (200 ng/ml) or cycloheximide 
(0,1-100 μg/ml as indicated) for 15 min. Pulse labeling with [3H]-uracil was performed for 5 min followed by a 16 min 
chase with an excess of unlabeled uracil (final concentration 1 mg/ml). RNA was isolated, separated in a denaturing 
agarose gel, and transferred to a positively charged nylon membrane. The autoradiogram shown was obtained after 
exposure of the membrane treated with EN3HANCE solution. Positions of the different rRNA processing products are 
indicated on the left. (B) The relative [3H]-incorporation in 25S rRNA was determined by excision of the 25S rRNA bands 
from an identical blot and analysis by liquid scintillation counting. The values obtained after a 5 min pulse followed by a 
16 min chase were normalized to the value obtained for the cultures grown for 15 min in YPD medium, which were 
arbitrarily set to 1. 
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As expected, production of mature rRNAs was severely impaired upon rapamycin treatment 
(Figure 24B). In the presence of 0.1 μg/ml cycloheximide, a concentration that reduces total 
protein production (but not r-protein production) to the level observed after rapamycin 
treatment (Figure 23B), robust 25S rRNA synthesis could still be observed (Figure 24B). In 
contrast, the defect in 25S rRNA production was virtually identical in rapamycin-treated cells 
and cells incubated at concentrations of 1 to 10 μg/ml cycloheximide (Figure 24B), in which     
r-protein production was similarly affected (Figure 23B). Thus, there is a very good correlation 
between r-protein production and rRNA synthesis.  
Since the imbalance of structural components of the ribosome is then presumably adjusted by 
rapid degradation of misassembled, excess rRNA precursors and since the exosome is one of 
the most important protein complexes involved in maintaining correct RNA levels in 
eukaryotic cells (Mitchell et al., 1997), we constructed a Δrrp6 mutant to see whether there is an 
enrichment of polyadenylated rRNAs after rapamycin or cycloheximide treatment. Rrp6 is a 
non-essential exosome subunit which conferres RNA stabilization and leads to 
hyperadenylation (Dez et al., 2006). 
Pules-chase experiments with the strain y1697 (BY4741 Δrrp6) revealed no significant 
differences in rRNA synthesis after rapamycin or cycloheximide treatment compared to its 
corresponding wild-type strain BY4741 (see Figure 25). 
 
 
Figure 25. Short-term rapamycin or cycloheximide treatment leads to severe pre-rRNA processing defects in 
strain BY4741 Δrrp6 
Strain y1697 (BY4741 Δrrp6) was grown in YPD at 30°C to mid-log phase before the culture was split in three parts and 
further cultivated in YPD either in the absence or in the presence of rapamycin (200 ng/ml) or cycloheximide (100 μg/ml) 
for 15 min. Pulse labeling with [3H]-uracil was performed for 5 min followed by a chase with an excess of unlabeled uracil 
(final concentration 1 mg/ml) for the times indicated above the panel. RNA was isolated, separated in a denaturing 
agarose gel, and transferred to a positively charged nylon membrane. The autoradiogram shown was obtained after 
exposure of the membrane treated with EN3HANCE solution. Positions of the different rRNA processing products are 
indicated on the left. 
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Furthermore, no difference was detected in an isolation of polyadenylated RNAs in the strain 
BY4741 Δrrp6, using biotinylated oligo-T primers, after rapamycin or cycloheximide treatment 
compared to untreated cells (data not shown). Our experiments indicate that in addition to 
Rrp6 other RNases participate in pre-rRNA degradation after TOR inactivation. 
 
We conclude that rapid depletion of the endogenous pool of “free” r-proteins is sufficient to 
explain the observed defects in rRNA processing and other prominent phenotypes observed in 
the quick response to TOR inactivation.  
 
 
2.3 Establishment of an in vivo system to study Pol I elongation 
 
To identify and characterize Pol I mutants or factors involved in transcription elongation we 
tried to establish an in vivo Pol I elongation assay. Our primary goal was to use this in vivo 
elongation assay to characterize the above mentioned Pol I mutants (section 2.1.1 – 2.1.4). The 
idea was to generate an artificial roadblock for Pol I which reduces elongation efficiency, but 
does not completely block transcription, and therefore leads to a reduced growth rate. This 
reduced growth rate was expected to be further affected if Pol I elongation is impaired due to 
the lack of an elongation factor or a deficient Pol I subunit. The roadblock should be generated 
by integration of a DNA sequence for a protein binding site in each of the 150 to 200 rDNA 
repeats. This could be done by the genetic manipulation of yeast strains. To this end, different 
DNA binding sites for DNA binding proteins such as LacI, LexA, TTF-I, the 601 nucleosome 
positioning sequence (Lowary and Widom, 1998) were integrated at the AflII restriction site 
between the 18S rRNA and 5.8S rRNA gene in every rDNA copy (Figure 26B).  
For details in strain construction see 5.2.1.6. 
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Figure 26. Generated strains with genetically modified 35S rRNA coding sequences  
(A) Schematic scetch of yeast rDNA manipulation. Linearized vector pT11 containing a modification of the rDNA locus 
(yellow) and flanking sites for homologous recombination (blue) is transformed in the yeast strain NOY989 for 
recombination and expansion of the modified rDNA. Restriction sites for linearization of pT11 are marked as black 
triangles. (B) Cartoon of a yeast rDNA repeat. The positions of the 5S rRNA gene and the 35S rRNA gene including the      
5` and 3` external transcribed spacers (ETS), the internal transcribed spacers (ITS) 1 and 2 and the coding sequences for 
the mature 18S, 5.8S, and 25S rRNAs, as well as several cis elements (rDNA enhancer binding protein binding site (Reb1), 
the RNase III (Rnt1) cleavage site, and the replication fork barrier (RFB)) are indicated. An arrow depicts the Pol I 
transcription initiation site. Either one TTF-I binding site, three LexA binding sites, a binding site for the Lac-repressor 
protein as well as one or two 601 nucleosome positioning sequences were introduced at the AflII restriction site in ITS1 of 
the 35S rRNA gene. Yellow: DNA binding sites for non-yeast proteins. Pink: nucleosome positioning sequences. 
 
Furthermore, for modified strains with binding sites for non-yeast proteins (TTF-I, LexA, and 
LacI), vectors with wild-type and C-terminally MNase-tagged versions of these binding proteins 
were cloned. 
Experiments with TTF-I were performed with an N-terminally truncated version (TTF-IΔN348) of 
the protein which showed a higher affinity to its binding site (Németh et al., 2004). Expression 
of these proteins is galactose-dependent, creating a conditional system in which protein 
binding and the thereby generated effects can be induced by shifting cells from glucose to 
galactose containing media. To avoid repressing effects by residual amounts of glucose, cells 
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were shifted from raffinose to galactose. Expression of binding proteins after shift to galactose 
is shown in Figure 27B. A growth phenotype is detected in spot tests with serial dilutions for 
strains carrying the TTF-I binding site on galactose containing plates when TTF-I is expressed. 
In contrast, no effect is detected on SCG-leu plates in strains carrying integrated 3xLexA 
binding sites or the binding site for the Lac repressor (Figure 27C). 
 
 
Figure 27. TTF-I expression causes a growth phenotype in the strain carrying an integrated TTF-I binding site in 
ITS1 
(A) Schematic representation of the artificial elongation-block for non-yeast DNA binding proteins (BP). Yeast strains with 
integrated protein binding sites in the ITS1 rDNA sequence are transformed with YCplac111-pGAL-BP vectors expressing 
the non-yeast DNA binding protein (BP) from a galactose-inducible promoter. After shift to galactose, the wild-type or    
C-terminally MNase-tagged versions of these binding proteins are expressed and presumably bind to their respective 
binding site. (B) Expression of the C-terminally MNase-tagged binding proteins. Yeast strains y1599 (WT), y2034 (1x LacR), 
y1598 (3x LexA) and y2038 (1x TTF-I) were transformed with the vector for expression of the respective binding protein 
and cultured to early exponential growth phase in SCR-leu at 30°C before galactose was added to a final concentration of 
2% and cells were further grown for 4 hours. Samples were taken at the indicated times and denaturing protein 
extraction was performed from two OD600 of cells. 1/8 of the extracts was separated by SDS-PAGE in a 10% 
polyacrylamide gel and transferred to a PVDF membrane. Signal for the MNase-3xHA-tagged binding proteins and for 
the Pol I subunit A135, which served as loading control, were detected in Western blot analysis using antibodies α-HA 
(3F10) and α-A135, respectively. (C) Experiments were performed with strains y1599 (WT), y2034 (1x LacR),                   
y1598 (3x LexA) and y2038 (1x TTF-I) transformed with an empty vector or with the respective plasmids for expression of 
the MNase-tagged binding proteins (YCplac111-pGAL, YCplac111-pGAL-LacI-MNase, YCplac111-pGAL-LexA-MNase, 
YCplac111-pGAL-TTF-I-MNase). Strains were spotted in serial dilutions on plates containing either glucose (no expression) 
or galactose (expression) and grown at 30°C for 2-3 days before pictures were taken.  
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To analyse whether the DNA binding proteins are able to bind to their introduced binding site 
in vivo we performed ChEC assays (Schmid et al., 2004). The factor of interest (TTF-I, LacI, or 
LexA) is expressed as a fusion protein with a C-terminal Micrococcal nuclease (MNase)-tag from 
a plasmid under the control of the galactose-inducible promoter. Cells were treated with 
formaldehyde to crosslink the DNA-bound proteins to the DNA after a shift of 4h to galactose 
for expression of the MNase-tagged binding proteins. Nuclei are prepared and incubated in a 
calcium-containing buffer to activate the MNase which should cleave the genomic DNA in the 
vicintiy of the binding site of the MNase fusion protein. After DNA isolation, the cleavage site 
introduced by the MNase can be mapped precisely to the DNA sequence by Southern blot 
analysis. Chromatin was digested with KpnI and a probe detecting fragments upstream from 
the KpnI restriction site in the 25S rDNA was used for indirect endlabeling. After induction of 
the MNase fusion protein expression DNA cleavage is detected at the expected position 3` of 
the 18S rRNA gene for TTF-I-MNase as well as for LexA-MNase (Figure 28). LacI-MNase showed 
no cleavage at the expected site, meaning that the MNase-fusion protein does not bind to the 
Lac-repressor binding site.  
 
 
Figure 28. In vivo binding of TTF-I- MNase, LacI- MNase and LexA-MNase to binding sites within the genetically 
modified 35S rRNA coding sequence  
Yeast strains y1599 (WT), y2034 (1x LacR), y1598 (3x LexA) and y2038 (1x TTF-I) transformed with vectors expressing 
either LacI-MNase, LexA-MNase, or TTF-I-MNase fusion proteins from a galactose-inducible promoter were cultured to 
early exponential growth phase in SCR-leu at 30°C before galactose was added to a final concentration of 2% and cells 
were further grown for 4h. After formaldehyde crosslinking for 15 min at 30°C cells were harvested and crude nuclei were 
isolated. The nuclei suspension was incubated in the absence (0) or presence of calcium thereby activating DNA cleavage 
by MNase fusion proteins for the times indicated on top of the panels (min). DNA was isolated, linearized with the 
restriction endonuclease KpnI, separated in an agarose gel, and analysed in a Southern blot by indirect endlabeling using 
an rDNA specific probe. The cartoon on the right shows a map of the corresponding KpnI rDNA fragment to localize the 
cleavage events mediated by the MNase fusion proteins. The positions of the rRNA coding sequences (18S, 5.8S, 25S, 5S), 
of the integrated protein binding sites (BS) (yellow) and of the target sequence of the radiolabeled probe (light gray) are 
depicted.  
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In summary, all DNA binding proteins are expressed as MNase fusion proteins but only         
TTF-I-MNase and LexA-MNase can bind to their respective introduced binding site. 
Furthermore, only in strains with an integrated TTF-I binding site a growth defect was detected 
after protein expression. 
 
We next investigated whether Pol I is paused as a consequence of TTF-I binding. To assess this, 
the Pol I subunit A190 was MNase-tagged and ChEC was performed. We observed a specific 
accumulation of Pol I (A190-MNase) upstream of the TTF-I binding site in strain y2056              
(1x TTF-I / A190-MNase), after induction of TTF-I and binding to its respective binding site, 
which indicates that Pol I is paused (Figure 29). This effect was not observed in strains with a 
3xLexA binding site and induction of LexA (data not shown). 
 
 
Figure 29. TTF-I binding accumulates Pol I upstream of the introduced TTF-I binding site in vivo 
Experiments were performed with strains y1620 (WT) and y2056 (1x TTF-I) carrying either wild-type 35S rRNA gene or one 
TTF-I binding site introduced into ITS1 of the rRNA gene. Corresponding strains expressing TTF-I from a plasmid based 
galactose-inducible promoter and A190-MNase fusion protein from its endogenous promoter were cultured to early 
exponential phase in SCR-leu at 30°C before galactose was added to a final concentration of 2% and cells were further 
grown for 4 hours. ChEC was performed as described in Figure 28. 
 
Next, we wanted to know if an intact TTF-I binding site in its natural orientation is required for 
termination of transcription. This was already shown in vitro in mammals (Henderson and 
Sollner-Webb, 1986; Gerber et al., 1997). We wanted to test whether this hypothesis is true       
in vivo and created a yeast strain carrying an inverted TTF-I binding site in the ITS1 sequence.  
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Figure 30. Inversion of the TTF-I binding site still leads to TTF-I binding but has no effect on cell growth in vivo 
Experiments were done with strains y1599 (WT), y2038 (1x TTF-I) and y2039 (1x TTF-I INV) transformed with vectors 
expressing TTF-I from a galactose-inducible promoter (YCplac111-pGAL-TTF-I, YCplac111-pGAL-TTF-I-MNase).                   
(A) No binding site (WT), one TTF-I binding site in its natural orientation (TTF-I) or one TTF-I binding site in its inverse 
orientation (INV) were introduced into ITS1 of the rRNA gene. Yeast strains were cultured to early exponential phase in 
SCR-leu at 30°C before galactose was added to a final concentration of 2% and cells were further grown for 4h. ChEC was 
performed as described in Figure 28. Signals surrounding the area of the artificial binding site are enhanced. (B) Strains 
transformed with the indicated vectors were spotted in serial dilutions on plates containing either glucose                        
(no expression) or galactose (expression) and grown at 30°C for 2-3 days before pictures were taken. 
 
Although the cleavage-signal is very weak, binding of TTF-I-MNase can be detected at the 
naturally orientated and at the inverted TTF-I binding site (Figure 30A). Interestingly, upon 
induction of TTF-I expression from a galactose-inducible promoter, a growth phenotype is 
detected only in strains carrying the correctly orientated TTF-I binding site integrated in the 
ITS1 region (Figure 30B) indicating that efficient Pol I pausing/termination in vivo is dependent 
on the right orientation of the DNA-bound termination factor.  
Furthermore, in a preliminary approach, we tried to find out whether the Pol I subunits A49 
and A12.2 are involved to pass the artificial barrier. Therefore RPA49 deletions and RPA12 
deletions were created in strains carrying the manipulated rDNA sequence with integrated 
TTF-I binding sites (correct and inverse orientation), Lac repressor binding site, 3x LexA binding 
site, aside from a wild-type control with no integrated binding site. Growth tests by serial 
dilutions of strains transformed with empty vectors as well as vectors expressing the DNA 
binding proteins from a galactose-inducible promoter are shown in Figure 31.  
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Figure 31. Deletion of RPA12 as well as RPA49 reinforces the observed growth phenotype in strains carrying the 
TTF-I binding site 
Experiments were performed in strains y1615 (WT), y2288 (1x TTF-I), y2290 (1x TTF-I INV), and y2286 (1x LacR) carrying a 
RPA49 deletion (A) and in strains y1618 (WT), y2287 (1x TTF-I), y2289 (1x TTF-I INV), y2285 (1x LacR), and y1612 (3x LexA) 
carrying a RPA12 deletion (B). Strains transformed with the indicated vectors were spotted in serial dilutions on SC-leu 
plates containing either glucose (no expression) or galactose (expression) and grown at 30°C for 2-3 days before pictures 
were taken. Strains carrying a 3x LexA binding site and a RPA49 deletion were not included in this experiment. For the 
wild-type strain carrying the RPA49 deletion and an empty vector control, less cells were spotted in general.  
 
Interestingly, TTF-I binding in the strain carrying the TTF-I binding site in its natural orientation 
in the Δrpa49 as well as in the Δrpa12 genetic background causes an even stronger growth 
reduction. For all other strains tested, neither the deletion of RPA49 nor RPA12 has an effect on 
growth. 
In summary, TTF-I binding to its introduced binding site, which is in its natural orientation, is 
able to accumulate Pol I upstream of the binding site and thereby causes a growth reduction. 
The effect on growth is enhanced if either the Pol I subunit A49 or A12.2 is missing. Both 
subunits are discussed to play a role in Pol I elongation (Kuhn et al., 2007). 
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2.4 In vivo characterization of Pol I termination 
 
2.4.1 Identification of Ydr026c as yeast Pol I termination factor 
 
In another related approach we wanted to establish an artificial rDNA termination region into 
the ITS1 sequence of every yeast rDNA unit. Therefore strains were constructed as described in 
5.2.1.6, containing a terminator element covering the Reb1 binding site and the replication 
fork barrier (RFB) sequence with Fob1 binding sites (Figure 32A). Since the DNA binding 
proteins are yeast proteins and constitutively expressed from their wild-type promoters, no 
galactose-inducible expression is needed and growth related effects of their binding can be 
directly analysed on glucose plates (Figure 32B).  
 
 
Figure 32. Integration of the enhancer region in ITS1 causes growth reduction  
(A) Cartoon of the modified yeast rDNA with integrated enhancer region in ITS1. The positions of the 5S rRNA gene and 
the 35S rRNA gene including the 5` and 3` external transcribed spacers (ETS), the internal transcribed spacers (ITS) 1 and 2 
and the coding sequences for the mature 18S, 5.8S, and 25S rRNAs, as well as several cis elements (rDNA enhancer 
binding protein binding site (Reb1), the RNase III (Rnt1) cleavage site, and the replication fork barrier (RFB)) are indicated. 
An arrow depicts the Pol I transcription initiation site. Integrated enhancer sequence contains the Reb1 binding site and 
the RFB, but not the Rnt1 cleavage site. (B) Strains carrying either no protein binding site y1599 (WT) or the enhancer 
sequence y2042 (ENH) in ITS1 were spotted in serial dilutions on YPD plates and grown at 30°C for 2-3 days before 
pictures were taken.  
 
A growth phenotype was detected in the strain carrying the enhancer sequence. We next 
wanted to know whether this growth defect is the result of protein binding to the introduced 
enhancer sequence. 
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Interestingly, the uncharacterized protein Ydr026c, which was identified as a potential DNA 
binding protein in a monohybrid assay and which appeared to bind to the terminator region 
of yeast rDNA, interacts physically with Fob1 (Mohanty and Bastia, 2004). In vivo binding of the 
designated terminator binding proteins (Reb1, Fob1 and Ydr026c) was measured with the 
ChEC method as described above. Weak cleavage at the integrated enhancer element was 
observed in ChEC experiments with Reb1-MNase, whereas a clear distinct cleavage band is 
detected for Ydr026c-MNase. Presumably Ydr026c associates to the Reb1 binding site.       
Fob1-MNase also cleaves the DNA at the RFB 3` of the terminator region (Figure 33).  
 
 
Figure 33. In vivo binding of putative terminator proteins to the integrated enhancer element in ITS1 
ChEC-experiments were performed in strains y2050 (WT) and y2054 (ENH) (A), y2051 (WT) and y2055 (ENH) (B), y2090 
(WT) and y2093 (ENH) (C) with endogenously MNase-3xHA-tagged Reb1, Fob1 or Ydr026c respectively. Either no binding 
site (WT) or the rDNA enhancer region (ENH) were introduced into ITS1 of the rRNA gene. Yeast strains endogenously 
expressing the indicated MNase fusion proteins were grown in YPD to mid-log phase. ChEC was performed as described 
in Figure 28. 
 
To determine whether Ydr026c also binds to the wild-type terminator at the Reb1 binding site, 
we performed ChEC with MNase-tagged Reb1 and Ydr026c at the terminator and the 
promoter, respectively. The wild-type yeast strain was tested in this approach. Reduced     
Reb1-MNase mediated DNA cleavage is observed at the terminator compared to the promoter 
as seen in Figure 34, which is in agreement with ChIP data from HA-tagged Reb1 reported by 
(Kawauchi et al., 2008). Interestingly, Ydr026c-MNase mediated DNA cleavage shows the 
opposite pattern with strong cleavage events at the Pol I terminator and no cleavage at the 
promoter (Figure 34).  
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Figure 34. ChEC and ChIP analyses show that Reb1 binds preferentially to the promoter and Ydr026c to the 
terminator in vivo 
ChEC- and ChIP-experiments were performed in strains y2090 (WT Ydr026c-MN) and y2050 (WT Reb1-MN). (A) ChEC at 
rDNA promoter: Wild-type yeast strains endogenously expressing the indicated MNase fusion proteins were grown in 
YPD to mid-log phase. ChEC was performed as described in Figure 28 except that DNA was linearized with the restriction 
endonuclease XcmI and analysed in a Southern blot by indirect endlabeling using an rDNA promoter specific probe. The 
cartoon on the right shows a map of the corresponding XcmI rDNA fragment to localize the cleavage events mediated by 
the MNase fusion proteins. The positions of the rRNA coding sequences (18S, 5.8S, 25S), of the Reb1 protein binding sites 
(Reb1-BS) at the promoter, and of the target sequence of the radiolabeled probe (light gray) are depicted. In the strains 
used for the experiment an artificial L-element (used for homologous recombination of the rDNA locus) of about 500bp is 
introduced between the promoter Reb1 binding site and the Pol I transcription start site in every rDNA copy. (B) ChEC at 
rDNA terminator: Wild-type yeast strains were treated as described in (A) except for linearization of prepared DNA with 
restriction endonuclease AvaII and a 5S specific probe was used for indirect endlabeling. The cartoon on the right shows 
a map of the corresponding AvaII rDNA fragment to localize the cleavage events mediated by the MNase fusion proteins. 
The positions of the rRNA coding sequences (25S, 5S), of the Reb1 protein binding sites (Reb1-BS) at the terminator as 
well as the sequence for the replication fork barrier (RFB), and of the target sequence of the radiolabeled probe           
(light gray) are depicted. (C) ChIP of Ydr026c and Reb1, respectively, at Reb1 binding sites at the promoter, terminator, 
and in ITS2 serving as an internal background control. The data presented in the bar diagram is the average of two 
independent ChIP experiments each analysed in triplicate quantitative PCR reactions. The percentage of the total input 
DNA recovered after ChIP for the different rDNA regions is depicted. For experimental procedure see 5.2.7.1. 
 
For more quantitative statements on the binding of those two factors to the promoter or 
terminator, a chromatin immunoprecipitation (ChIP) experiment was applied. With ChIP we 
could reproduce the observed ChEC data showing that Reb1 binds preferentially to the 
promoter and Ydr026c to the terminator region (Figure 34C). Since the sequence surrounding 
of the Reb1 binding sites differ at the promoter and terminator but the binding site itself is 
almost identical, the affinity for Reb1 or Ydr026c, respectively, to the binding sites might be 
altered in a sequence specific way causing a preferential binding of Ydr026c at the terminator. 
While the core consensus sequence for Reb1 binding has been identified as CGGGTAA        
(Liaw and Brandl, 1994), substantial flexibility is permissible and the adjacent nucleotides 
influence the binding affinity of Reb1 or Ydr026c (Wang and Warner, 1998). 
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Taken together, the presented data suggests that Ydr026c rather than Reb1 binds to the    
wild-type yeast rDNA terminator region and to the artificially introduced terminator in ITS1 
indicating that Ydr026c could be the yeast Pol I terminator. 
 
2.4.2 Pol I accumulates in front of an artificially introduced termination site 
 
Due to the observed growth defect in strains with an integrated enhancer sequence, we were 
interested whether Pol I pausing is a consequence of Reb1- or Ydr026c binding. As described 
for TTF-I, the Pol I subunit A190 was MNase-tagged and ChEC was performed using the      
KpnI-probe to detect Pol I pausing in the ITS1 region. When compared to wild-type strains, 
A190-MNase mediated DNA cleavage of accumulated Pol I at the expected region is detected 
only in strains with integrated enhancer (Figure 35A).  
If less polymerase is bound to the 3` rDNA region in strains with an integrated artificial 
termination site one would expect changes in the chromatin structure since polymerase free 
rDNA will eventually be packed into nucleosomes (Wittner et al., 2011). To detect changes in 
the chromatin state of the rDNA as a result of Pol I pausing at the introduced binding sites, 
psoralen analysis was performed (Conconi et al., 1989). It is possible to distinguish transcribed 
(open) from non-transcribed (closed) templates by this method. Psoralen is incorporated and 
crosslinked only in transcribed rDNA repeats whereas nucleosome-covered rDNA is much less 
crosslinked, resulting in a faster migrating `f-band` in native agarose gels. Heavily crosslinked   
nucleosome-free rDNA produces a slow-migrating `s-band`. When psoralen treated chromatin 
is EcoRI digested and separated on an agarose gel, 18S and 25S fragments can be obtained 
with the 25S-18S-probe which detects a 3.4 kb rDNA fragment. Interestingly, in strains 
containing the integrated enhancer element, the s- and f-band of the 25S rDNA fragment seem 
to merge compared to the wild-type situation, suggesting that only the 5` part of the rDNA is 
transcribed by Pol I in the mutant strain (Figure 35B). Profile analyses of this blot-region 
supports this observation, indicating that less polymerases can enter the 25S rRNA gene due to 
efficient pausing of Pol I at the Reb1 site, thus leading to impaired opening of 3` rDNA 
fragments (Wittner et al., 2011).  
In another approach, we used electron microscopy (EM) to analyse Miller spreads of actively 
transcribed rDNA in strains with integrated enhancer regions and wild-type strains (French et 
al., 2003). Apparently, the length of the Miller trees was shorter in the mutant strain compared 
to the wild-type strain. Quantification of this observation was done by measuring the Pol I 
occupied length of the 5` rDNA gene region using the ImageJ software on EM images with 
40000 fold magnification. Representative examples of wild-type and mutant EM images of 
actively transcribing Pol I genes and a quantification of the average length of more than          
30 Miller spreads in wild-type and mutant, respectively, are depicted in Figure 35C.                      
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A significant discrepancy in Pol I occupied 5` and 3` rDNA regions is detected in the observed 
strains.  
These three analyses indicate that there exists a different Pol I density before and after the 
artificial termination site which suggests transcription termination at this region.  
 
Figure 35. RNA Pol I accumulates upstream of the introduced enhancer element in ITS1 leading to a changed 
chromatin state in the 25S rDNA region 
(A and B) Experiments were performed in strains y1620 (WT) and y2094 (ENH) with endogenously MNase-3xHA-tagged 
Pol I subunit A190. (A) Yeast strains endogenously expressing the indicated MNase fusion proteins were grown in YPD to 
mid-log phase. ChEC was performed as described in Figure 28. (B) Psoralen cross-linking was performed with yeast 
strains y1620 (WT) and y2094 (ENH). DNA was isolated, digested with EcoRI and analysed in a Southern blot with the   
25S-18S-probe detecting a 3.4 kb rDNA fragment encompassing regions of the 18S and 25S rRNA gene. Graphs to the 
right depict profiles of open and closed 18S and 25S rDNA for wild-type (black) and ENH (gray) (see 5.2.7.3 for details).   
(C) Miller spread of a representative 35S rRNA gene from wild-type (left) and ENH (right) (y1599, y2042) at                         
40000x magnification. Length of Pol I occupied regions are retraced as depicted and measured with the ImageJ software. 
Statistical average length of more than 30 Miller trees in wild-type and ENH are shown in the table to the right. Averaged 
length of wild-type Miller spreads was arbitrarily set to 1.  
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2.4.3 Ydr026c binding is sufficient to terminate at an artificially introduced 
termination site 
 
To elucidate which trans-acting binding factor is responsible for the described phenotypes we 
created knock-outs of FOB1- and YDR026c-genes to rescue the growth defect. Since REB1 is 
essential and linked to many different targets, definitive conclusions of its role in this whole 
process are hard to state (Ju et al., 1990). Surprisingly, both FOB1 and YDR026c knock-outs are 
able to cure the growth phenotype to some extent, whereas galactose dependent                
overexpression of only Ydr026c restores and even enforces slow growth in all strains 
containing the integrated enhancer element, including the knock-out strains (Figure 36A-B). 
This observation was rather surprising since Fob1 seemed to have no direct effect on 
termination. Possible unknown secondary effects of FOB1 deletion could contribute to the 
rescue of the growth phenotype. Recruitment of Fob1 to DNA in a Δydr026c genetic 
background and vice versa is not impaired as shown in Figure 36C, arguing for no 
cooperativeness of these factors with regard to binding to their proposed sites.  
 
 
Figure 36. Ydr026c significantly contributes to Pol I terminaton in vivo  
(A) Spot tests of strains y1599 (WT), y2042 (ENH), y2275 (WT Δfob1), y2280 (ENH Δfob1), y2276 (WT Δydr026c), and y2281 
(ENH Δydr026c). Serial dilutions of above mentioned strains were spotted on YPD plates and incubated at 30°C for 2-3 
days before pictures were taken. (B) Spot tests of strains y1599 (WT), y2042 (ENH), y2275 (WT Δfob1), y2280 (ENH Δfob1), 
y2276 (WT Δydr026c), and y2281 (ENH Δydr026c) either transformed with plasmid YCplac111-pGAL-FOB1 (left) or plasmid 
YCplac111-pGAL-YDR026c (right). Serial dilutions of above mentioned strains were spotted on SCG-leu plates and 
incubated at 30°C for 2-3 days before pictures were taken. (C) Yeast strains (y2231, y2236) with a FOB1 deletion and 
(y2232, y2237) with a YDR026c deletion, respectively, expressing the indicated MNase fusion proteins from their 
endogenous locus were grown in YPD to mid-log phase. ChEC was performed as described in Figure 28. 
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However, we cannot exclude cooperative effects of these factors concerning efficient Pol I 
pausing and termination. Therefore, we created yeast strains with only the Reb1 binding site or 
the RFB inserted 3` of the 18S rRNA gene to uncouple possible cooperativity. Additionally, 
strains with an inverted orientation of the above mentioned binding sites were created to 
differentiate between orientation-dependent effects of DNA binding. An overview of the 
created strains is shown in Figure 37A.  
Serial dilutions of strains (y1599 (WT), y2042 (ENH), y2323 (5`-ENH fwd), y2327 (5`-ENH rev), 
y2331 (3`-ENH fwd), y2335 (3`-ENH rev)) on YPD plates are shown in Figure 37B. A growth 
phenotype is detected only for the strain containing the 5` enhancer sequence with the Reb1 
binding site in the natural orientation. Inverting the orientation of the Reb1 binding site as well 
as inserting the RFB or an inverted RFB does not result in a detectable growth phenotype. 
However, the growth phenotype detected for strains with just the 5` enhancer is not as 
pronounced as for strains containing the whole terminator region (compare lane ENH with 
lane 5`-ENH fwd on serial dilution plate Figure 37B). Whether this is due to cooperative effects 
of Ydr026c and Fob1 remains unclear since the `failsafe`-terminator (a T-rich stretch between 
the Reb1 binding site and the RFB), which could also contribute to a more efficient termination 
in the ENH strain, is missing in the 5`-ENH fwd strain (see Figure 37A).  
To clarify whether Fob1 binding is detected in the 5`-ENH strains or Ydr026c binding is 
detected in the 3`-ENH strains, which would argue for a strong direct interaction and possibly 
cooperation in termination of these two factors, ChEC with MNase-tagged Ydr026c and Fob1, 
respectively, was performed in the above mentioned strains.  
Strong cleavage signals are detected only for Ydr026c binding to the region containing the   
5`-ENH in the natural orientation. Neither Ydr026c binding nor Fob1 binding can be detected 
to a significant extent in strains which are not harboring the respective binding site, indicating 
that no or very little cooperativity exists between these factors with respect to transcription 
termination. 
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Figure 37. The Reb1 binding site in its natural orientation and Ydr026c binding is sufficient to cause a growth 
phenotype 
(A) Sequence of the 3` end of the rRNA coding region beginning 6bp 3` of the 25S rRNA gene. Gray bars below the 
sequence indicate the location of the Rnt1 cleavage site, the T-rich element, the Reb1 binding site, the Failsafe terminator 
(Reeder et al., 1999), and the replication fork barrier (RFB). Colored bars above the sequence indicate the different DNA 
fragments used for integration in ITS1 (see color-code for respective strains). (B) Spot tests of strains y1599 (WT), y2042 
(ENH), y2323 (5`-ENH fwd), y2327 (5`-ENH rev), y2331 (3`-ENH fwd) and y2335 (3`-ENH rev). Serial dilutions of above 
mentioned strains were spotted on YPD plates and incubated at 30°C for 2-3 days before pictures were taken. (C) Binding 
of respective binding proteins analysed by ChEC. Yeast strains y2325 and y2326 (5`-ENH fwd), y2329 and y2330 (5`-ENH 
rev), y2333 and 2334 (3`-ENH fwd), y2337 and 2338 (3`-ENH rev) expressing the indicated MNase fusion proteins from 
their endogenous locus were subjected to ChEC analysis. Strains were grown in YPD to mid-log phase. ChEC was 
performed as described in Figure 28. 
 
Taken together, the Reb1 binding site in its natural orientation and Ydr026c binding 
significantly contribute to Pol I termination in vivo at the artificial terminator and Ydr026c 
binding is sufficient to cause the described growth phenotype. 
 
2.4.4 Characterization of the DNA element required for termination 
 
In addition to the Reb1 binding site it was reported that the presence of a T-rich region 5` of 
the terminator protein binding site is required for efficient termination in yeast and mammals 
(Lang and Reeder, 1995; Mason et al., 1997a). To assay the effects of this stretch of thymidine 
nucleotides in vivo, strains were created containing the whole enhancer element with the        
T-rich sequence integrated 3` of the 18S rRNA gene (ENH T-rich). Spot tests on YPD plates 
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demonstrate that a combination of the T-rich element with the Reb1 binding site enforces the 
obtained growth defect in ENH strains (Figure 38B).  
In in vitro studies which characterized Reb1 as termination factor, mutations in the binding site 
were generated to test for better or no Reb1 binding. A mutated Reb1 binding site in which 
two guanine residues are replaced by thymines (ENH mut1) (Figure 38A) eliminates Reb1 
binding as assayed by gel-shift analysis and concurrently prevents Pol I termination in vitro 
(Lang and Reeder, 1993). Additionally, a Reb1 binding site mutant (ENH mut2), where AAA is 
substituted for CCC in the 3` part of the Reb1 binding site (see Figure 39A) increases Reb1 
binding about 10-fold in vitro and thereby increased overall termination efficiency (Lang and 
Reeder, 1993; Reeder et al., 1999). To test whether these mutations also affect Ydr026c – and 
Reb1 binding in vivo, strains carrying the enhancer element with the mutated Reb1 binding 
sites were created. For ENH mut1, the created mutations at these sites restored wild-type 
growth (Figure 38B). This observation is in agreement with other in vivo data of Pol I 
termination on a ribosomal minigene (Reeder et al., 1999). ChEC experiments with           
MNase-tagged binding proteins show Ydr026c-MNase and Fob1-MNase binding in the         
ENH T-rich strain, whereas Ydr026c-MNase binding is abolished in the strain with the mutated 
Reb1 binding site (ENH mut1) (Figure 38C).  
 
 
Figure 38. A T-rich element upstream of the Pol I terminator and a correct Reb1 binding site are needed for 
efficient termination 
(A) Representation of WT and mutated Reb1 binding sites. Consensus sequence for the Reb1 binding site at the Pol I 
terminator is shown in bold black (WT) and mutated nucleotides are shown in bold gray (ENH mut1). ENH mut1 contains 
a two-base substitution in the Reb1 site that abolishes Reb1 binding (Lang and Reeder, 1993). (B) Spot tests of strains 
y1599 (WT), y2042 (ENH), y2273 (ENH T-rich), and y2274 (ENH mut1). Serial dilutions of above mentioned strains were 
spotted on YPD plates and incubated at 30°C for 2-3 days before pictures were taken. (C) Yeast strains y2239 and y2238 
(ENH T-rich), y2241 and y2240 (ENH mut1) expressing the indicated MNase fusion proteins from their endogenous locus 
were subjected to ChEC analysis. Strains were grown in YPD to mid-log phase. ChEC was performed as described in 
Figure 28. 
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No difference in growth was detected in the strain carrying the mutated Reb1 binding site 
(ENH mut2) for better binding compared to the non-mutated strain in spot tests (Figure 39B). 
Reb1 binding and Ydr026c binding was measured by ChEC in this strain. Clear cleavage signals 
are detected for both fusion proteins at the indicated binding site (Figure 39C) but no 
significantly enhanced growth phenotype is detected due to significantly better Reb1 binding 
compared to strains with a wild-type terminator (Figure 39B). 
 
 
Figure 39. A mutation in the Reb1 binding site leads to better Reb1 binding but to no difference in growth 
(A) Representation of WT and mutated Reb1 binding sites. Consensus sequence for the Reb1 binding site at the Pol I 
terminator is shown in bold black (WT) and mutated nucleotides are shown in bold gray (ENH mut2). ENH mut2 contains 
a three-base substitution in the Reb1 site that increases Reb1 binding about 10-fold (Lang and Reeder, 1993). (B) Spot 
tests of strains y1599 (WT), y2042 (ENH) and y2339 (ENH mut2). Serial dilutions of above mentioned strains were spotted 
on YPD plates and incubated at 30°C for 2-3 days before pictures were taken. (C) Experiments were performed with 
strains y2341 (ENH mut2) and y2342 (ENH mut2) with endogenously MNase-3xHA-tagged Ydr026c or Reb1, respectively 
(Ydr026c-MN, Reb1-MN). Yeast strains expressing the indicated MNase fusion proteins were grown in YPD to mid-log 
phase. ChEC was performed as described in Figure 28. 
 
In summary, a T-rich element upstream of the Pol I terminator and a correct Reb1 binding site 
are needed for efficient termination. Increased Reb1 binding at the artificial terminator does 
not lead to an enhanced growth defect.  
 
2.4.5 Effects of premature termination on rRNA processing 
 
If Pol I transcription is blocked at the artificial termination site, rRNA synthesis should be 
impaired downstream of the termination sits. This would lead to an imbalance of the 18S / 25S 
synthesis which can be detected in pulse experiments and Northern blotting. We wanted to 
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test this in our mutant strains. Therefore logarithmically growing yeast cells were pulsed with 
[3H]-uracil for 15 min before RNA was extracted and separated by denaturing agarose gel 
electrophoresis. An autoradiograph with long exposure-time of the blotted RNA is shown in 
(Figure 40A). According to the insertion of an additional DNA sequence 5` of the A2-processing 
site an up-shift of the 20S pre-rRNA band should be observed in strains with integrated 
enhancer sequences. This up-shift can be seen in the pulse experiment in Figure 40A (compare 
lane 1 (WT) with lane 4 (ENH mut1)). An additional band (marked by an arrow) appears in ENH 
and ENH T-rich strains migrating with a higher molecular weight than the 20S+ rRNA             
(see Figure 40A, compare lane 2 and 3 with lane 4). Furthermore, the quantification of several 
Northern blot signals for 25S and 18S shows an even more drastic effect on the 25S/18S 
imbalance in a steady state situation than observed in the pulse experiments for strains ENH 
and ENH T-rich (Figure 40, compare quantification from panel B to A). Transcription and 
processing seem to be generally affected in these two strains. Since prevention of Ydr026c 
binding to the Reb1 site in ENH mut1 cures this phenotype, secondary effects are likely to be 
the reason for the impairment of efficient transcription/processing in these strains. Whether 
these effects are due to defective processing or initiation remains unclear and has not been 
further investigated. The appearance of this additional band as well as the detected imbalance 
in the 25S/18S ratio observed in ENH and ENH T-rich strains (Figure 40A) point towards an 
unprocessed and not degraded termination product.  
To further characterize this unexpected band, we analysed rRNA of the above described strains 
by Northern hybridization (Figure 40C). For rRNA detection we used probes identifying the 
very 5` region of the 35S rRNA (1), as well as probes recognizing ITS1 sequences upstream of 
the A2-processing site either 5` or 3` of the integrated enhancer region (2 and 3) (for probe 
positions see schematic sketch in Figure 40C). The additional band can be detected with 
probes 1 and 2 but is absent when probe 3 is used arguing for an unprocessed termination 
product (Figure 40C). Signal intensity of this band appears to be significantly stronger in the 
ENH T-rich strain compared to the ENH strain indicating increased termination efficiency due 
to the T-rich sequence. 
Taken together, pulse experiments and Northern hybridization with strains carrying an 
integrated terminator sequence in ITS1 revealed an imbalance in the 25S/18S rRNA ratio. 
Furthermore, an additional band, which could represent an unprocessed termination product, 
appears in these strains. 
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Figure 40. A termination product is detected in [3H]-pulse experiments and Northern analyses 
(A) [3H]-uracil pulse. Top: [3H]-uracil metabolic labeling of newly synthesized RNA in strains y1599 (WT), y2042 (ENH), 
y2273 (ENH T-rich), and y2274 (ENH mut1). Cells were pulsed for 15 min at 30°C. Total RNA was extracted and separated 
by gel electrophoresis. Radio-labeled RNA was visualized by fluorography. Bottom: [3H]-uracil incorporation in 18S and 
25S rRNA was determined by excision of the 18S and 25S rRNA bands from an identical blot and analysis by liquid 
scintillation counting. The 25S/18S ratio of the obtained values was calculated and normalized to wild-type, which was 
arbitrarily set to 1. (B) Top: Northern hybridization with 25S and 18S probes. RNA of yeast strains y1599 (WT), y2042 (ENH), 
y2273 (ENH T-rich), and y2274 (ENH mut1) was extracted, separated by gel electrophoresis, and Northern blotting was 
performed. Bottom: The calculated 25S/18S ratio was obtained by quantification of 25S and 18S signals of several 
Northern blots as described in 5.2.4.5. The 25S/18S ratio was normalized to wild-type, which was arbitrarily set to 1.        
(C) Northern hybridization to analyse the additional band. RNA of yeast strains y1599 (WT), y2042 (ENH), y2273              
(ENH T-rich), and y2274 (ENH mut1) was extracted, separated by gel electrophoresis, and Northern blotting was 
performed as described in 5.2.4.5. The used probe is depicted below the blot. The position of the probes, as well as the 
location of the A0, A1, and A2 processing sites and the artificially introduced enhancer site are indicated on a schematic 
sketch below.  
 
 
2.4.6 Ydr026c is a bona fide Pol I transcription termination factor  
 
So far, the role of Ydr026c was analysed only at the artificial termination site. It remains unclear 
whether Pol I can read through the natural termination site when Ydr026c is missing. To 
analyse this, we performed chromatin immunoprecipitation (ChIP) experiments in strains 
y1620 (WT), y2094 (ENH), y2229 (WT Δydr026c), and y2234 (ENH Δydr026c) expressing an 
endogenously MNase-3xHA-tagged Pol I subunit (A190). The results of the ChIP analysis are 
shown as the percentage of the total input DNA recovered after ChIP for the different rDNA 
regions (Figure 41). Deletion of YDR026c (strains y2229 (WT Δydr026c), y2234 (ENH Δydr026c)) 
shows significantly increased Pol I occupancy downstream of the Reb1 binding site and the 
RFB (amplicon 7 and 8) in strains with and without integrated enhancer sequences 3` of the 
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18S rRNA gene. This underlines that Ydr026c is required for efficient termination of rDNA 
transcription. We also analysed the Pol I occupancy in strains carrying the artificial terminator 
and no YDR026c knock-out. Pol I occupancy at the promoter and throughout the 18S rRNA 
gene is slightly affected compared to wild-type (y1620) whereas the ChIP signals from the 
rDNA downstream of the integrated enhancer sequence differ significantly from wild-type 
signals (compare amplicons 1, 2, 3 with 4, 5, 6 in Figure 41). This data is in agreement with the 
Miller spread data from Figure 35C. The qPCR signal at the 5S gene (amplicon 9) serves as an 
internal control. Pol I occupancy of the YDR026c deletion strains (y2229 (WT Δydr026c),                      
y2234 (ENH Δydr026c)) is similar to wild-type except for the increase at the terminator and RFB. 
In particular, when signals for the two strains with integrated binding sites are compared 
(strain y2094 (ENH), y2234 (ENH Δydr026c)) it becomes obvious that Ydr026c is required for 
polymerase I blocking. The rescue of the growth phenotype detected in strain ENH through 
YDR026c deletion can now be entirely explained by a reconstitution of the wild type Pol I 
occupancy on the rDNA.  
 
 
Figure 41. A deletion of YDR026c leads to transcription read-through of polymerases at the terminator site 
Yeast strains y1620 (WT), y2094 (ENH), y2229 (WT Δydr026c), and y2234 (ENH Δydr026c) expressing the Pol I subunit A190 
as a fusion protein with a C-terminal MNase-3xHA-tag were subjected to ChIP experiments as described in 5.2.7.1. The 
data presented in the bar diagram is the average of two independent ChIP experiments each analysed in triplicate 
quantitative PCR reactions. The percentage of the total input DNA recovered after ChIP for the different rDNA regions is 
depicted. The 5S rRNA coding sequence (9) serves as an internal control. The positions of the amplified rDNA regions are 
indicated in the cartoon on the bottom. Primer pairs used in ChIP experiments are listed in 5.1.4. 
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2.4.7 Deletion of YDR026c is viable and causes rDNA repeat expansion 
 
Apparently, exact termination and ongoing transcription does not seem to be so important 
since YDR026c deletion shows no growth phenotype as already seen in Figure 36A. We started 
to look for other phenotypes caused by YDR026c deletion. Furthermore, we wanted to 
determine whether changes in the rDNA copy number can be detected. For this we used 
quantitative PCR as well as pulse-field gel electrophoresis. An expansion of the rDNA copy 
number was observed by qPCR in ΔYDR026c strains compared to wild-type strains and strains 
with a fixed rDNA copy number (Figure 42A). Genomic DNA was extracted and signals for     
25S rDNA were compared to signals obtained from the single copy PHO5 gene in the analysed 
strains. Pulse-field gel electrophoresis of yeast chromosomes was performed in collaboration 
with Jorge Perez-Fernandez and could confirm this result, since the rDNA carrying 
chromosome XII in Δydr026c yeast strains migrates with a significantly higher molecular 
weight than chromosome XII in wild-type strains or strains with a fixed rDNA copy number 
(NOY886 with ~40 copies; NOY1064 with ~190 copies; NOY1071 with ~25 copies)                    
(see Figure 42B).  
It is possible that the increased number of non-terminated Pol I transcription complexes 
interferes with a) the bidirectional Pol II promoter which is located in a region shown to be 
required for repeat expansion and which drives the transcription of non-coding RNAs (Ganley 
et al., 2005; Houseley et al., 2007) or b) the replication machinery which then might cause more 
uncoordinated recombination events and an extension of the rDNA locus (Kobayashi et al., 
1998; Kobayashi, 2003).  
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Figure 42. Expansion of rDNA copy number in YDR026c deletion strain 
(A) Experiments were performed with strains y1599 (WT), y2276 (WT Δydr026c) and y352 (NOY1064). Copy number was 
measured by qPCR from genomic DNA. 25S signals of the indicated strains (NOY1064 with fixed copy number of 190) 
were compared to the signals of the single copy gene PHO5. Signals were normalized to 190 copies of NOY1064.             
(B) Experiments were performed with strains y206 (BY4741), y349 (NOY886), y352 (NOY1064), y353 (NOY1071), y1599 
(WT), and y2276 (WT Δydr026c). Pulse-field gel electrophoresis of S. cerevisiae chromosomes of indicated strains              
(for detailed description see 5.2.3.4). Top: rDNA on chromosome XII determined by Southern hybridization with an rDNA 
specific probe in different strains. Bottom: EtBr stained agarose gel after pulse-field gel electrophoresis. Yeast 
chromosomes are depicted on the left. (Experiments were performed by Jorge Perez-Fernandez) 
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3 DISCUSSION 
 
 
3.1 Possible roles of Pol I phosphorylation 
 
The identified phosphosites apparently belong to the major phosphorylated sites in the Pol I 
complex. In vivo analysis of mutants which mimic a constitutive unphosphorylated or 
phosphorylated state of these phosphosites (Table 3) showed that all Pol I phosphorylations 
analysed are non-essential posttranslational modifications. Furthermore, the mutations have 
no apparent effect on cell growth. Mutants have been further characterized with regard to 
drug- (MMS, 6AU) and UV-sensitivity. Additionally, a large scale screen for synthetic lethality of 
the A43 phosphomutants was performed in collaboration with the lab of Olivier Gadal from 
the CNRS in Toulouse. None of the experiments resulted in a detectable growth phenotype or 
genetic interaction for the investigated phosphomutants. Thus, none of the phosphosites 
seems to play a crucial role in the regulation of Pol I transcription, which was quite unexpected 
since previous results indicate that Pol I activity is linked to its phosphorylation state (Fath et 
al., 2001, 2004). However, not all posttranslational modifications seem to play a role in 
regulation as seen for methylation and pseudouridinylation of rRNA (Zebarjadian et al., 1999). 
These modifications could be structural checkpoints, since the binding sites for some                 
r-proteins or biogenesis factors might be formed only if the modification mark is set           
(Song and Nazar, 2002). 
Pol I phosphorylations involved in the regulation of the RNA polymerase activity might rather 
contribute to the fine-tuning of the enzyme. The kinetics of an assay measuring the in vitro 
transcription activity after different time points of alkaline phosphatase treatment showed that 
the removal of one or few phosphorylations has little effect or even leads to an increased 
activity (Fath et al., 2004). Only longer phosphatase incubation and the further 
dephosphorylation resulted in complete inactivation.  
Nevertheless, combined phosphosite mutations of the A190 and A43 subunit, respectively, 
resulted in no detectable growth phenotype. For further in vivo characterization a strain would 
have to be established expressing a polymerase with mutations in all identified phosphosites. 
A change in the Pol I transcription activity should result in a changed rate of rRNA production, 
which would influence the growth rate of the cell. However, apparently other regulatory 
mechanisms can compensate lowered levels of rRNA production, one of which could be the 
increase of actively transcribed rDNA copies and/or a denser polymerase loading on these 
genes (French et al., 2003).  
Another possibility explaining the lack of growth defects in the analysed mutant strains would 
be a role of the corresponding phosphorylation sites in redundant functions which are not 
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necessarily related to the transcription activity. Possible aspects of Pol I phosphorylation in 
correct enzyme assembly, where it could serve as a structural checkpoint, will be discussed in 
section 3.4. 
Plausible roles for single selected phosphosite mutants are discussed in the thesis of Jochen 
Gerber (Gerber, 2008). Moreover, additional sites might have escaped detection, e.g. sites 
which are required for complex formation with the transcription factor Rrn3 and which are 
present in only about 2% of the total Pol I population. Since overexpression of Rrn3 results in 
increased amounts of Pol I-Rrn3 complexes (Steinbauer, 2010), this system could be used to 
isolate these complexes and further identify specific, complex forming posttranslational 
modifications. 
 
 
3.2 Formation of Pol I-Rrn3 complexes  
 
The crucial interactions of A43 include the complex formation with Rrn3, which renders Pol I 
competent for transcription initiation (Peyroche et al., 2000). This complex formation is 
accompanied by a change in the Pol I phosphorylation pattern in vivo (Fath et al., 2001). 
Furthermore, the in vitro interaction seems to depend on the phosphorylation status of Pol I 
but not of Rrn3 (Fath et al., 2001). Most information on the putative binding site for Rrn3 came 
from the ts-mutant rpa43-6 (Peyroche et al., 2000) which contains three different mutations 
resulting in an unstable Pol I-Rrn3 complex. The three amino acid exchanges were mapped to 
a conserved region of A43 spanning from amino acid 42 to 172 in the primary structure 
(Peyroche et al., 2000). In the solved crystal structure of a truncated A43/A14 heterodimer, two 
of the three rpa43-6 mutations are located on the surface of A43 (Kuhn et al., 2007).  
Only one (S220) of the four identified A43 phosphosites is included in this structure. The others 
are lying in flexible regions which were deleted from the recombinant proteins in order to 
facilitate crystallization.  
However, none of the major phosphorylation sites showed an involvement in the mechanism 
of the binding or release of Rrn3. Only about 2% of the total cellular Pol I is present in the 
initiation-competent form, the rest belongs to the pools of transcribing or free polymerases 
and the identified phosphosites most probably originated from these latter two.  
In an approach to investigate possible roles of phosphorylation in the A43-Rrn3 complex 
formation, serines within the conserved putative A43-Rrn3 interaction domain were mutated 
and tested for complementation of wild-type A43. Interestingly, the S141/143A mutation but 
not the S141/143D mutation is able to complement the loss of the wild-type subunit. In fact, it 
remains unclear whether these serine residues are in vivo phosphorylated. In vivo and in vitro 
experiments to further characterize these lethal mutations were carried out. 
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A conditional system, in which this A43 phenotype can be analysed in a more direct way, will 
be established. Therefore, vectors were constructed containing either wild-type, S141/143A or 
S141/143D mutant versions of A43 expressed from their endogenous promoter and either an 
N-terminally FLAG-tagged or untagged A43 wild-type protein expressed from a           
galactose-inducible promoter. This system allows the elimination of wild-type A43 expression 
by shifting cells from galactose to glucose. 
Co-immunoprecipitation (Co-IP) experiments can be employed to compare the total amounts 
and the stability of Pol I-Rrn3 complexes in wild-type and mutant strains. Furthermore, the 
association of Rrn3 with the elongating Pol I as well as efficient promoter recruitment of the 
polymerase can be tested in vivo by chromatin immunoprecipitation (ChIP) assays.  
For further in vitro A43-Rrn3 interaction studies, Rrn3 purified from SF21 insect cells via the 
baculovirus expression system can be used together with the recombinant A43/A14 mutants 
obtained from E. coli.  
 
 
3.3 Uncoupling transcription and pre-rRNA processing after short-term 
TOR inactivation 
 
The cellular level of the transcription factor Rrn3 significantly influences RNA polymerase I 
transcription and thus the rate of rRNA synthesis (Steinbauer, 2010). However, the simple 
down-regulation of Rrn3 and Pol I–Rrn3 levels cannot explain the dramatic reduction of rRNA 
synthesis in the immediate cellular response to impaired TOR signalling (Philippi et al., 2010). 
Rapamycin treatment leads to a fast down regulation of both cell growth and mature rRNA 
production (Philippi et al., 2010). These results point towards a more drastic and rapid effect of 
rapamycin- or starvation-induced TOR inactivation than just down regulating Pol I 
transcription via reducing the amount of Rrn3. Controlling the level of Rrn3 might serve as a 
tool for the cell to adjust the rate of ribosome synthesis in the long term (Steinbauer, 2010). At 
early stages of TOR inactivation, however, a target presumably downstream of Pol I 
transcription initiation must be affected. In order to elucidate this issue, the quick effects of 
TOR inactivation on Pol I transcription and rRNA production were investigated. Interestingly, 
neither the level of Rrn3 nor the association of Pol I with the rDNA locus was substantially 
decreased after 15 min of rapamycin-induced TOR inactivation (Reiter et al., 2011). Moreover, 
polymerase molecules engaged in transcription elongation were still able to finish their 
initiated rRNA synthesis. Under these conditions RNA Pol I was still mobile, giving rise to 
nascent 35S pre-rRNA, which does not, however, exclude the possibility that transcription 
elongation is partly affected (Stefanovsky et al., 2006; Zhang et al., 2010). While 35S pre-rRNA 
production is maintained, a drastic decrease in the level of intermediate and mature rRNAs is 
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already detectable after 15 min of rapamycin treatment compared to untreated cells in several 
strain backgrounds (see section 2.2). TOR inactivation affects not only rRNA gene transcription 
by Pol I, but decreases also very fast translation initiation and pre-rRNA maturation (Barbet et 
al., 1996; Powers and Walter, 1999). The protein synthesis inhibitor cycloheximide was used to 
analyse whether a significant decrease of protein production causes the observed pre-rRNA 
processing defects which follow TOR inactivation. In fact, 15 min of cycloheximide treatment 
was sufficient to generate even more severe pre-rRNA maturation defects (see section 2.2), 
which is consistent with diverse earlier reports (de Kloet, 1966; Udem and Warner, 1972; 
Warner and Udem, 1972). 
In summary, TOR-dependent inhibition of r-protein expression appears to play the dominant 
role in the drastic down regulation of ribosome production rather than the decrease in Pol I 
transcription. Ribosomal proteins have to be produced in at least stoichiometric amounts to 
the ribosomal RNAs in the cell to support proper assembly, processing, and maturation of the 
ribosomal subunits (Warner, 1999). An impairment in the production of these structural 
components very likely provokes drastic effects on the synthesis of ribosomes, especially if 
ribosome assembly occurs not strictly according to hierarchical orders.  
It is known that different ribosomal domains can assemble independently                        
(Ferreira-Cerca et al., 2007). All improperly assembled subdomains result in rapid degradation 
(see model in Figure 43). In support of this idea, in vivo depletion of individual r-proteins of the 
large or small ribosomal subunit frequently leads to a drastic accumulation of the 
corresponding other subunit both in yeast and in mammals (O’Donohue et al., 2010; Pöll et al., 
2009; Robledo et al., 2008). This imbalance of structural components of the ribosome is then 
presumably adjusted by rapid degradation of misassembled, excess rRNA precursors             
(Pöll et al., 2009).  
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Figure 43. Two different models for ribosome assembly 
Upper panel: Ribosomal proteins can assemble independently to rRNA. Shortage of individual r-proteins leads to 
misassembled ribosomes and rapid rRNA degradation. Lower panel: Ribosome assembly follows an assembly gradient. 
Shortage of individual r-proteins leads to decelerated ribosome production. 
 
Analysis of yeast strains which exhibit severe growth defects due to a moderate reduction in 
the level of a single ribosomal protein in the context of gene haploinsufficiency further 
strengthen this point (Steinbauer, 2010). This observation was already described by others 
(Abovich et al., 1985; Lucioli et al., 1988; Deutschbauer et al., 2005). Interestingly, the impact of 
short-term rapamycin treatment is indeed predominantly directed towards the expression of 
ribosomal proteins, whereas cycloheximide treatment for the same time affects the overall 
expression of proteins in the cell. By using lower cycloheximide concentrations, which have a 
similar impact on the synthesis of ribosomal proteins as rapamycin treatment, a virtually 
identical defect in the production of mature rRNAs could be obtained (Reiter et al., 2011). 
Although the CARA strain, when compared to the wild-type strain, displays an attenuated 
decrease in the mRNA levels specifically of r-proteins upon TOR inactivation (Laferté et al., 
2006), r-protein production is equally decreased in both the mutant and the wild-type cells 
after 15 min of rapamycin treatment (Steinbauer, 2010). It is noteworthy that the decrease in 
the mRNA levels of r-proteins in the CARA mutant is only slightly delayed compared to the 
wild-type strain after 15 min of rapamycin treatment. However, rRNA processing is also heavily 
affected in the CARA strain as seen in (Laferté et al., 2006). Consistent with this, similar defects 
in pre-rRNA processing and mature rRNA synthesis could be observed in wild-type and mutant 
strain in our experiments (see section 2.2). Further evidence for an early shortage of ribosomal 
proteins derives from a recent study showing that amino acid starvation leads to a very rapid 
inhibition of mRNA splicing in yeast, which predominantly affects the expression of r-protein 
genes (Pleiss et al., 2007). Since ribosomal protein genes account for almost 50% of the   
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intron-containing genes and about 90% of mRNA splicing is devoted to r-protein transcripts in 
yeast, a general depletion of the cellular r-protein pool was already speculated to link 
impairments in the nuclear pre-mRNA splicing machinery to ribosome biogenesis defects 
(Hartwell et al., 1970; Warner and Udem, 1972; Rosbash et al., 1981; Spingola et al., 1999; 
Warner, 1999). These observations indicate that the drastic reduction in ribosomal protein 
production following rapamycin or cycloheximide treatment is sufficient to provoke severe 
defects in the processing and maturation steps of pre-rRNAs, which are then obviously rapidly 
degraded.  
In a recently described TOR1 mutant strain, the rapamycin-induced pre-rRNA processing 
phenotype can be uncoupled from the inhibition of r-protein mRNA synthesis (Li et al., 2006). 
These observations don`t necessarily contradict  the model of depleted r-proteins generating 
the immediate shut-off of ribosome production, as it is not clear yet whether under the 
conditions used in this publication rapamycin still prevents the translation of the r-protein 
mRNAs and thus the expression of the ribosomal proteins as it was previously observed 
(Barbet et al., 1996). In this regard, it would be interesting to correlate rRNA maturation with    
r-protein production upon TOR inactivation in these genetic backgrounds. 
 
 
3.4 The importance of correct Pol I assembly and possible roles of 
phosphorylation in this process 
 
The phosphorylation site A190 S685 is localized on the part of the Pore 1 domain which 
contributes to the backside of the polymerase complex in the vicinity of ABC14.5, the 
AC40/AC19 heterodimer and a conserved loop of the hybrid binding-domain of A135. 
Mutation of S685 to either alanine or aspartate resulted in no detectable growth defect on full 
media. 
A striking difference between the alanine and aspartate mutations of A190 S685 is the genetic 
interaction with the non-essential Pol I subunit A12.2. The mutation rpa190 S685D was found 
to be synthetic lethal with the deletion of RPA12 (Reiter, 2007). In contrast, the growth 
behavior of the analogous rpa190 S685A / Δrpa12 strain was similar to a Δrpa12 control strain. 
Synthetic lethality indicates a functional linkage between the two genetic interaction partners. 
Accordingly, reversible phosphorylation at A190 S685 seems to be linked to one of the 
functions of the non-essential Pol I subunit A12.2. Interaction of A12.2 with A190 seems to be 
important for the correct conformation of the largest subunit and its assembly into the 
polymerase complex (Nogi et al., 1993; Mullem et al., 2002). A deletion of RPA12 leads to a       
ts-growth phenotype. Interestingly, the A12.2 binding site is localized in the jaw region of 
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A190, which is on the opposite side of the polymerase with respect to the phosphorylation site 
A190 S685 (Gerber et al., 2008). Thus, a direct interaction seems to be rather unlikely.  
Phosphorylation at the A190 S685 site might allosterically induce a conformational change of 
the pore and the adjacent active center (Johnson and O’Reilly, 1996; Johnson and Lewis, 2001). 
In this conformational state, the loss of A12.2 might lead Pol I into a dead end situation 
resulting in synthetic lethality by reinforcing the Δrpa12 ts-phenotype.  
The 6AU sensitivity as well as the ts-phenotype of a Δrpa12 strain can be rescued by the           
N-terminal domain of A12.2 (Mullem et al., 2002), indicating that the full deletion has an 
impact on transcription elongation. This effect is independent from the reported RNA cleavage 
activity of the C-terminal domain of A12.2 and most probably due to disturbed complex 
stability as a consequence of affected Pol I assembly. Furthermore, synthetic lethality of the                    
rpa190 S685D / Δrpa12 mutant can be rescued by the expression of the N-terminal domain of 
A12.2 pointing towards an impaired complex stability as the possible cause of the SL 
phenotype. 
Semi-quantitative mass spectrometric comparison of co-purified Pol I subunits revealed a Pol I 
complex which is partially depleted for A190 and associated subunits like A43, ABC27, ABC23, 
and A14 in the SL mutant strain. This observation of defective Pol I assembly could additionally 
indicate that the common ABC23 subunit is involved in enzyme assembly (Nouraini et al., 1996; 
Minakhin et al., 2001) and forms the main interaction interface of the core polymerase to its 
respective ‘stalk’ heterodimer (Peyroche et al., 2002).  
Taken together, an involvement of the A190 S685 phosphosite in enzyme assembly becomes 
plausible. This indicates a possible hierarchical assembly order in which the phosphorylation of 
S685 could serve as a structural checkpoint occuring after A12.2 assembly and the thereby 
induced conformational changes in A190. The S685 phosphorylation might act as an energy 
barrier locking the achieved assembly state by impeding the backward reaction. 
 
 
3.5 A12.2, a Pol I specific subunit involved in many processes 
 
The C-terminal domain of the TFIIS-like subunit A12.2 exhibits an intrinsic Pol I cleavage 
activity in vitro (Kuhn et al., 2007). It contains the highly conserved motif Q.RSADE..T.F shared 
with the other members of the TFIIS-like protein family (Chédin et al., 1998; Hausner et al., 
2000). Full deletion of this non-essential Pol I subunit results in a ts-phenotype and 6AU 
sensitivity, while truncation of the C-terminal half apparently has no consequences on cell 
growth (Nogi et al., 1993; Mullem et al., 2002). Thus, it was surprising that mutation of the 
aspartate and glutamate residues of the conserved C-terminal motif to alanines is lethal   
(A12.2 D105A/E106A). Apparently, the full or partial deletions of A12.2 can be compensated by 
the cell while the DE/AA mutation leads to a `dead end situation`. 
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In a similar manner the analogous mutation in the homologous but essential Pol III subunit 
C11 was found to be lethal (Chédin et al., 1998). The DE/AA mutation in the non-essential      
Pol II cleavage factor TFIIS has only been tested in vitro where it resulted in a loss of function    
(Jeon et al., 1994). Structural analysis of TFIIS bound to Pol II revealed that the two acidic amino 
acids of the conserved motif coordinate a metal ion in the active site required for RNA cleavage 
(Kettenberger et al., 2003). Moreover, significant amounts of in vitro data on the function of 
TFIIS in transcript cleavage and Pol II backtracking is contributed by the group of Jesper 
Svejstrup (Svejstrup, 2007; Sigurdsson et al., 2010). However, as discussed in section 3.4 the 
location of A12.2 in the Pol I complex could contradict an RNA cleavage mechanism analogous 
to the one described for TFIIS. A12.2, like its homologous Pol II subunit Rpb9, binds to the jaw 
region of the largest subunit. Interestingly, recent studies with chimeric fusion proteins 
between the N-terminal domain of Rpb9 and the C-terminal domain of the Pol III counterpart 
C11, which shows a higher degree of homology with the A12.2 C-terminus than with the Rpb9        
C-terminus, could show that this C-terminus is more mobile, catalytic, and enters the Pol II core 
to induce strong RNA cleavage (Ruan et al., 2011). It is discussed that the A12.2 and C11            
C-terminus may be able to swing between surface and pore locations. However, replacing the 
C-terminus of Rpb9 with the A12.2 C-terminus did not confer strong cleavage to Pol II. 
The use of a conditional system in which the A12.2 DE/AA mutant is expressed under the 
control of a galactose-inducible promoter provides a useful tool to investigate the possible 
function of A12.2 in the intrinsic RNA cleavage activity of Pol I. In theory, the polymerase 
molecules apparently become trapped in the `dead end situation` upon induction. 
Overexpressing the A12.2 DE/AA mutant in a wild-type strain at higher temperatures (37°C) did 
not result in a growth phenotype as documented at lower temperatures, probably due to 
greater flexibility of the C-terminal domain resolving the `dead end situation`. Additionally, the 
induced growth phenotype can be rescued by the presence of a C-terminal FLAG-tag which 
could, apparently due to sterical hinderence, prevent the possibly stuck intermediate state of 
the A12.2 dependent RNA cleavage process during polymerase backtracking. Since pulse 
experiments showed a general impairment of Pol I transcription and initial ChIP analyses could 
give indications for problems with Pol I initiation or early elongation (Pilsl, 2010), the 
hypothesis of a Pol I molecule stuck in early transcription due to affected backtracking is worth 
to be further discussed.  
In vitro transcription assays could be used to investigate whether these `dead end situation` 
polymerase complexes are still active but stalled or completely inactive. Furthermore, RT-qPCR 
of 5` rRNA, extracted at different time points after induction of A12.2 DE/AA expression, could 
give more detailed information on the length of the produced RNAs and thereby reveal 
possible pausing sites and backtracking hotspots on the 5` rDNA gene. 
 
 
DISCUSSION 
81 
3.6 In vivo Pol I elongation assay 
 
We established an elaborate in vivo system which relies on the genetic manipulation of the 
entire endogenous rDNA locus (Wai et al., 2000) with each of the 150 to 200 rDNA repeats 
harboring the manipulated in vivo template of Pol I.  
Thus, we introduced DNA binding sites for various DNA binding proteins including TTF-I, LacI, 
LexA as well as the 601 nucleosome positioning sequence into the internal transcribed    
spacer 1 (ITS1) in between the 18S rRNA and 5.8S rRNA within each 35S rRNA coding sequence.  
We are able to conditionally express the different heterologous DNA binding proteins which 
are under the control of a galactose-inducible promoter. DNA binding of MNase fusion 
proteins was detected in vivo by Chromatin Endogenous Cleavage (ChEC) analyses and 
Southern blotting (Merz et al., 2008; Schmid et al., 2004). 
We could demonstrate that TTF-I- and LexA-MNase fusion proteins bind to their cognate DNA 
sequence within the transcribed rDNA region. 
No binding could be detected for the LacI-MNase fusion protein, which could be due to sterical 
hinderence caused by the MNase-tag since LacI forms homotetramers and is able to bind two 
operators at the same time (Santillán and Mackey, 2008). 
Interestingly, although TTF-I terminates transcription in vitro (Kuhn et al., 1990), the 
orientation-dependent binding of this protein interferes with, but does not inhibit Pol I 
elongation in vivo as monitored by ChEC analysis of Pol I-MNase fusion proteins. 
Growth phenotypes under different conditions (different temperature, presence of 6AU, 
nutrient starvation, UV, and other environmental stress situations) can be monitored in the 
future after expression of the DNA binding protein in induced wild-type and mutant strains. 
Preliminary experiments in mutant strains with deletions of A49 or A12.2 showed that the 
growth phenotype of TTF-I binding is more pronounced in these strains. Corresponding 
analyses can also be performed in mutant strains in which non-essential factors of the Pol I 
transcription machinery like Hmo1, the remaining non-essential Pol I subunits A34.5 and A14 
or factors involved indirectly or directly in elongation like Top1, Spt4, or Paf1 are impaired. Pol I 
distribution on the rDNA can be monitored using ChEC and ChIP analyses and by electron 
microscopic inspection of rDNA Miller chromatin spreads. The ability of Pol I to pass the barrier 
in vivo can be compared with the results of in vitro assays. This will allow a direct correlation 
between requirements in a defined in vitro system and the in vivo situation. 
Furthermore, the described in vivo system can be used to identify factors which support Pol I to 
overcome different barriers. While binding of LexA does not change growth rate, binding of 
TTF-I results in a significant growth defect. The above yeast strains can be subjected to random 
mutagenesis. Clones can be selected which fail to grow if expression of the DNA binding 
protein is induced by shifting the culture from glucose to galactose. The respective mutations 
responsible for the growth phenotype can be identified by co-expression of a yeast expression 
DISCUSSION 
82 
library in these strains and subsequent isolation of plasmids encoding complementing genes. 
The impact of the identified gene products on transcription elongation can be subsequently 
analysed in in vitro assays. 
 
 
Figure 44. In vivo screen for Pol I specific elongation factors 
TTF-I induction reduces growth rate. After random mutagenesis, galactose induction and replica plating, clones will be 
selected which cannot grow on galactose. Respective mutations responsible for the growth phenotype will be identified 
by co-expression of a yeast expression library and subsequent isolation of plasmids encoding complementing genes. 
 
Furthermore, the random mutagenesis strategy can be used for single Pol I subunits to identify 
their possible role in elongation. These strains contain a shuffle-plasmid which encodes the 
wild-type subunit and complements the chromosomal knock-out. The mutant plasmids are 
transformed and after the wild-type copy is shuffled out, yeast clones are replica plated on 
galactose to induce the expression of the binding protein. Strains that are either impaired in 
growth or grow significantly better than the control strain can be isolated and the mutations 
within the respective Pol I subunit can be identified. 
Furthermore, already described mutants, e.g. the Pol I phosphosite mutants, can be 
investigated in this elongation assay to screen for possible roles of phosphorylation in 
elongation. 
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3.7 `Torpedo termination` or not?  
 
There exists a discrepancy between in vitro and in vivo data on Pol I termination. Reb1 has been 
reported to pause Pol I and to support transcript release in vitro (Lang and Reeder, 1993). 
However, Reb1 binding in vivo can only be detected at its binding site near the Pol I promoter 
but not at the terminator, and a fourfold reduction of Reb1 in vivo had no effect on termination 
(Kawauchi et al., 2008). An alternative, torpedo-like model - similar to Pol II termination - was 
recently proposed. This model is supported by analyses of yeast mutants deficient in the 
endonuclease Rnt1 which is required for 3´ end processing of 25S pre-rRNA, and which 
accumulates transcripts beyond the T1 termination site (Prescott et al., 2004; Reeder et al., 
1999). Furthermore, inactivation of the nuclear exonuclease Rat1 and the RNA helicase Sen1 
leads to accumulation of extended pre-rRNAs (Kawauchi et al., 2008). Inactivation of Rat1 also 
increased Pol I occupancy in the region downstream of the T1 terminator. This all leads to a 
model in which the nascent pre-RNA is co-transcriptionally cleaved by Rnt1. The 5´ end of the 
cleaved transcript serves as a substrate for the exonuclease Rat1 which progressivly degrades 
the Pol I bound transcripts with the help of the helicase Sen1 and, thus, finally releases Pol I 
from the template. Very recent studies suggest that such a torpedo-like termination 
mechanism functions even in the absence of the Rnt1-dependent cleavage. A second cleavage 
site at the T-rich region of T1 was proposed as a failsafe termination site. Cleavage at this site 
should allow co-transcriptional recruitment of the exonuclease Rat1 (Braglia et al., 2010b). 
However, in all of these analyses it is difficult to distinguish between termination of rRNA 
transcription or processing since no 5` and 3` ends, which would appear after cleavage, are 
shown. 
Therefore we decided to investigate Pol I termination in vivo by using a similar system as the 
previously described screen for Pol I specific elongation factors. Since several cis elements 
within the Pol I termination region were reported to be involved in transcription termination, 
we inserted various termination elements in the ITS1 spacer of the rDNA gene locus.  
We examined which of these elements are required to cause growth reduction in our 
established in vivo system. Growth analyses revealed that neither the RFB nor the T2 element 
(failsafe terminator) significantly contributes to growth reduction. However, elimination of the 
T-rich element upstream of the Reb1 binding site at T1 leads to less growth inhibition. This 
confirms previous studies which showed that efficient in vitro termination depends on the 
presence of this T-rich element (Lang et al., 1994; Lang and Reeder, 1995) and underlines T1 
function also for in vivo termination.  
Interestingly, the Rnt1 cleavage site which was proposed as a prerequisite for `torpedo`-like 
termination (El Hage et al., 2008; Kawauchi et al., 2008; Reeder et al., 1999) is missing in all 
constructs causing growth defects. Even in the absence of the postulated failsafe cleavage site 
at T1 (Braglia et al., 2010b) a significant growth inhibition can be observed. 
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Furthermore, possible cleavage candidates like Rpa12, Dis3 (a core exosome subunit) and the 
NRD complex show no involvement in this postulated co-transcriptional cleavage process 
(Braglia et al., 2010b). 
In our analysis, we identified and characterized the protein Ydr026c as the in vivo Pol I 
termination factor in yeast. The binding of Ydr026c to the introduced Reb1 binding site within 
ITS1 appears to be the only necessary prerequisite for growth reduction in our in vivo system 
since no growth reduction was obtained when either the direction of the Ydr026c binding site 
was changed or the binding site was missing.  
Though Reb1 also binds to a number of Pol II genes (Remacle and Holmberg, 1992; Graham 
and Chambers, 1994; Carmen and Holland, 1994), Ydr026c is solely reported to bind to rDNA 
(Mohanty and Bastia, 2004). In a global analysis of protein localization in yeast performed with 
GFP-tagged proteins, Ydr026c was described to be nucleolar, whereas Reb1 is found in the 
nucleus (Huh et al., 2003) which would altogether argue for the specific role of Ydr026c in Pol I 
termination. 
Considering the possibility that a factor bound to the Reb1 binding site could position the 
paused Pol I on top of the T-rich element, it seems rather unlikely that an unknown factor 
could perform the proposed failsafe cleavage at T1. However, this question could be addressed 
by bioinformatical protein modeling.  
 
According to our data a `pause and release` termination model in which protein-mediated 
pausing of Pol I at termination sites causes backtracking of the polymerase and its release by 
slippage on an upstream pyrimidine-rich sequence is favoured in contrast to the above 
mentioned `torpedo` model (Reeder and Lang, 1997; Mason et al., 1997b).  
Taken together, Ydr026c serves as an in vivo Pol I terminator protein and Rat1-mediated 
`torpedo termination` may contribute to a more efficient Pol I termination instead of playing a 
central role in this complex process. 
The described in vivo system can be used to identify factors which support Pol I termination in 
an approach similar to the screen for Pol I in vivo elongation factors described in 3.6. 
Furthermore, the random mutagenesis strategy can also be used for single Pol I subunits to 
identify their possible role in termination as outlined for possible roles in elongation in section 
3.6. 
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4 SUMMARY – ZUSAMMENFASSUNG 
 
 
4.1 Summary 
 
RNA polymerase I (Pol I) is a specialized enzyme which transcribes the ribosomal RNA (rRNA) 
genes in all eukaryotes. Pol I transcription is regulated by specific DNA cis-elements and    
trans-acting factors as well as the usage of a specific chromatin template. 
Regulation and efficiency of rRNA synthesis in yeast depend on many processes including 
recruitment of the Pol I machinery and binding of Pol I-dependent transcription factors to the 
promoter, activity of the DNA-associated Pol I complexes, termination of transcription at 
specific sites, and co- and posttranscriptional RNA processing steps. 
Analyses of molecular defects of several Pol I mutants as well as the investigation of the 
immediate downregulation of rRNA synthesis upon growth arrest, mediated by the TOR 
pathway, were part of this study. Furthermore, an in vivo screen to determine Pol I specific 
elongation and termination factors has been established and the so far uncharacterized 
protein Ydr026c has been identified as Pol I termination factor. 
 
The Pol I phosphosites, identified by Jochen Gerber, were further mutated and analysed in vivo. 
All Pol I phosphorylations were found to be non-essential posttranslational modifications since 
none of the mutants showed a detectable, significant growth phenotype. 
Transcription initiation depends on the A43-Rrn3 complex formation and                                    
(de-) phosphorylation of Pol I subunits is likely to be involved in its regulation. We have 
identified and initially characterized a lethal Pol I mutant which probably interferes with this 
essential process.  
Additionally, the mutation of the A190 phosphosite S685 from serine to aspartate but not to 
alanine was found to be synthetic lethal with the deletion of the non-essential Pol I subunit 
A12.2. Our data suggest that the reversible phosphorylation at A190 S685 plays a significant 
role in Pol I assembly and stability. 
Furthermore, a lethal phenotype resulting from a mutation in the TFIIS-like C-terminal domain 
of the non-essential Pol I subunit A12.2 was initially characterized in vivo.  
Regulation of rRNA transcription by reduction of initiation competent Pol I-Rrn3 complexes 
after TOR inactivation seems to be too slow to explain the strong pre-rRNA processing defects. 
To distinguish between primary and secondary effects in the regulation of ribosome 
biogenesis, Pol I transcription and rRNA synthesis were investigated shortly after TOR 
inhibition by rapamycin. The fast downregulation of mature rRNA synthesis correlates with 
strong pre-rRNA processing defects and subsequent RNA degradation. The quick 
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downregulation of r-protein synthesis after TOR inhibition is sufficient to explain the severe 
pre-rRNA processing defects.  
 
To analyse Pol I elongation in vivo we created possible roadblocks for Pol I transcription within 
every rDNA copy through genetic manipulation of the entire endogenous yeast rDNA locus. 
We established plasmids for inducible expression of the respective (heterologous) DNA 
binding proteins and we could demonstrate that many of these proteins bind to their cognate 
DNA sequence within the transcribed rDNA region. Although they are all blocking 
transcription in vitro, the binding of some of these proteins hampers, but does not inhibit Pol I 
elongation in vivo. The presented in vivo system allows the identification of factors supporting 
Pol I to overcome different barriers. 
To identify specific factors involved in Pol I termination, we used an artificially introduced 
terminator region in every rDNA copy. We could identify and characterize Ydr026c as the Pol I 
terminator protein. Interestingly, this factor and not the previously published Reb1 is 
associated with the Reb1 binding site at the termination region in vivo and is required for         
in vivo Pol I transcription termination. Our data suggests that a `pause and release` mechanism 
is sufficient to support transcription termination in vivo, which indicates that the recently 
proposed `torpedo termination` model represents no necessary prerequisite for termination. 
Additionally, this in vivo system can be used to further characterize Pol I termination. 
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4.2 Zusammenfassung 
 
Die RNA Polymerase I (Pol I) ist ein spezialisiertes Enzym, welches die ribosomale RNA (rRNA) in 
allen Eukaryonten transkribiert. In die Regulation der Polymerase I Transkription sind spezielle 
DNA cis-Elemente, trans-agierende Faktoren sowie der Gebrauch einer besonderen 
Chromatinmatrize eingebunden.  
Die Effizienz und Regulation der rRNA Synthese ist bei der Hefe von vielen unterschiedlichen 
Prozessen abhängig. Dazu zählen die Rekrutierung der Pol I Maschinerie und die Bindung Pol I 
abhängiger Transkriptionsfaktoren an den Promotor, die Aktivität des DNA assoziierten Pol I 
Komplexes, Transkriptionstermination an genau determinierten Stellen und ko- bzw. 
posttranslationale RNA Prozessierungsschritte. 
Ein Teil dieser Arbeit bestand aus Analysen der molekularen Defekte mehrerer Pol I Mutanten 
sowie der Erforschung der sofortigen Herabregulation der rRNA Synthese nach 
Wachstumshemmung, hervorgerufen durch Inaktivierung der TOR Signalweges. Desweiteren 
wurde ein in vivo Screen etabliert um Pol I spezifische Elongations- und Terminationsfaktoren 
zu ermitteln. Dabei wurde das bis dahin nicht charakterisierte Protein Ydr026c als Pol I 
Terminationsfaktor identifiziert. 
 
Die von Jochen Gerber identifizierten Pol I Phosphorylierungsstellen wurden weiter mutiert 
und in vivo analysiert. Alle Pol I Phosphorylierungen wurden als nicht essenzielle 
posttranslationale Modifikationen eingestuft, da keine der Mutanten einen signifikantan 
Wachstumsphänotyp zeigte.  
Die Transkriptionsinitiation ist entscheidend von der Bildung des A43-Rrn3 Komplexes 
abhängig. Die Phosphorylierung bzw. Dephosphorylierung von Pol I Untereinheiten ist 
wahrscheinlich an der Regulation dieser Komplexbildung beteiligt. Wir haben eine letale Pol I 
Mutante identifiziert, die diesen essenziellen Prozess möglicherweise beeinträchtigt, und 
anfänglich charakterisiert. 
Bei weiterführenden Untersuchungen wurde die Mutation der Phosphorylierungsstelle S685 
der Pol I Untereinheit A190 von Serin nach Aspartat nicht aber nach Alanin in Kombination mit 
der Deletion der nicht essenziellen Pol I Untereinheit A12.2 für synthetisch letal befunden. 
Unsere Daten suggerieren eine besondere Rolle der reversiblen Phosphorylierung an dieser 
Stelle für die Polymeraseassemblierung und –stabilität. 
Desweiteren wurde ein letaler Phänotyp, resultierend aus einer Mutation in der TFIIS ähnlichen 
C-terminalen Domäne der nicht essenziellen Pol I Untereinheit A12.2, anfänglich in vivo 
charakterisiert. 
Bislang ging man davon aus, dass die Regulation der rRNA Transkription durch die 
Verringerung der initiationskompetenten Pol I-Rrn3 Komplexe nach TOR Inaktivierung 
geschieht. Dieser Mechanismus ist jedoch zu träge, um die starken prä-rRNA 
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Prozessierungsdefekte zu erklären, die sehr schnell nach TOR Inaktivierung auftreten. Zur 
Klärung dieser Frage wurden die Pol I Transkription und rRNA Synthese kurz nach TOR 
Inaktivierung durch Rapamycin untersucht. Hierbei zeigte sich, dass die schnelle 
Herabregulation der Synthese der reifen rRNA stark mit prä-rRNA Prozessierungsdefekten 
korreliert und anschließenden RNA Abbau nach sich zieht. Die schnelle Herabregulation der         
r-Protein Synthese nach TOR Inaktivierung ist dabei ausreichend um die schweren prä-rRNA 
Prozessierungsdefekte zu erklären. 
 
Zur Untersuchung der Pol I Elongation in vivo wurden über genetische Manipulation des 
gesamten endogenen rDNA Lokus mögliche Transkriptionsbarrieren für Pol I in jeder rDNA 
Einheit erzeugt. Desweiteren stellten wir Plasmide zur induzierbaren Expression der jeweiligen 
(artfremden) DNA Bindeproteine her. Wir konnten zeigen dass viele dieser Proteine an ihre 
verwandte DNA Bindesequenz innerhalb der transkribierten rDNA binden. Obwohl alle diese 
Proteine die Transkription in vitro blockieren, wird die Pol I Elongation in vivo durch einige 
dieser Proteine lediglich erschwert, jedoch nicht komplett verhindert. Das vorgestellte in vivo 
System erlaubt die Identifikation von Faktoren welche Pol I beim Überwinden verschiedener 
Barrieren unterstützen. 
Zur Identifizierung spezifischer Faktoren, die an der Pol I Termination beteiligt sind, benutzten 
wir eine künstlich in jede rDNA Einheit eingeführte Terminatorregion. Dadurch konnten wir 
Ydr206c als Pol I Terminatorprotein identifizieren und charakterisieren. Interessanterweise ist 
dieser Faktor und nicht das zuvor veröffentlichte Reb1 mit der Reb1 Bindestelle am Terminator 
in vivo assoziiert und wird für die in vivo Pol I Termination benötigt. Unsere Daten suggerieren, 
dass ein `pause and release` Terminationsmechanismus ausreichend ist um die Pol I 
Termination in vivo zu fördern. Dies weist darauf hin, dass das vor kurzem vorgeschlagene 
`torpedo termination` Modell keine notwendige Voraussetzung für die Pol I Termination 
darstellt. Zusätzlich kann dieses in vivo System zur weiteren Charakterisierung der Pol I 
Termination genutzt werden. 
 
 
 
 
 
 
 
 
MATERIAL AND METHODS 
89 
5 MATERIAL AND METHODS 
 
 
5.1 Material 
 
5.1.1 Saccharomyces cerevisiae strains 
 
Strain Parent 
strain 
Genotype Reference 
of source 
W303-1a  mata ade2-1 can1-100 his3-11,-15 leu2-3,112 trp1-1 ura3-1 (Thomas and 
Rothstein, 
1989) 
BY4741  mata his3­1 leu2­0 met15­0 ura3­0  EUROSCARF 
BY4742  matα his3­1 leu2­0 ura3­0 lys2­0 EUROSCARF 
D101-I2  mata ade2-101 ura3-52 lys2-801 trp1-Δ63 his3-Δ200 leu2-Δ1 
rpa43::LEU2 yCPA43 (URA3) 
(Thuriaux et 
al., 1995) 
NOY222  matα trp1­1 his4­401 leu2-3,112 ura3-52 can RPA190::URA3 pNOY20 (Wittekind et 
al., 1988) 
NOY989  mata ade2-1 ura3-1 trp1-1 leu2-3,112 his3-11 can1-100 
rdn::URA3/pNOY353  
(Wai et al., 
2000) 
NOY886  matα ade2-1 ura3-1 his3-11,15 trp1-1 leu2-3,112 can1-100 
rpa135­::LEU2 fob1::HIS pNOY117 
(Cioci et al., 
2003) 
NOY1064  mata ade2-1 ura3-1 his3-11 trp1-1 leu2-3,112 can1-100 fob1::HIS3 (Cioci et al., 
2003) 
NOY1071  mata ade2-1 ura3-1 his3-11 trp1-1 leu2-3,112 can1-100 fob1::HIS3 (Cioci et al., 
2003) 
YPH500  matα ade2-101 his3-200 leu2-1 lys2-801 trp1-63 ura3-52 (Sikorski and 
Hieter, 1989) 
CARA YPH500 matα ade2-101 his3-200 leu2-1 lys2-801 trp1-63 ura3-52 RRN3::HIS5 
RPA43::kan pGEN-RRN3-A43 (TRP1) 
(Laferté et al., 
2006) 
y532 D101-I2 mata ade2-101 ura3-52 lys2-801 trp1-Δ63 his3-Δ200 leu2-Δ1 
rpa43::LEU2 yCPA43 (URA3) RPA135-ProtA::kanMX6 
(Gerber, 
2008) 
y601 BY4741 mata his3­1 leu2­0 met15­0 ura3­0 RPA12::KanMX4 EUROSCARF 
y612 D101-I2 mata ade2-101 ura3-52 lys2-801 trp1-Δ63 his3-Δ200 leu2-Δ1 
rpa43::LEU2 pRS314-rpa43-S208D (TRP1) 
(Gerber, 
2008) 
y658  ura3-52 his3-∆200 leu2-∆1 trp1∆63 lys2-801 ade2-101 prc1-1 
RRN3::RRN3-TAP (URA3) RPA43::RPA43-HA3 (HIS3) 
(Philippi, 
2007) 
y726 NOY222 matα trp1­1 his4­401 leu2-3,112 ura3-52 can1-100 RPA190::URA3 
RPA12::KanMX4 pNOY20 
(Reiter, 2007) 
y1178 D101-I2 mata ade2-101 ura3-52 lys2-801 trp1-Δ63 his3-Δ200 leu2-Δ1 
rpa43::LEU2 pRS314-rpa43-S262D (TRP1) 
this study 
MATERIAL AND METHODS 
90 
y1179 D101-I2 mata ade2-101 ura3-52 lys2-801 trp1-Δ63 his3-Δ200 leu2-Δ1 
rpa43::LEU2 pRS314-rpa43-S263D (TRP1) 
this study 
y1180 D101-I2 mata ade2-101 ura3-52 lys2-801 trp1-Δ63 his3-Δ200 leu2-Δ1 
rpa43::LEU2 pRS314-rpa43-S262/263D (TRP1) 
this study 
y1181 D101-I2 mata ade2-101 ura3-52 lys2-801 trp1-Δ63 his3-Δ200 leu2-Δ1 
rpa43::LEU2 pRS314-rpa43-S262/285D (TRP1) 
this study 
y1182 D101-I2 mata ade2-101 ura3-52 lys2-801 trp1-Δ63 his3-Δ200 leu2-Δ1 
rpa43::LEU2 pRS314-rpa43-S285D (TRP1) 
this study 
y1183 D101-I2 mata ade2-101 ura3-52 lys2-801 trp1-Δ63 his3-Δ200 leu2-Δ1 
rpa43::LEU2 pRS314-rpa43-S220D (TRP1) 
this study 
y1597 W303-1a mata ade2-1 can1-100 his3-11,-15 leu2-3,112 trp1-1 ura3-1 
RPA12::KanMX4 
this study 
y1598 NOY989 mata ade2-1 ura3-1 trp1-1 leu2-3,112 his3-11 can1-100 rdn-3xLexA this study 
y1599 NOY989 mata ade2-1 ura3-1 trp1-1 leu2-3,112 his3-11 can1-100 rdn-WT this study 
y1600 y726 matα trp1­1 his4­401 leu2-3,112 ura3-52 can1-100 RPA190::URA3 
RPA12::KanMX4 pRS314-RPA190-pGAL-RPA12 
this study 
y1601 y726 matα trp1­1 his4­401 leu2-3,112 ura3-52 can1-100 RPA190::URA3 
RPA12::KanMX4 pRS314-rpa190 S685A-pGAL-RPA12 
this study 
y1602 y726 matα trp1­1 his4­401 leu2-3,112 ura3-52 can1-100 RPA190::URA3 
RPA12::KanMX4 pRS314-rpa190 S685D-pGAL-RPA12 
this study 
y1612 y1598 mata ade2-1 ura3-1 trp1-1 leu2-3,112 his3-11 can1-100 rdn-3xLexA 
Δrpa12 
this study 
y1615 y1599 mata ade2-1 ura3-1 trp1-1 leu2-3,112 his3-11 can1-100 rdn-WT Δrpa49 this study 
y1618 y1599 mata ade2-1 ura3-1 trp1-1 leu2-3,112 his3-11 can1-100 rdn-WT Δrpa12 this study 
y1620 y1599 mata ade2-1 ura3-1 trp1-1 leu2-3,112 his3-11 can1-100 rdn-WT 
RPA190-MNase-3xHA::KanMX6 
this study 
y1697 y206 mata his3­1 leu2­0 met15­0 ura3­0 RRP6::kanMX4 EUROSCARF 
y2034 NOY989 mata ade2-1 ura3-1 trp1-1 leu2-3,112 his3-11 can1-100 rdn-LacR this study 
y2036 NOY989 mata ade2-1 ura3-1 trp1-1 leu2-3,112 his3-11 can1-100 rdn-1x601 this study 
y2037 NOY989 mata ade2-1 ura3-1 trp1-1 leu2-3,112 his3-11 can1-100 rdn-2x601 this study 
y2038 NOY989 mata ade2-1 ura3-1 trp1-1 leu2-3,112 his3-11 can1-100 rdn-TTF-I this study 
y2039 NOY989 mata ade2-1 ura3-1 trp1-1 leu2-3,112 his3-11 can1-100 rdn-TTF-I-
INVERT 
this study 
y2042 NOY989 mata ade2-1 ura3-1 trp1-1 leu2-3,112 his3-11 can1-100 rdn-ENH this study 
y2043 y2088 matα trp1­1 his4­401 leu2-3,112 ura3-52 can1-100 RPA190::URA3 
RPA12::NatMX RPA135-ProtA::KanMX pRS314-RPA190-pGAL-RPA12 
this study 
y2044 y2088 matα trp1­1 his4­401 leu2-3,112 ura3-52 can1-100 RPA190::URA3 
RPA12::NatMX RPA135-ProtA::KanMX pRS314-rpa190 S685A-pGAL-
RPA12 
this study 
y2045 y2088 matα trp1­1 his4­401 leu2-3,112 ura3-52 can1-100 RPA190::URA3 
RPA12::NatMX RPA135-ProtA::KanMX pRS314-rpa190 S685D-pGAL-
RPA12 
this study 
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y2050 y1599 mata ade2-1 ura3-1 trp1-1 leu2-3,112 his3-11 can1-100 rdn-WT REB1-
MNase-3xHA::KanMX6 
this study 
y2051 y1599 mata ade2-1 ura3-1 trp1-1 leu2-3,112 his3-11 can1-100 rdn-WT FOB1-
MNase-3xHA::KanMX6 
this study 
y2054 y2042 mata ade2-1 ura3-1 trp1-1 leu2-3,112 his3-11 can1-100 rdn-ENH REB1-
MNase-3xHA::KanMX6 
this study 
y2055 y2042 mata ade2-1 ura3-1 trp1-1 leu2-3,112 his3-11 can1-100 rdn-ENH FOB1-
MNase-3xHA::KanMX6 
this study 
y2056 y2038 mata ade2-1 ura3-1 trp1-1 leu2-3,112 his3-11 can1-100 rdn-TTF-I 
RPA190-MNase-3xHA::KanMX6 
this study 
y2088  matα trp1­1 his4­401 leu2-3,112 ura3-52 can1-100 RPA190::URA3 
RPA12::NatMX pNOY20 
this study 
y2089 D101-I2 mata ade2-101 ura3-52 lys2-801 trp1-Δ63 his3-Δ200 leu2-Δ1 
rpa43::LEU2 yCPA43 (URA3) RRN3-TEV-ProtA::kanMX6 
this study 
y2090 y1599 mata ade2-1 ura3-1 trp1-1 leu2-3,112 his3-11 can1-100 rdn-WT 
YDR026c-MNase-3xHA::KanMX6 
this study 
y2093 y2042 mata ade2-1 ura3-1 trp1-1 leu2-3,112 his3-11 can1-100 rdn-ENH 
YDR026c-MNase-3xHA::KanMX6 
this study 
y2094 y2042 mata ade2-1 ura3-1 trp1-1 leu2-3,112 his3-11 can1-100 rdn-ENH 
RPA190-MNase-3xHA::KanMX6 
this study 
y2229 y2276 mata ade2-1 ura3-1 trp1-1 leu2-3,112 his3-11 can1-100 rdn-WT 
ydr026c::klTRP1 RPA190-MNase-3xHA::KanMX6 
this study 
y2231 y2275 mata ade2-1 ura3-1 trp1-1 leu2-3,112 his3-11 can1-100 rdn-WT 
fob1::klTRP1 YDR026c-MNase-3xHA::KanMX6 
this study 
y2232 y2276 mata ade2-1 ura3-1 trp1-1 leu2-3,112 his3-11 can1-100 rdn-WT 
ydr026c::klTRP1 FOB1-MNase-3xHA::KanMX6 
this study 
y2234 y2281 mata ade2-1 ura3-1 trp1-1 leu2-3,112 his3-11 can1-100 rdn-ENH 
ydr026c::klTRP1 RPA190-MNase-3xHA::KanMX6 
this study 
y2236 y2280 mata ade2-1 ura3-1 trp1-1 leu2-3,112 his3-11 can1-100 rdn-ENH 
fob1::klTRP1 YDR026c-MNase-3xHA::KanMX6 
this study 
y2237 y2281 mata ade2-1 ura3-1 trp1-1 leu2-3,112 his3-11 can1-100 rdn-ENH 
ydr026c::klTRP1 FOB1-MNase-3xHA::KanMX6 
this study 
y2238 y2273 mata ade2-1 ura3-1 trp1-1 leu2-3,112 his3-11 can1-100 rdn-ENH T-rich 
FOB1-MNase-3xHA::KanMX6  
this study 
y2239 y2273 mata ade2-1 ura3-1 trp1-1 leu2-3,112 his3-11 can1-100 rdn-ENH T-rich 
YDR026c-MNase-3xHA::KanMX6 
this study 
y2240 y2274 mata ade2-1 ura3-1 trp1-1 leu2-3,112 his3-11 can1-100 rdn-ENH mut1 
FOB1-MNase-3xHA::KanMX6 
this study 
y2241 y2274 mata ade2-1 ura3-1 trp1-1 leu2-3,112 his3-11 can1-100 rdn-ENH mut1 
YDR026c-MNase-3xHA::KanMX6 
this study 
y2273 NOY989 mata ade2-1 ura3-1 trp1-1 leu2-3,112 his3-11 can1-100 rdn-ENH T-rich this study 
y2274 NOY989 mata ade2-1 ura3-1 trp1-1 leu2-3,112 his3-11 can1-100 rdn-ENH mut1 this study 
y2275 y1599 mata ade2-1 ura3-1 trp1-1 leu2-3,112 his3-11 can1-100 rdn-WT 
fob1::klTRP1 
this study 
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y2276 y1599 mata ade2-1 ura3-1 trp1-1 leu2-3,112 his3-11 can1-100 rdn-WT 
ydr026c::klTRP1 
this study 
y2280 y2042 mata ade2-1 ura3-1 trp1-1 leu2-3,112 his3-11 can1-100 rdn-ENH 
fob1::klTRP1 
this study 
y2281 y2042 mata ade2-1 ura3-1 trp1-1 leu2-3,112 his3-11 can1-100 rdn-ENH 
ydr026c::klTRP1 
this study 
y2285 y2034 mata ade2-1 ura3-1 trp1-1 leu2-3,112 his3-11 can1-100 rdn-LacR 
Δrpa12 
this study 
y2286 y2034 mata ade2-1 ura3-1 trp1-1 leu2-3,112 his3-11 can1-100 rdn-LacR 
Δrpa49 
this study 
y2287 y2038 mata ade2-1 ura3-1 trp1-1 leu2-3,112 his3-11 can1-100 rdn-TTF-I 
Δrpa12 
this study 
y2288 y2038 mata ade2-1 ura3-1 trp1-1 leu2-3,112 his3-11 can1-100 rdn-TTF-I 
Δrpa49 
this study 
y2289 y2039 mata ade2-1 ura3-1 trp1-1 leu2-3,112 his3-11 can1-100 rdn-TTF-I-
INVERT Δrpa12 
this study 
y2290 y2039 mata ade2-1 ura3-1 trp1-1 leu2-3,112 his3-11 can1-100 rdn-TTF-I-
INVERT Δrpa49 
this study 
y2313 D101-I2 mata ade2-101 ura3-52 lys2-801 trp1-Δ63 his3-Δ200 leu2-Δ1 
rpa43::LEU2 pRS314-rpa43-S208/220/262/263A (TRP1) 
this study 
y2314 D101-I2 mata ade2-101 ura3-52 lys2-801 trp1-Δ63 his3-Δ200 leu2-Δ1 
rpa43::LEU2 pRS314-rpa43-S208/220/262/263/285A (TRP1) 
this study 
y2315 D101-I2 mata ade2-101 ura3-52 lys2-801 trp1-Δ63 his3-Δ200 leu2-Δ1 
rpa43::LEU2 pRS314-rpa43-S220/262/263D (TRP1) 
this study 
y2316 D101-I2 mata ade2-101 ura3-52 lys2-801 trp1-Δ63 his3-Δ200 leu2-Δ1 
rpa43::LEU2 pRS314-rpa43-S208/220/262/263D (TRP1) 
this study 
y2317 D101-I2 mata ade2-101 ura3-52 lys2-801 trp1-Δ63 his3-Δ200 leu2-Δ1 
rpa43::LEU2 pRS314-rpa43-S208/220/262/263/285D (TRP1) 
this study 
y2323 NOY989 mata ade2-1 ura3-1 trp1-1 leu2-3,112 his3-11 can1-100 rdn-5`-ENH 
fwd 
this study 
y2325 y2323 mata ade2-1 ura3-1 trp1-1 leu2-3,112 his3-11 can1-100 rdn-5`-ENH 
fwd YDR026c-MNase-3xHA::KanMX6 
this study 
y2326 y2323 mata ade2-1 ura3-1 trp1-1 leu2-3,112 his3-11 can1-100 rdn-5`-ENH 
fwd FOB1-MNase-3xHA::KanMX6 
this study 
y2327 NOY989 mata ade2-1 ura3-1 trp1-1 leu2-3,112 his3-11 can1-100 rdn-5`-ENH rev this study 
y2329 y2327 mata ade2-1 ura3-1 trp1-1 leu2-3,112 his3-11 can1-100 rdn-5`-ENH rev 
YDR026c-MNase-3xHA::KanMX6  
this study 
y2330 y2327 mata ade2-1 ura3-1 trp1-1 leu2-3,112 his3-11 can1-100 rdn-5`-ENH rev 
FOB1-MNase-3xHA::KanMX6 
this study 
y2331 NOY989 mata ade2-1 ura3-1 trp1-1 leu2-3,112 his3-11 can1-100 rdn-3`-ENH 
fwd 
this study 
y2333 y2331 mata ade2-1 ura3-1 trp1-1 leu2-3,112 his3-11 can1-100 rdn-3`-ENH 
fwd YDR026c-MNase-3xHA::KanMX6 
 
this study 
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y2334 y2331 mata ade2-1 ura3-1 trp1-1 leu2-3,112 his3-11 can1-100 rdn-3`-ENH 
fwd FOB1-MNase-3xHA::KanMX6 
this study 
y2335 NOY989 mata ade2-1 ura3-1 trp1-1 leu2-3,112 his3-11 can1-100 rdn-3`-ENH rev this study 
y2337 y2335 mata ade2-1 ura3-1 trp1-1 leu2-3,112 his3-11 can1-100 rdn-3`-ENH rev 
YDR026c-MNase-3xHA::KanMX6 
this study 
y2338 y2335 mata ade2-1 ura3-1 trp1-1 leu2-3,112 his3-11 can1-100 rdn-3`-ENH rev 
FOB1-MNase-3xHA::KanMX6 
this study 
Y2339 NOY989 mata ade2-1 ura3-1 trp1-1 leu2-3,112 his3-11 can1-100 rdn-ENH mut2 this study 
 
 
5.1.2 Escherichia coli strains 
 
Name Genotype Origin 
XL1-blue endA1 gyrA96(nalR) thi-1 recA1 relA1 lac glnV44 F'[ ::Tn10 proAB+ lacIq 
∆(lacZ)M15] hsdR17(rK
- mK
+) 
Stratagene 
BL21 (DE3) F- ompT gal dcm lon hsdSB(rB
- mB
-) λ(DE3 [lacI lacUV5-T7 gene 1 ind1 sam7 
nin5]) 
Stratagene 
 
 
5.1.3 Plasmids 
 
# Name Gene Marker Features Origin 
48 YCplac22-pGAL  AmpR, TRP1 CEN4, ARS1 Hurt E. 
230 YCplac111-pGAL  AmpR, Leu2 CEN4, ARS1 Milkereit P. 
231 YCplac111-pGAL-FLAG  AmpR, Leu2 CEN4, ARS1 Milkereit P. 
375 pT11 rRNA AmpR  (Wild, 2005) 
652 pKM18 RPA190 AmpR, KanMX6  Merz K. 
774 pR3 LEXA AmpR, LEU2 CEN4, ARS1 (Reiter, 2007) 
825 pAG2.1 REB1 AmpR, KanMX6  Merz K. 
839 pAG24 FOB1 AmpR, KanMX6  Griesenbeck J. 
840 pAG25 YDR026c AmpR, KanMX6  Griesenbeck J. 
936 pAG36 kl. TRP1 AmpR  Griesenbeck J. 
1785 pT11-WT rRNA AmpR  this study 
1786 pT11-3xLexA rRNA AmpR  this study 
1787 pT11-TTF1 rRNA AmpR  this study 
1788 pT11-TTF1-invert rRNA AmpR  this study 
1789 pT11-1x LacI rRNA AmpR  this study 
1791 pT11-1x 601 rRNA AmpR  this study 
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1792 pT11-2x 601 rRNA AmpR  this study 
1793 pT11-ENH rRNA AmpR  this study 
1794 pT11-5`-ENH fwd rRNA AmpR  this study 
1795 pT11-5`-ENH rev rRNA AmpR  this study 
1796 pT11-3`-ENH fwd rRNA AmpR  this study 
1797 pT11-3`-ENH rev rRNA AmpR  this study 
1798 pT11-ENH-T-rich rRNA AmpR  this study 
1800 pT11-ENH-mut1 rRNA AmpR  this study 
1801 pT11-ENH-mut2 rRNA AmpR  this study 
1802 YCplac111-pGAL-FOB1 FOB1 AmpR, LEU2 CEN4, ARS1 this study 
1803 YCplac111-pGAL-
YDR026c 
YDR026c AmpR, LEU2 CEN4, ARS1 this study 
1804 YCplac111-pGAL-REB1 REB1 AmpR, LEU2 CEN4, ARS1 this study 
1805 YCplac111-pGAL-LexA LEXA AmpR, LEU2 CEN4, ARS1 this study 
1806 YCplac111-pGAL-LexA-
MNase 
LEXA AmpR, LEU2 CEN4, ARS1 this study 
1807 YCplac111-pGAL-TTF-I TTF-I AmpR, LEU2 CEN4, ARS1 this study 
1808 YCplac111-pGAL-TTF-I-
MNase 
TTF-I AmpR, LEU2 CEN4, ARS1 this study 
1809 YCplac111-pGAL-LacI LACI AmpR, LEU2 CEN4, ARS1 this study 
1810 YCplac111-pGAL-LacI-
MNase 
LACI AmpR, LEU2 CEN4, ARS1 this study 
1811 pRS314-rpa43 (S208D) RPA43 AmpR, TRP1 CEN6, ARSH4  this study 
1812 pRS314-rpa43 (S220D) RPA43 AmpR, TRP1 CEN6, ARSH4  this study 
1813 pRS314-rpa43 (S262D) RPA43 AmpR, TRP1 CEN6, ARSH4  this study 
1814 pRS314-rpa43 (S263D) RPA43 AmpR, TRP1 CEN6, ARSH4  this study 
1815 pRS314-rpa43 
(S262/263D) 
RPA43 AmpR, TRP1 CEN6, ARSH4  this study 
1816 pRS314-rpa43 (S285D) RPA43 AmpR, TRP1 CEN6, ARSH4  this study 
1817 pRS314-rpa43 
(S262/285D) 
RPA43 AmpR, TRP1 CEN6, ARSH4  this study 
1818 pRS314-rpa43 
(S208/220/262/263A) 
RPA43 AmpR, TRP1 CEN6, ARSH4  this study 
1819 pRS314-rpa43 
(S208/220/262/263/285A) 
RPA43 AmpR, TRP1 CEN6, ARSH4  this study 
1820 pRS314-rpa43 
(S220/262/263D) 
RPA43 AmpR, TRP1 CEN6, ARSH4  this study 
1821 pRS314-rpa43 
(S208/220/262/263D) 
RPA43 AmpR, TRP1 CEN6, ARSH4  this study 
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1822 pRS314-rpa43 
(S208/220/262/263/285D) 
RPA43 AmpR, TRP1 CEN6, ARSH4  this study 
1823 pRS314-rpa43 (S48A) RPA43 AmpR, TRP1 CEN6, ARSH4  this study 
1824 pRS314-rpa43 (S141A) RPA43 AmpR, TRP1 CEN6, ARSH4  this study 
1825 pRS314-rpa43 (S143A) RPA43 AmpR, TRP1 CEN6, ARSH4  this study 
1826 pRS314-rpa43 
(S141/143A) 
RPA43 AmpR, TRP1 CEN6, ARSH4  this study 
1827 pRS314-rpa43 (S156A) RPA43 AmpR, TRP1 CEN6, ARSH4  this study 
1828 pRS314-rpa43 (S213A) RPA43 AmpR, TRP1 CEN6, ARSH4  this study 
1829 pRS314-rpa43 (S244A) RPA43 AmpR, TRP1 CEN6, ARSH4  this study 
1830 pRS314-rpa43 (S48D) RPA43 AmpR, TRP1 CEN6, ARSH4  this study 
1831 pRS314-rpa43 (S141D) RPA43 AmpR, TRP1 CEN6, ARSH4  this study 
1832 pRS314-rpa43 (S143D) RPA43 AmpR, TRP1 CEN6, ARSH4  this study 
1833 pRS314-rpa43 
(S141/143D) 
RPA43 AmpR, TRP1 CEN6, ARSH4  this study 
1834 pRS314-rpa43 (S156D) RPA43 AmpR, TRP1 CEN6, ARSH4  this study 
1835 pRS314-rpa43 (S213D) RPA43 AmpR, TRP1 CEN6, ARSH4  this study 
1836 pRS314-rpa43 (S244D) RPA43 AmpR, TRP1 CEN6, ARSH4  this study 
1837 pCM182-Leu  AmpR, LEU2 CEN4, ARS1 this study 
1838 pCM182-Leu-RPA12 RPA12 AmpR, LEU2 CEN4, ARS1 this study 
1839 pCM182-Leu-rpa12 (1-69) 
(rpa12ΔC) 
RPA12 AmpR, LEU2 CEN4, ARS1 this study 
1840 pCM182-Leu-rpa12 (69-
125)  (rpa12ΔN) 
RPA12 AmpR, LEU2 CEN4, ARS1 this study 
1841 YCplac111-pGAL-RPA12 RPA12 AmpR, LEU2 CEN4, ARS1 (Gerber, 2008) 
1842 YCplac111-pGAL-rpa12 
(D105A) 
RPA12 AmpR, LEU2 CEN4, ARS1 this study 
1843 YCplac111-pGAL-rpa12 
(E106A) 
RPA12 AmpR, LEU2 CEN4, ARS1 this study 
1844 YCplac111-pGAL-rpa12 
(DE/AA) 
RPA12 AmpR, LEU2 CEN4, ARS1 (Gerber, 2008) 
1845 YCplac111-pGAL-FLAG-
RPA12  
RPA12 AmpR, LEU2 CEN4, ARS1 this study 
1846 YCplac111-pGAL-FLAG-
rpa12 (D105A) 
RPA12 AmpR, LEU2 CEN4, ARS1 this study 
1847 YCplac111-pGAL-FLAG-
rpa12 (E106A) 
RPA12 AmpR, LEU2 CEN4, ARS1 this study 
1848 YCplac111-pGAL-FLAG-
rpa12 (DE/AA) 
 
RPA12 AmpR, LEU2 CEN4, ARS1 this study 
MATERIAL AND METHODS 
96 
1849 YCplac111-pGAL-RPA12-
FLAG  
RPA12 AmpR, LEU2 CEN4, ARS1 this study 
1850 YCplac111-pGAL-rpa12 
(DE/AA)-FLAG  
RPA12 AmpR, LEU2 CEN4, ARS1 this study 
1861 pRS314-RPA190-pGAL-
RPA12 
RPA190, 
RPA12 
AmpR, TRP1 CEN6, ARSH4  this study 
1862 pRS314-rpa190-S685A-
pGAL-RPA12 
RPA190, 
RPA12 
AmpR, TRP1 CEN6, ARSH4  this study 
1863 pRS314-rpa190-S685D-
pGAL-RPA12 
RPA190, 
RPA12 
AmpR, TRP1 CEN6, ARSH4  this study 
1864 YCplac22-pGAL-RPA43 RPA43 AmpR, TRP1 CEN4, ARS1 this study 
1865 YCplac22-pGAL-rpa43 
(S141/143A) 
RPA43 AmpR, TRP1 CEN4, ARS1 this study 
1866 YCplac22-pGAL-rpa43 
(S141/143D) 
RPA43 AmpR, TRP1 CEN4, ARS1 this study 
1867 YCplac22-pGAL-FLAG  AmpR, TRP1 CEN4, ARS1 this study 
1868 YCplac22-pGAL-FLAG-
RPA43 
RPA43 AmpR, TRP1 CEN4, ARS1 this study 
1869 YCplac22-pGAL-FLAG-
rpa43 (S141/143A) 
RPA43 AmpR, TRP1 CEN4, ARS1 this study 
1870 YCplac22-pGAL-FLAG-
rpa43 (S141/143D) 
RPA43 AmpR, TRP1 CEN4, ARS1 this study 
1871 YCplac22-pGAL-RPA43-
FLAG 
RPA43 AmpR, TRP1 CEN4, ARS1 this study 
1872 YCplac22-pGAL-rpa43 
(S141/143A)-FLAG 
RPA43 AmpR, TRP1 CEN4, ARS1 this study 
1873 YCplac22-pGAL-rpa43 
(S141/143D)-FLAG 
RPA43 AmpR, TRP1 CEN4, ARS1 this study 
1874 pET21b-A14/A43 RPA14, 
RPA43 
AmpR pBR322 
origin, f1 
origin 
(Geiger et al., 2008) 
1876 pET21b-A14/A43 
(S141/143A) 
RPA14, 
RPA43 
AmpR pBR322 
origin, f1 
origin 
this study 
1877 pET21b-A14/A43 
(S141/143D) 
RPA14, 
RPA43 
AmpR pBR322 
origin, f1 
origin 
this study 
1884 pRS314-RPA43-pGAL-
RPA43 
RPA43 AmpR, TRP1 CEN6, ARSH4 this study 
1885 pRS314-rpa43 
(S141/143A) -pGAL-RPA43 
RPA43 AmpR, TRP1 CEN6, ARSH4 this study 
1886 pRS314-rpa43 
(S141/143D)-pGAL-RPA43 
 
RPA43 AmpR, TRP1 CEN6, ARSH4 this study 
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1887 pRS314-RPA43-pGAL-
FLAG-RPA43 
RPA43 AmpR, TRP1 CEN6, ARSH4 this study 
1888 pRS314-rpa43 
(S141/143A)-pGAL-FLAG-
RPA43 
RPA43 AmpR, TRP1 CEN6, ARSH4 this study 
1889 pRS314-rpa43 
(S141/143D)-pGAL-FLAG-
RPA43 
RPA43 AmpR, TRP1 CEN6, ARSH4 this study 
 pRset-deltaNTTF TTF-I AmpR pUC ori, f1 
origin 
(Németh et al., 
2004) 
 
 
5.1.4 Oligonucleotides 
 
# Name Sequence Gene/locus 
683 No6 TCCGTATTTTCCGCTTCCGC rDNA 
698 fob1_A TTCATCATACCTAACATTGTGATCG FOB1 
710 M1 TGGAGCAAAGAAATCACCGC rDNA 
711 M2 CCGCTGGATTATGGCTGAAC rDNA 
712 M3 GAGTCCTTGTGGCTCTTGGC rDNA 
713 M4 AATACTGATGCCCCCGACC rDNA 
817 rDNA-709_for GAGGGACGGTTGAAAGTG rDNA 
818 rDNA-461_rev ATACGCTTCAGAGACCCTAA rDNA 
920 5S ChIP-F1 GCCATATCTACCAGAAAGCACC 5S 
921 5S ChIP-R1 GATTGCAGCACCTGAGTTTCG 5S 
969 Prom ChIP-F2 TCATGGAGTACAAGTGTGAGGA rDNA 
970 Prom ChIP-R1 TAACGAACGACAAGCCTACTC rDNA 
1049 R25 GCTTAGAGAAGGGGGCAACT rDNA 
1056 fob1_D GCCTCTTGTAATATTGTTCAAGGAA FOB1 
1064 3_LEXA_up CAGATATCCTTAAGGCCGAAAGATTAAAATCAA
CG 
LexA-BS 
1065 3_LEXA_down CAGATATCCTTAAGCGGGTCGACTCTAGAGGAT
CT 
LexA-BS 
1191 Kpn_sonde_up TGAGCGTCATTTCCTTCTCA rDNA 
1192 Kpn_sonde_down ATCCCGGTTGGTTTCTTTTC rDNA 
1199 RPA49for GCATAGAATAAGAACTTGACC RPA49 
1200 RPA49rev TCACCTATATAACACGTTGG RPA49 
1203 RPA135-pYM-for CTATCCGCAATGGGTATAAGATTGCGTTATAAT
GTAGAGCCCAAACGTACGCTGCAGGTCGAC 
pYM 
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1204 RPA135-pYM-rev CCTTCATTTACCATTCTATATCAATTTGGAAAGA
AGGGTATTTCTATCGATGAATTCGAGCTC 
pYM 
1600 Mnase-lexa-for-1 ATTCAAGCTGTACAGTACATATGTCGTACGCTG
CAGG 
MNase (pKM9) 
1601 Mnase-lexa-rev ATTCAAGCTGTACAGTACATATGTCGTACGCTG
CAGG 
MNase (pKM9) 
1603 RPA43-down CTACGTATGCAGGACTATTGAT RPA43 
1604 RPA43-208-Asp-up GGGCAAATTTGACTTTGGAAAC RPA43 
1605 RPA43-208-Asp-do GTTTCCAAAGTCAAATTTGCCC RPA43 
1606 RPA43-220-Asp-up CTGGGTAGATGATAATGGTGAA RPA43 
1607 RPA43-220-Asp-do TTCACCATTATCATCTACCCAG RPA43 
1608 RPA43-262-Asp-up ATGGCTATAACGACTCTCGTTC RPA43 
1609 RPA43-262-Asp-do GAACGAGAGTCGTTATAGCCAT RPA43 
1610 RPA43-263-Asp-up CTATAACAGCGATCGTTCCCAA RPA43 
1611 RPA43-263-Asp-do TTGGGAACGATCGCTGTTATAG RPA43 
1612 RPA43-262/63-Asp-
up 
GCTATAACGACGATCGTTCCCA RPA43 
1613 RPA43-262/63-Asp-
do 
TGGGAACGATCGTCGTTATAGC RPA43 
1614 RPA43-285-Asp-up GACGAAGTTGATATCGAAAAC RPA43 
1615 RPA43-285-Asp-do GTTTTCGATATCAACTTCGTC RPA43 
1617 RPA43-262/63-Ala-
up 
GCTATAACGCCGCTCGTTCCCA RPA43 
1618 RPA43-262/63-Ala-
do 
TGGGAACGAGCGGCGTTATAGC RPA43 
1619 RPA43-285-Ala-up GACGAAGTTGCAATCGAAAAC RPA43 
1620 RPA43-285-Ala-do GTTTTCGATTGCAACTTCGTC RPA43 
1621 A190-AhdI-up AGATGGTAAGCCCTCCCGTAT RPA190 
1622 A190-EcoRI-up CAAGCTCGGAATTCACCCTCACTAAA RPA190 
1623 A190-EcoRI-do TTTAGTGAGGGTGAATTCCGAGCTTG RPA190 
1624 A190-BamHI-do CCGTAGGATTGGTAATTTGCT RPA190 
1626 A43-S48Ala-up CTCTATGTTGCTTTGGCACCAA RPA43 
1627 A43-S48Ala-do TTGGTGCCAAAGCAACATAGAG RPA43 
1628 A43-S48Asp-up CTCTATGTTGATTTGGCACCAA RPA43 
1630 A43-S141Ala-up TTTCATTCAAGCCGCCTCACAC RPA43 
1631 A43-S141Ala-do GTGTGAGGCGGCTTGAATGAAA RPA43 
1632 A43-S141Asp-up TTTCATTCAAGACGCCTCACAC RPA43 
1634 A43-S143Ala-up TCAATCCGCCGCACACATTGGT RPA43 
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1635 A43-S143Ala-do ACCAATGTGTGCGGCGGATTGA RPA43 
1636 A43-S143Asp-up TCAATCCGCCGATCACATTGGT RPA43 
1638 A43-S141/43Ala-up CATTCAAGCCGCCGCACACATT RPA43 
1639 A43-S141/43Ala-do AATGTGTGCGGCGGCTTGAATG RPA43 
1640 A43-S141/43Asp-
up 
CATTCAAGACGCCGATCACATT RPA43 
1642 A43-S156Ala-up GTTTAATGCTGCTATCAAAAAG RPA43 
1643 A43-S156Ala-do CTTTTTGATAGCAGCATTAAAC RPA43 
1644 A43-S156Asp-up GTTTAATGCTGATATCAAAAAG RPA43 
1646 A43-S213Ala-up TGGAAACAGAGCTTTGGGCCAC RPA43 
1647 A43-S213Ala-do GTGGCCCAAAGCTCTGTTTCCA RPA43 
1648 A43-S213Asp-up TGGAAACAGAGATTTGGGCCAC RPA43 
1650 A43-S244Ala-up AAGAGTTGTTGCTGTGGACGGT RPA43 
1651 A43-S244Ala-do ACCGTCCACAGCAACAACTCTT RPA43 
1652 A43-S244Asp-up AAGAGTTGTTGATGTGGACGGT RPA43 
1729 FOB1_KO_f TTAAGCCTTCAGGGGGGAGAACAATTTAACGAT
TGTGTGAGTGTGAATTTCGTACGCTGCAGGTCG
AC 
klTRP1 
1731 YDR026C_KO_f AGAGCAAGCAGCCGTTTCTTGTCTGCGTCAAGA
AGAAAGATAAAGGTAGACGTACGCTGCAGGTC
GAC 
klTRP1 
1738 YDR026C_A TGAAGAAATGATCAAACAATGAAGA YDR026c 
1739 YDR026C_D AGCTGGTTATGAATCAGCATAAGAC YDR026c 
1745 FOB1_r CTACCGCGGTTTTTTTTTCACCTATGGTGACTCC
TCCTTTCATTCTATCCTACATATTAATCGATGAA
TTCGAGCTCG 
klTRP1 
1747 YDRC026C_r CTACCGCGGAATATGCTTTTATCTATTGGGTCTG
TATATGTTTGGGAAAGTAACCCTTCATCGATGA
ATTCGAGCTCG 
klTRP1 
2099 5S_probe_fwd TGTCCTCCACCCATAACACC rDNA 
2100 5S_probe_rev ATTTAGCATAGGAAGCCAAG rDNA 
2731 Flag-up CCCCGGATCGGATCCATGTCTGTT RPA12 
2732 Flag-do CCTTGCATGCTCACTTATCGTCGTCATCCTTGTA
ATCATTGTTGGTACGGAACTTGTAACC 
RPA12 
2733 NdeI-up GCAAGGATACGATCTGATCATATGC RPA43 
2734 S48D-do ACATTGGTGCCAAATCAACATAGAG RPA43 
2735 S141D-do AATGTGTGAGGCGTCTTGAATGAAA RPA43 
2736 S143D-do AAGACCAATGTGATCGGCGGATTGA RPA43 
2737 S141/43D-do ACCAATGTGATCGGCGTCTTGAATG RPA43 
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2738 S156D-do ATTCTTTTTGATATCAGCATTAAAC RPA43 
2739 S213D-do CCAGTGGCCCAAATCTCTGTTTCCA RPA43 
2740 S244D-do TGTACCGTCCACATCAACAACTCTT RPA43 
2744 A43-pET-do CAACGTCAAAGGGCGAAAAACC RPA43 
2745 A43-141/43A-do ACCAATGTGTGCGGCGGCTTGAATG RPA43 
2746 A43-141/43D-do AGACCAATGTGATCGGCGTCTTGAATGAA RPA43 
2748 A43-pET-up1 CGAGATCTCGATCCCGCGAAATTAATAC RPA43 
2759 A43-BamHI-up CGGATCGGATCCATGTCACAAGTAAAAAG RPA43 
2760 A43-SphI-do CCGTAGCATGCCTACTAATCACTATCACTCG RPA43 
2761 A43-Flag-do CCTTGCATGCTCACTTATCGTCGTCATCCTTGTA
ATCATCACTATCACTCGATTCACCAT 
RPA43 
2764 A12-up-BamHI CGGATCGGATCCATGTCTGTTGTA RPA12 
2765 A12-D105A-up TAAGATCTGCAGCTGAAGGTGCTAC RPA12 
2766 A12-D105A-do GTAGCACCTTCAGCTGCAGATCTTA RPA12 
2767 A12-E106A-up GATCTGCAGATGCAGGTGCTACTGT RPA12 
2768 A12-E106A-do ACAGTAGCACCTGCATCTGCAGATC RPA12 
2769 A12-do-SphI ATTACGCCAAGCTTGCATGCGGAT RPA12 
2770 A12-up-new AAGTGAAGGGCATTGCATGGCAA RPA12 
2771 A12-do-new GATGTTCACATGATGAAAGCGGG RPA12 
2794 A12-69/125-
BamHI-up 
GATGCGGATCCATGTCTTTGAAGAAGAACGAA
CTGAAA 
RPA12 
2797 601-up-AflII GATGCACTTAAGGAATTCGAGCTCGGTACCCG
GGTG 
601-NPS 
2798 601-do-AflII GATGCACTTAAGGGATCCCCGGGATGTATATAT
CTGA 
601-NPS 
2801 1xTTF1-up-AflII TTAAGACTTCGGAGGTCGACCAGTACTCCGC TTF-I-BS 
2802 1xTTF1-do-AflII TTAAGCGGAGTACTGGTCGACCTCCGAAGTC TTF-I-BS 
2803 1xlacR-up-AflII TTAAGTGTGGAATTGTGAGCGGATAACAATTTC
ACAC 
LacR-BS 
2804 1xlacR-do-AflII TTAAGTGTGAAATTGTTATCCGCTCACAATTCCA
CAC 
LacR-BS 
2807 A12-1/69-NotI-do GATGCGCGGCCGCTCAAGTTTTAACCACGGATT
TCTTGGCTCT 
RPA12 
2808 A12-69/125-NotI-
do 
GATGCGCGGCCGCTCAACAACCCAATCAATTGT
TGGTACGGAA 
RPA12 
2811 Enh-AflII-up GATGCACTTAAGAATTCTATGATCCGGGTAAAA
ACA 
rDNA 
2814 RFB-AflII-do GATGCACTTAAGTCAATTCTCTAAACTTATACAA
G 
rDNA 
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2815 pLacI-BamHI-up GATGCGGATCCATGGTGAAACCAGTAACGTTAT
ACGAT 
LacI 
2816 pLacI-XbaI-do GATGCTCTAGACTGCCCGCTTTCCAGTCGGGAA
AC 
LacI 
2817 MNase-XbaI-up GATGCTCTAGAGAATTCAAAATGCCCAAGAAG
AAG 
MNase  
2818 MNase-SbfI-do GATGCCCTGCAGGTCATTACCGGTAGCGTAGTC
TGGAACG 
MNase 
2820 dNTTF1-BamHI-up GATGCGGATCCATGGAGAGCACCAAAGAATCC
CACAGT 
TTF-I (pRset-
deltaNTTF) 
2821 dNTTF1-XbaI-do GATGCTCTAGACTGCACATCAGAGGCGCTGGG
CTC 
TTF-I (pRset-
deltaNTTF) 
2825 A43-PstI-DO GATGCCTGCAGATCACTATCACTCGATTCACCA
TC 
RPA43 
2826 A43-PstI-stop-DO GATGCCTGCAGCTAATCACTATCACTCGATTCA
CCATC 
RPA43 
2827 pLacI-XbaI-stop GATGCTCTAGATCACTGCCCGCTTTCCAGTCGG
GAAAC 
LacI 
2828 dNTTF1-XbaI-stop GATGCTCTAGATCACTGCACATCAGAGGCGCTG
GGCTC 
TTF-I (pRset-
deltaNTTF) 
2829 LexA-BamHI-up GATGCGGATCCATGAAAGCGTTAACGGCCAGG
CAA 
pR3 
2830 LexA-XbaI-stop GATGCTCTAGATCACAGCCAGTCGCCGTTGCGA
ATAA 
pR3 
2832 SOE-NheI-up CGAGACCTTAACCTACTAAATAGTG rDNA 
2833 SOE-XhoI-do AACCCTCACTAAAGGGAACAAAAGCT rDNA 
2836 Reb1-BS-a-up AATTCTATGATCCTTGTAAAAACATGT rDNA 
2837 Reb1-BS-a-do ACATGTTTTTACAAGGATCATAGAATT rDNA 
2838 Reb1-BS-b-up ATGATCCGGGTAACCCCATGTATTGTA rDNA 
2839 Reb1-BS-b-do TACAATACATGGGGTTACCCGGATCAT rDNA 
2840 FOB1-Bam-up GATGCGGATCCATGACGAAACCGCGTTACAAT
GACGT 
FOB1 
2841 FOB1-Xba-do GATGCTCTAGATCATTATTACAATTCCATTGATG
TGCCAA 
FOB1 
2842 YDR026c-Bam-up GATGCGGATCCATGGACAGCGTGTCAAACCTTA
AGAG 
YDR026c 
2843 YDR026c-Xba-do GATGCTCTAGATCATTAATTGATTTGTTCCAACA
ATGAA 
YDR026c 
2847 E-T-rich-do ACAAATAAAATTTATAGAGACCGCAGGCCCGG
CTGGACTCTCCATC 
rDNA 
2848 E-T-rich-up GTCTCTATAAATTTTATTTGTCTTAAGAATTCTAT
GATCCGGGTAA 
rDNA 
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2851 GAL-EcoRI-up CAGTGAATTCTTATATTGAATTTTC GAL1 
2852 A43-Xho-do GACACTCGAGCTAATCACTATCACTCGATTCAC
CAT 
RPA43 
2863 R25-rev-q CGGCTGGACTCTCCATCTCT rDNA 
2864 IGS2-up-q GCATGCCTGTTTGAGCGTC rDNA 
2865 IGS2-do-q CGACCGTACTTGCATTATACC rDNA 
2874 REB1-prom-do1 CCGAGATCATATCACTGTGG pT11 
2877 Enh-AflII-do2 GATGCACTTAAGGTAACTTACATACATTAGTAA
ATGG 
rDNA 
2878 RFB-AflII-up2 GATGCACTTAAGTTCGTTGCAAAGATGGGTTGA
AAG 
rDNA 
2879 RFB-AflII-do2 GATGCACTTAAGTGTTAACTATAGGAAATGAGC
TTTT 
rDNA 
2882 25S-Jo-up ATCATTTGTATACGACTTAGATGTACAACG rDNA 
2883 25S-Jo-do AACAAATCAGACAACAAAGGCTTAATC rDNA 
2884 3`-REB-Jo-up TACGATGAGGATGATAGTGTGTAAGAGTG rDNA 
2885 3`-REB-Jo-do TACGATGAGGATGATAGTGTGTAAGAGTG rDNA 
2886 Fob-bs-Jo-up GAGAAAAGCTCATTTCCTATAGTTAACAG rDNA 
2887 Fob-bs-Jo-do TTCACTTGTCTCTTACATCTTTCTTGG rDNA 
2997 REB1-TER-do CACTCTTACACACTATCATCCTCATCGTA rDNA 
2998 REB1-TER-up GCCTAGTTTAGAGAGAAGTAGACTGAACA rDNA 
 
 
5.1.5 Southern Probes 
 
Name Synthesis Locus Restriction 
enzyme 
Fragment 
size 
KpnI-probe PCR from genomic DNA using primers  
#1191/#1192 
rDNA KpnI 10.3kb 
25S-18S-probe NcoI digestion of pNOY373 and 
purification of a 3.4kb fragment 
rDNA EcoRI 3.4kb 
5S-probe PCR from genomic DNA using primers  
#2099/#2100 
rDNA AlwNI 5.4kb 
XcmI-prom-
probe 
PCR from genomic DNA using primers  
#817/#818 
rDNA XcmI 4.9kb 
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5.1.6 Northern probes 
 
# Name Sequence 
204 o1-5’A0 GGTCTCTCTGCTGCCGG 
205 o2-18S CATGGCTTAATCTTTGAGAC 
212 o9-25S CTCCGCTTATTGATATGC 
1819 ext_ITS1_2 GTAAAAGCTCTCATGCTCTTGCC 
2880 AflII-A2-probe1 ACTTACAAGCCTAGCAAGACCG 
 
 
5.1.7 Antibodies 
 
Antibody Species Dilution Origin 
α-A43 rabbit 1:50000 A. Sentenac, Paris (Buhler et al., 
1980)  
α-A135 rabbit 1:50000 A. Sentenac, Paris (Buhler et al., 
1980)  
α-HA (3F10) rat 1:5000 Roche 
α-mouse IgG (H+L) (peroxidase-conjugated) goat 1:5000 Jackson IR/Dianova 
α-rabbit IgG (H+L) (peroxidase-conjugated) goat 1:5000 Jackson IR/Dianova 
α-rat IgG+IgM (H+L) (peroxidase-
conjugated) 
goat 1:5000 Jackson IR/Dianova 
PAP (peroxidase anti-peroxidase) rabbit 1:5000 DakoCytomation 
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5.1.8 Enzymes 
 
Enzyme Origin 
Antarctic Phosphatase New England Biolabs 
HotStarTaq DNA Polymerase Qiagen 
iProof High-Fidelity DNA Polymerase Bio-Rad 
Restriction Endonucleases New England Biolabs 
T4 DNA Ligase New England Biolabs 
Taq DNA Polymerase New England Biolabs 
Go Taq DNA Polymerase Promega 
Trypsin, sequencing grade Roche 
RNase A Invitrogen 
Proteinase K Sigma-Aldrich 
Zymolyase 100T Seikagaku Corporation 
 
 
5.1.9 Kits 
 
Kit Origin 
PureLinkTM PCR Purification Kit Invitrogen 
PureLinkTM Quick Gel Extraction Kit Invitrogen 
PureLinkTM Quick Plasmid Miniprep Kit Invitrogen 
RadPrime DNA Labeling System Invitrogen 
 
 
5.1.10 Media 
 
Medium Composition 
YPD 
(yeast extract, peptone, dextrose) 
1% (w/v) yeast extract 
2% (w/v) peptone 
2% (w/v) glucose 
YPD+gen/+hyg 
(YPD plus geneticin/hygromycin B) 
YPD + 200 µg/ml geneticin (G418) / + 300 µg/ml 
hygromycin B 
YPAD 
(YPD plus adenine) 
YPD + 100 mg/l adenine 
YPUD 
(YPD plus uracil) 
YPD + 2 mg/ml uracil 
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YPD+dox 
(YPD plus doxycycline) 
YPD + 10 µg/ml doxycycline 
2% (w/v) agar 
YPG 
(yeast extract, peptone, galactose) 
1% (w/v) yeast extract 
2% (w/v) peptone 
2% (w/v) galactose 
YPUG 
(YPG plus uracil) 
YPG + 2 mg/ml uracil 
YPG+gen/+hyg 
(YPG plus geneticin/hygromycin B) 
YPG + 200 µg/ml geneticin (G418) / + 300 µg/ml 
hygromycin B 
YPG+dox 
(YPG plus doxycycline) 
YPG + 10 µg/ml doxycycline 
2% (w/v) agar 
SCD 
(synthetic complete dextrose) 
0.67% (w/v) YNB + nitrogen 
0.062% (w/v) CSM-his-leu-trp 
2% (w/v) glucose 
+ 20 mg/l L-histidine 
+ 100 mg/l L-leucine 
+ 50 mg/l L-tryptophan 
SCD-leu/-trp 
(SCD minus leucine/tryptophan) 
0.67% (w/v) YNB + nitrogen 
0.062% (w/v) CSM-his-leu-trp 
2% (w/v) glucose 
+ 20 mg/l L-histidine 
+ 50 mg/l L-tryptophan / + 100 mg/l L-leucine 
SCD-arg-trp 0.67% (w/v) YNB + nitrogen 
0,006% (w/v) CSM-arg-his-lys-trp-ura 
2% (w/v) glucose 
+ 20 mg/l L-histidine 
+ 50 mg/l L-lysine 
+ 20 mg/l uracil 
SCD-arg-trp + CAN SCD-arg-trp + 6 mg/l L-canavanine 
SCD-leu+5FOA 
(SCD minus leucin plus 5-FOA) 
SCD-leu + 0.1% (w/v) 5-FOA 
SCD-trp+5FOA 
(SCD minus tryptophan plus 5-FOA) 
SCD-trp + 0.1% (w/v) 5-FOA 
SCG 
(synthetic complete galactose) 
0.67% (w/v) YNB + nitrogen 
0.062% (w/v) CSM-his-leu-trp 
2% (w/v) galactose 
+ 20 mg/l L-histidine 
+ 100 mg/l L-leucine 
+ 50 mg/l L-tryptophan 
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SCG-leu 
(SCG minus leucine) 
0.67% (w/v) YNB + nitrogen 
0.062% (w/v) CSM-his-leu-trp 
2% (w/v) galactose 
+ 20 mg/l L-histidine 
+ 50 mg/l L-tryptophan 
SCR 
(synthetic complete raffinose) 
0.67% (w/v) YNB + nitrogen 
0.13% AAM-leu-ura-his 
+ 100 mg/l L-leucine 
+ 20 mg/l L-uracil 
+ 20 mg/l L-histidine 
+ 2% (w/v) raffinose 
SCR-leu 
(SCR minus leucine) 
0.67% (w/v) YNB + nitrogen 
0.13% AAM-leu-ura-his 
+ 20 mg/l L-uracil 
+ 20 mg/l L-histidine 
+ 2% (w/v) raffinose 
SCR-leu+gal 
(SCR minus leucine plus galactose) 
SCR-leu + 2% (w/v) galactose 
LB 
(luria broth) 
1% (w/v) tryptone 
0.5% (w/v) yeast extract 
0.5% (w/v) NaCl 
LB+amp 
(LB plus ampicillin) 
LB + 100 µg/ml ampicillin 
The solvent is H2O, if not indicated otherwise. The pH values were measured at room 
temperature (RT).  
 
 
5.1.11 Buffers 
 
Buffer Ingredients Concentration 
5x TBE buffer Tris 
Boric acid 
EDTA 
 
445mM 
445mM 
10mM 
10x DNA loading buffer Bromphenol blue 
Xylen cyanol 
Glycerine 
 
0,25% 
0,25% 
40% 
10x MOPS buffer Sodium acetate trihydrate 
MOPS (Fluka) 
EDTA pH8 
pH7 with NaOH 
 
 
 
 
20mM 
0,2M 
10mM 
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RNA hybridisation buffer Formamide deionised 
SSC 
SDS 
H2O 
Denhards 
 
50% 
5x 
0,5% 
10% 
5x 
50x Denhards Ficoll (Typ 400) 
Polyvinylpyrolidone 
BSA (Fraction 5) 
Store at -20°C 
 
10 mg/ml 
10 mg/ml 
10 mg/ml 
RNA solubilisation buffer Formamide 
Formaldehyde 
MOPS buffer 
H2O 
 
50% 
8% 
1x 
18% 
Buffer R Glucose 
Peptone 
Malt extract 
Yeast extract 
Mannitol 
Magnesium acetate 
 
2% 
1% 
0,6% 
0,01% 
12% 
17,8mM 
20x SSC NaCl 
Tri-sodium citrate dehydrate 
pH7 with HCl 
 
3M 
0,3M 
Protease inhibitors 100x Benzamidine 
PMSF 
33 mg/ml 
17 mg/ml 
10x Electrophoresis buffer Tris 
Glycine 
SDS 
 
250mM 
192mM 
1% 
Transfer buffer (Western Blot) Tris 
Glycine 
Methanol 
 
25mM 
192mM 
20% 
4x Upper Tris Tris 
SDS 
Bromphenol blue 
pH 6,8 with HCl 
 
0,5M 
0,4% 
4x Lower Tris Tris 
SDS 
pH 8,8 with HCl 
 
1,5M 
0,4% 
HU buffer SDS 
Tris-HCl pH 6,8 
EDTA 
β-mercapto-ethanol 
Urea 
Bromphenol blue, store at -20°C 
 
5% 
200mM 
1mM 
1,5% 
8M 
TELit LiOAc 
Tris-HCl pH 8 
EDTA pH 8 
pH 8 with HOAc 
 
 
100mM 
10mM 
1mM 
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LitSorb Sorbitol 
Dissolved in TELit 
sterile filtration, store at 4°C 
 
1M 
Buffer A200 Tris-HCl pH 8 
KCl 
MgAc 
Triton X-100 
DTT 
Protease inhibitors 
 
20mM 
200mM 
5mM 
0,2% 
1mM 
1x 
Buffer MB Tris-HCl pH 8 
KCl 
MgAc 
Protease inhibitors 
 
20mM 
200mM 
5mM 
1x 
AE buffer NaOAc pH 5,3 
EDTA pH 8 
Xylene cyanol FF (Sigma) 
Bromphenole blue 
 
50mM 
10mM 
0,025% 
0,025% 
5x MaBS Maleic acid 
NaCl 
pH 7,5 
 
0,5M 
0,75M 
IRN buffer Tris-HCl pH 8 
EDTA 
NaCl 
 
50mM 
20mM 
0,5M 
Buffer A (ChEC) Tris-HCl pH 7,4 
Spermine 
Spermidine 
KCl 
EDTA 
 
15mM 
0,2mM 
0,5mM 
80mM 
4mM 
Buffer Ag (ChEC) Buffer A without EDTA 
EGTA 
 
 
0,1mM 
10x PBS NaCl 
KCl 
Na2HPO4 x2H2O 
KH2PO4 
pH 7,4 with HCl or NaOH 
 
1,37M 
27mM 
10mM 
20mM 
PBST PBS 
Tween 20 
 
1x 
0,05% 
ChIP Lysis buffer Hepes pH 7,5 
NaCl 
EDTA 
EGTA 
Triton X-100 
DOC 
 
50mM 
140mM 
5mM 
5mM 
1% 
0,1% 
ChIP Wash buffer I Hepes pH 7,5 
NaCl 
EDTA 
Triton X-100 
DOC 
50mM 
500mM 
2mM 
1% 
0,1% 
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ChIP Wash buffer II Tris-HCl pH 8 
LiCl 
EDTA 
Nonidet P40 
DOC 
 
10mM 
250mM 
2mM 
0,5% 
0,5% 
PEG LiOAc 
Tris-HCl pH 8 
EDTA 
PEG3350 
100mM 
10mM 
1mM 
40% 
The solvent is H2O, if not indicated otherwise. The pH values were measured at room 
temperature (RT).  
 
 
5.1.12 Chemicals 
 
Chemicals were purchased at the highest purity available from Sigma-Aldrich, Merck, Fluka, 
Roth or J.T.Baker, except 5-FOA (Toronto Research Chemicals), electrophoresis-grade agarose 
(Invitrogen), bromophenol blue (Serva), G418/Geneticin (Gibco), milk powder (Sukofin), 
Nonidet P40 (NP40) (USB Corporation), Tris ultrapure (USB Corporation) and Tween 20 (T20) 
(Serva).  
Ingredients for growth media were purchased from BD Becton, Dickinson and Co. (agar, 
peptone, tryptone and yeast extract), Qbiogene, Bio101 or Sunrise Science Products (complete 
supplement mixtures (CSM), yeast nitrogen base (YNB), amino acids and adenine),             
Sigma-Aldrich (D(+)-glucose, D(+)-galactose, amino acids and uracil), PerkinElmer                 
(5’,6’-[3H] uracil) and Hartmann Analytic (α-[32P]-ATP, γ-[32P]-ATP). Water was always purified 
with an Elga Purelab Ultra device prior to use. 
 
 
5.1.13 Other materials 
 
Material Origin 
Protein Marker, Broad Range (2-212 kDa) New England Biolabs 
ColorPlus Prestained Protein Marker, Broad Range (7-175 kDa) New England Biolabs 
1 kb DNA ladder New England Biolabs 
100 bp DNA ladder New England Biolabs 
Salmon Sperm DNA (10 mg/ml) Invitrogen 
yeast genomic DNA (strain S288C) Invitrogen 
Immobilion-P Membrane PVDF 0,45 µm Millipore 
Membrane PositiveTM MP Biomedicals 
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Blotting papers MN 827 B Millipore 
Extra Thick Blot Paper Bio-Rad 
BM Chemiluminescence Blotting Substrate (POD) Roche 
SimplyBlueTM SafeStain Invitrogen 
IgG SepharoseTM 6 Fast Flow GE Healthcare 
Protein G SepharoseTM 4 Fast Flow GE Healthcare 
Protein Assay Dye Reagent Concentrate Bio-Rad 
SYBR Safe DNA Gel Stain Invitrogen 
SYBR Green Roche 
glass beads (∅ 0.75-1 mm) Roth 
BioMax MS Film Sigma-Aldrich 
EN3HANCE Spray Surface Autoradiography Enhancer PerkinElmer 
 
 
5.1.14 Equipment 
 
Device Manufacturer 
4700 Proteomics Analyser MALDI-TOF/TOF Applied Biosystems 
4800 Proteomics Analyser MALDI-TOF/TOF Applied Biosystems 
Biofuge Fresco refrigerated tabletop centrifuge Hereaus 
Biofuge Pico tabletop centrifuge Hereaus 
C412 centrifuge Jouan 
Centrikon T-324 centrifuge Kontron Instruments 
CT422 refrigerated centrifuge Jouan 
Electrophoresis system model 45-2010-i Peqlab Biotechnologie GmbH 
FastPrep Instrument Qbiogene 
Gel Max UV transilluminator Intas 
IKA-Vibrax VXR IKA 
Incubators Memmert 
LAS-3000 chemiluminescence imager Fujifilm 
MicroPulser electroporation apparatus Bio-Rad 
NanoDrop ND-1000 spectrophotometer Peqlab Biotechnologie GmbH 
Avanti J-20 XP centrifuge Beckman Coulter 
Optima L-80 X ultracentrifuge Beckman Coulter 
PCR Sprint thermocycler Hybaid 
MATERIAL AND METHODS 
111 
Power Pac 3000 power supplies Bio-Rad 
Roto-Shake Genie Scientific Industries 
Shake incubators Multitron / Minitron Infors 
Speed Vac Concentrator Savant 
Thermomixer compact Eppendorf 
Trans-Blot SD Semi-Dry Transfer Cell Bio-Rad 
Ultrospec 3100pro spectrophotometer Amersham 
XCell SureLock Mini-Cell electrophoresis system Invitrogen 
AxioCam MR CCD camera Zeiss 
Axiovert 200M microscope Zeiss 
Rotor-Gene 3000 Corbett Research 
Sonifier 250 Branson 
Mono Q PC 1.6/5 Pharmacia Biotech 
Superose 12 PC 3.2/30 GE Healthcare 
FLA-3000 phosphor imager Fujifilm 
 
 
5.1.15 Software 
 
Software Producer 
4000 Series Explorer v.3.6 Applied Biosystems 
Acrobat 7.0 Professional v.7.0.9 Adobe 
Data Explorer v.4.5 C Applied Biosystems 
GPS Explorer v.3.5 Applied Biosystems 
Image Reader LAS-3000 V2.2 Fujifilm 
Mascot Matrix Science 
Microsoft Office 2007 Microsoft 
ND-1000 v.3.5.2 Peqlab Biotechnologie GmbH 
Photoshop CS v.8.0.1 Adobe 
Illustrator CS3 Adobe 
Axiovision V 4.7.1.0 Zeiss 
Multi Gauge V3.0 Fujifilm 
Rotor-Gene V6.1 Corbett Research 
Image Reader FLA-3000 V1.8 Fujifilm 
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5.2 Methods 
 
5.2.1 Work with Saccharomyces cerevisiae 
5.2.1.1 Cultivation of yeast strains 
Saccharomyces cerevisiae strains were cultivated using standard microbiological methods 
(Sherman, 2002). 
Liquid cultures were grown in the appropriate medium usually at 30°C, except for 
temperature-sensitive mutants (24°C), or stated otherwise. Cell growth was monitored by 
measuring the optical density at 600 nm (OD600).  
For cultivation on solid agar plates containing the appropriate medium, single colonies or 
small aliquots of glycerol stocks were striked out using sterile disposable inoculation loops in 
order to obtain colonies derived from single yeast cells. Plates were incubated upside down at 
the respective temperatures for 1-5 days. Short-term storage of yeast strains was accomplished 
by keeping the agar plates at 4°C. 
 
5.2.1.2 Preparation of competent yeast cells 
50 ml of a logarithmically growing yeast culture (OD600 ∼ 0.5-0.7) were harvested by 
centrifugation for 5 min at 4000 rpm and RT. Cells were washed with 25 ml sterile H2O and 5 ml 
LitSorb before resuspending in 360 µl LitSorb. 40 µl of denatured Salmon Sperm DNA were 
added to the cell suspension. After mixing, 50 µl aliquots were transferred to 1.5 ml tubes 
before storage at -80°C.  
 
5.2.1.3 Transformation of competent yeast cells 
Competent yeast cells were thawed on ice. DNA (100 ng of plasmid DNA or 5-10 µg of linear 
DNA, respectively) was added and the sample was mixed. Six volumes of LitPEG were added 
and the suspension was again mixed thoroughly and incubated for 30 min at RT on a turning 
wheel. The sample was mixed with 1/9 total volume of sterile DMSO followed by a heat-shock 
at 42°C for 15 min and centrifugation for 1 min at 3000 rpm and RT.  
When selecting for auxotrophic markers the cell pellet was directly resuspended in 100 µl 
sterile H2O and plated on SCD- or SCG-plates, respectively, lacking the corresponding amino 
acid.  
If selection for antibiotic resistance was required, the cell pellet was resuspended in 5 ml YPD 
or YPG, respectively, and incubated for 3-6 h at 30°C while shaking to allow the expression of 
the marker before plating on the respective selection media. Since selection for antibiotic 
resistance often results in a high number of transient transformants, these plates were    
replica-plated on fresh selection plates to identify positive clones. 
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5.2.1.4 Formaldehyde-Crosslinking of yeast cells 
Logarithmically growing cells from 50 ml liquid culture were crosslinked by adding 1,35 ml 
37% (v/v) formaldehyde and subsequent incubation for additional 15 min at the respective 
growth temperature while shaking. Crosslinking was quenched by adding 2.5 ml 2.5 M glycine. 
The culture was further incubated at growth temperature for additional 5 min. Cells were 
harvested by centrifugation in a 50 ml tube for 3 min at 3000 rpm and 4°C. The cell pellet was 
washed with cold water, transferred to a 1.5 ml tube, and frozen in liquid nitrogen before 
storage at -80°C.  
 
5.2.1.5 Yeast plasmid shuffle 
Plasmid shuffle yeast-strains were used to replace the essential RPA-genes for the mutant 
alleles. In these strains the chromosomal locus of the gene of interest is knocked-out with a 
marker gene and the deletion complemented by a wild-type copy of the gene of interest on a 
plasmid containing a counterselectable marker. The mutant copy is introduced on another 
plasmid and the strain grown on the corresponding selection-medium. If the mutant allele is 
able to complement the chromosomal deletion, the plasmid containing the wild-type copy 
can be lost during cultivation. Finally growth on the respective counterselection medium is 
lethal for all cells still containing the wild-type plasmid.  
Single clones derived from LiAc-transformations of the mutant vectors (see 5.2.1.3) into the 
corresponding shuffle-yeast strains were striked on the counterselection-plates with sterile 
disposable inoculation loops (Sarstedt). A portion of the same clones was striked on        
control-plates containing the same medium except for the counterselection drug. 
Transformants of the RPA190-shuffle strain NOY222 (Wittekind et al., 1988) were cultivated on 
plates containing L-canavanine to select against the CanS-allele of the CAN1-gene which codes 
for a functional arginine permease and thus allows for the uptake and incorporation of this 
lethal arginine-derivate (Grenson et al., 1966; Whelan et al., 1979; Broach et al., 1979). The 
transformants of all other RPA-shuffle strains were cultivated on plates with 5-FOA                     
(5-Fluoro-orotic acid) which facilitates counterselection against strains carrying a functional 
URA3 gene. URA3 codes for the enzyme orotidin-5’-phosphate decarboxylase of the uracil-
biosynthesis pathway which also converts 5-FOA into the toxic 5-fluorouracil                       
(Boeke et al., 1984, 1987).  
Single clones were controlled for i) the presence of the mutant vector, ii) the loss of the       
wild-type plasmid and iii) the maintenance of the chromosomal deletion via the respective 
auxotrophic markers. Single clones were further cultivated on YPD plates to obtain the mutant 
strains listed in 5.1.1. 
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5.2.1.6 Construction of yeast strains with integrated protein binding sites in the 
rDNA locus 
Protein binding sites were either PCR-amplified (601, 3x LexA, ENH) or obtained through oligo 
annealing (TTF-I, LacR) and cloned into the pT28 vector (composed of the 18S rRNA gene and 
the complete ITS1 sequence) at the AflII restriction site. From these pT28 variants, fragments 
containing the protein binding sites were subcloned in several steps into the final vector pT11, 
consisting of the whole rDNA locus flanked by sequences for homologous recombination. 
SpeI-linearized pT11 was transformed in NOY989 for endogenous integration through 
homologous recombination and expansion of the rDNA locus as described in (Wai et al., 2000). 
Correct integration of the rDNA unit and maintenance of the artificially integrated sequence 
downstream of the 18S rRNA gene was confirmed by PCR of genomic DNA. Integrated regions 
3` of the 18S rRNA gene were sequenced from a PCR of genomic DNA to check for mutations.  
 
5.2.1.7 Spot test analysis of yeast strains 
Overnight cultures of yeast strains were diluted in sterile 96 well plates to OD600 = 0.2 with 
sterile H2O. 7-10 µl of this cell suspension and of serial 1:10, 1:100 and 1:1000 dilutions with 
sterile H2O were spotted on the appropriate test plates. Phenotypes were monitored after 
incubation for 2-4 days at 16°C, 24°C, 30°C and 37°C, respectively.  
 
5.2.1.8 Growth kinetic analysis of yeast strains 
Cultures of yeast strains were grown to stationary phase overnight. From these pre-cultures 
fresh cultures were inoculated to OD600 = 0.1 in the appropriate medium and growth at 30°C 
was monitored by measuring the OD600 in 1h intervals. Dilution with the respective media has 
to be taken into account for growth kinetics calculations. 
 
5.2.1.9 Long-term storage of yeast strains 
2 ml of an overnight culture of the yeast strain were mixed with 1 ml sterile 50% (v/v) glycerol 
and separated into two aliquots. Glycerol stocks were stored at -80°C.  
 
5.2.2 Work with Escherichia coli 
5.2.2.1 Cultivation of bacterial strains 
Liquid cultures were grown in LBamp medium at 37°C. Cell growth was monitored by measuring 
the optical density at 600 nm (OD600). For cultivation on agar plates containing LBamp medium, 
single colonies or small aliquots of glycerol stocks were striked out using sterile disposable 
inoculation loops in order to obtain colonies derived from single bacterial cells. Plates were 
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incubated upside down at 37°C for 1 day. Short term storage of bacterial strains was 
accomplished by keeping the agar plates at 4°C.  
 
5.2.2.2 Preparation of competent bacterial cells for electroporation 
The XL1-Blue strain was used as a host for amplification of plasmid DNA. In order to increase 
the efficiency of plasmid DNA uptake, competent cells for electroporation were prepared. Cells 
were grown in 400 ml SOB medium at 37°C to mid-log phase (OD600 ∼ 0.35-0.6), chilled on ice 
for 15 min and centrifuged for 10 min at 6000 rpm and 4°C.  
Cells were washed 3x with cold sterile H2O and 1x with sterile 10% (v/v) glycerol. After 
resuspending the cells in 1.5 ml sterile 10% (v/v) glycerol, 50 µl aliquots were transferred to   
1.5 ml tubes before storage at -80°C. 
 
5.2.2.3 Transformation of competent bacterial cells by electroporation 
Competent bacterial cells were thawed on ice. DNA (1 ng of plasmid DNA or up to 3 µl of a 
ligation sample) was added and the sample was mixed. Pulsing was performed with program 
EC2 in a MicroPulser electroporation apparatus after pipetting the suspension into a cold       
0.2 cm electroporation cuvette. 1 ml LB medium was added immediately after the pulse and 
the sample was transferred to a 1.5 ml tube following incubation for 30-60 min at 37°C. 50 µl of 
the cell suspension were plated on LBamp and incubated overnight at 37°C. The residual cells 
were centrifuged for 1 min at 5000 rpm and RT. About 900 µl of the supernatant were 
discarded and the pellet was resuspended in the remaining liquid, plated on LBamp and 
incubated overnight at 37°C. 
 
5.2.2.4 Protein-purification from E. coli 
A14/A43 heterodimer purification and purification of respective A43 mutants was performed 
basically as described in (Kuhn et al., 2007). 
The genes for A14 and A43 were cloned sequentially into vector pET21b (Novagen), resulting 
in a thrombin-cleavable N-terminal hexahistidine tag on A14. A ribosomal binding site was 
introduced before A43 to enable bicistronic expression. A14/43 was expressed for 18 h at 18°C 
in E. coli BL21 (DE3) RIL cells (Stratagene) in 1 L of LB medium. Cells were harvested by 
centrifugation, resuspended in 100 ml buffer A (100 mM NaCl, 20 mM Tris pH 8.0,                        
10 mM β-mercaptoethanol, 1 mM protease inhibitor mix: 1 mM PMSF, 1 mM benzamidine,   
200 mM pepstatin, and 60 mM leupeptin) and lysed by sonication. After centrifugation, the 
supernatant was loaded onto a 3 ml Ni-NTA column equilibrated with buffer A. After washing, 
proteins were eluted with buffer A containing 100 mM imidazole. A Mono Q 10/10 GL anion 
exchange column was equilibrated with buffer B (100 mM NaCl, 20 mM Tris pH 8.0, 5 mM DTT), 
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and proteins were eluted with a linear gradient from 100mM to 1M NaCl. A14/ 43 eluted at    
220 mM NaCl. 
 
5.2.3 Work with DNA 
5.2.3.1 Phenol-chloroform extraction 
One volume of a phenol:chloroform:isoamyl alcohol-mixture (25:24:1) was added to the 
sample. The samples were mixed by vortexing until the solution was milky. After centrifugation 
for 5 min at 13000 rpm and RT, an aliquot of the upper aqueous phase was transferred to a    
1.5 ml tube. 
 
5.2.3.2 Ethanol precipitation of DNA 
DNA was precipitated from aqueous solution by mixing the sample with 1/10 volume of 3 M 
NaOAc pH 5.3 and 2.5 volumes of ethanol following incubation for at least 20 min at -20°C. 
Samples were centrifuged for 20 min at 13000 rpm and 4°C. To eliminate salt, the pellet was 
washed with cold 70% (v/v) ethanol. After removal of the supernatant, the nucleic acid pellet 
was dried at RT and solubilized in an appropriate volume of water or TE buffer. 
 
5.2.3.3 DNA quantification using UV spectroscopy 
Concentration of pure DNA samples was measured by UV spectroscopy at 260 nm                      
(1 OD260 = 50 µg/ml) using a NanoDrop ND-1000 spectrophotometer. To determine 
contamination with proteins, absorbance was concomitantly measured at 280 nm. The ratio of 
OD260/OD280 of pure DNA is between 1.8 and 2.0.  
 
5.2.3.4 Pulse-field gel electrophoresis (PFGE) 
Pellet cells by centrifuging at 3000 rpm (Falcon tubes, eppendorf centrifuge) 5 min at 4°C. 
Discard the supernatant and wash the cells twice in 0,05M EDTA (pH 7.5). When resuspending 
pellets after the final wash keep in mind that this solution will be diluted 1:1 into agarose. 
Calculate cell concentration and resuspension volume accordingly. Heat a 1.2% solution of 
LMP agarose in 0.125 M EDTA (pH 7.5) and equilibrate to 42–50°C in a waterbath. This solution 
can be held until ready for use. 
Mix the cells with an equal amount of agarose. Also add 15.5 μl of Zymolyase solution per ml of 
agarose:cell suspension. Warm the cell suspension briefly in a 37°C in a waterbath before 
mixing with agarose. When mixing, take care to pipette thoroughly but slowly, to avoid 
damaging the cells and shearing the DNA.  
Pipette the agarose:cell suspension into a casting mold, taking care to avoid air bubbles. Allow 
the molds to set at 4°C until the agarose has gelled. Unmold the solidified inserts and incubate 
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the inserts in 0.5 M EDTA containing 7.5% β-mercaptoethanol overnight at 37°C to create 
spheroplasts, disrupt membranes and digest other cellular debris.  
Drain the buffer from the tube and replace with NDSK. Incubate overnight in NDSK at 50°C. 
Change NDSK buffer with TE containing 0.01mM PMSF. Incubate overnight at 4°C or 25°C. 
Dialyse the inserts into a larger volume of TE. 
Load samples on a gel and perform PFGE overnight. 
(adapted from Herschleb et al., 2007) 
 
5.2.3.5 Native agarose gel electrophoresis 
Native agarose gel electrophoresis was used to separate DNA fragments. Electrophoresis was 
performed routinely with gels composed of 1.0-1.2% (w/v) agarose and 1x TBE and containing 
1x SYBR Safe DNA Gel Stain. 1x TBE was used as electrophoresis buffer and gels were run at 
100-150 V. For length determination, 0.5 µg of a DNA standard (1 kb ladder or 100 bp ladder) 
was used in a concentration of 50 µg/ml in 2.5x DNA loading buffer. DNA fragments could be 
visualized by exposing the gel to blue light (470 nm).  
 
5.2.3.6 Southern Blot (passive capillary transfer) 
Separated DNA fragments were transferred and immobilized on a positively charged 
membrane using the passive capillary transfer method. Prior to the transfer, the agarose gel 
was incubated for 20 min in 0,25M HCl on a shaker followed by 2x 15 min in 0.5 M NaOH/1.5 M 
NaCl to denature double-stranded DNA. Subsequently, the gel was incubated for 2x 15 min in 
1 M NH4OAc. Transfer of the DNA fragments from the agarose gel to the membrane was then 
achieved overnight by drawing the transfer buffer (1 M NH4OAc) from the reservoir through 
the gel and the membrane into a stack of paper towels. The DNA fragments were deposited 
onto the positively charged membrane. After the transfer, the DNA fragments were crosslinked 
to the dried membrane by exposition for 30 sec to UV light (0.3 J/cm2). 
 
5.2.3.7 Radioactive probe labeling, hybridization and detection 
Probes were radioactively labeled with α-[32P]-ATP using the RadPrime DNA Labeling System 
as indicated by the manufacturer.  
The membranes, separated by meshes in a hybridization tube, were pre-hybridized for 1 h at 
hybridization temperature (65°C) with 50 ml hybridization buffer. For hybridization, the 
membranes were incubated in fresh 15 ml hybridization buffer. The labeled probe was mixed 
with 150 µl Salmon Sperm DNA, incubated for 5 min at 95°C, immediately chilled on ice and 
added to the hybridization tube. Hybridization occurred overnight at hybridization 
temperature with tubes rotating in a hybridization oven. The membranes were rinsed 1x with 
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30 ml 3x SSC/0.1% (w/v) SDS and subsequently washed in each case for 2x 15 min with 30 ml 
0.3x SSC/0.1% (w/v) SDS, 0.1x SSC/0.1% (w/v) SDS and 0.1x SSC/1.5% (w/v) SDS at hybridization 
temperature. Membranes were dried and covered with an erased phosphor-imaging plate in a 
cassette. The time of exposure depended on the intensity of the radioactive signal. The 
phosphor-imaging plate was scanned by a FLA-3000 phosphor imager using Image Reader 
FLA-3000 V1.8 followed by quantitative analysis using Multi Gauge V3.0.  
 
5.2.3.8 Polymerase Chain Reaction (PCR) 
For amplification of DNA fragments for integration in the yeast genome, PCR was performed 
with yeast genomic DNA or plasmid DNA (50-100 ng) as templates in 50 µl reactions [20 mM 
Tris-HCl pH 8.8, 10 mM (NH4)2SO4, 10 mM KCl, 2 mM MgSO4, 0.1% (v/v) Triton X-100, 0.25 µM of 
forward and reverse primers, 0.25 mM dNTPs, 2.5-5 U Taq Polymerase]. The main PCR program 
used in this work was as following:  
95°C  5 min  (1x) 
95°C  1 min   
54°C  1 min  (35x) 
72°C  2 min   
72°C  10 min  (1x) 
For amplification of DNA fragments used for cloning, PCR was performed with yeast genomic 
DNA or plasmid DNA (50-100 ng) as templates in a 50 µl reaction [1x iProof HF Buffer, 0.5 µM of 
forward and reverse primers, 0.2 mM dNTPs, 2 U iProof High-Fidelity DNA Polymerase]. The 
PCR program was designed as indicated by the manufacturer.  
10% of the reactions were analysed by native agarose gel electrophoresis. The PCR product 
was purified with a PCR Purification Kit according to the manufacturer.  
 
5.2.3.9 Mutagenesis through SOE-PCR 
Mutagenesis by PCR is accomplished by incorporating desired genetic changes into       
custom-made primers used in amplification reactions. Because these mutagenizing primers 
have terminal complementarity, two separate DNA fragments amplified from a target gene 
can be fused into a single product by primer extension without relying on restriction 
endonuclease sites or ligation reactions. Briefly, mutagenesis is achieved by performing PCR 
with specially designed oligonucleotide primers that include the desired substitutions, 
insertions, or deletions in their sequence. The two overlapping fragments are fused together in 
a subsequent extension reaction. The inclusion of outside primers in the extension reaction 
amplifies the fused product by PCR. Theoretically, the primers can be moved anywhere along 
the targeted gene to introduce mutations. A limitation of SOE is the difficulty of manipulating 
large DNA segments (i.e., >1-2 kb). To circumvent this, a cassette system can be targeted, 
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modified by SOE, and reinserted using restriction endonuclease sites designed into the 
cassette structure. This approach also allows easy shuffling or replacement of gene segments. 
(protocol from Vallejo et al., 2008) 
 
 
Figure 45. Schematic representation of the mutagenesis strategy using SOE-PCR 
SOE-PCR mutagenesis strategy: The grey rectangle represents the gene to be mutated. PCR-primers are shown as short 
black lines. Restriction sites (RS) and the site to be mutated (red star) are indicated. 
 
 
5.2.3.10 Quantitative real-time Polymerase Chain Reaction (qPCR) 
Quantitative real-time PCR was used to measure a specific DNA fragment with high accuracy. 
The amount of DNA present at the end of each single PCR cycle was detected by measuring 
the fluorescence of SYBR Green. SYBR Green is a dye that exhibits fluorescence when bound to 
double-stranded DNA, but not in solution. Therefore, the intensity of the fluorescence signal 
allows direct measurement of the actual amount of DNA present in the sample. Quantitative 
real-time PCR reactions were performed in 0.1 ml tubes, the reaction volume was 20 µl. The 
reaction contained 4 µl of DNA sample and 16 µl of master mix. The master mix contained         
4 pmol of both the forward and the reverse primer, 0.25 µl of a 1:400000 SYBR Green stock 
solution in DMSO, 0.4 U HotStarTaq DNA Polymerase and a premix. The premix was composed 
of MgCl2 (final concentration in the reaction: 2.5 mM), dNTPs (final concentration in the 
reaction: 0.2 mM) and 10x PCR buffer (final concentration in the reaction: 1x). Quantitative  
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real-time PCR was performed in a Rotor-Gene 3000. The data were analysed with Rotor-Gene 
V6.1. 
 
5.2.3.11 Digestion of DNA with restriction endonucleases 
A variety of restriction endonucleases were used to digest DNA in order to prepare defined 
DNA fragments for cloning or to check for presence and correct orientation of inserted DNA 
fragments. Restriction endonucleases were essentially used as suggested by the manufacturer.  
 
5.2.3.12 DNA ligation 
In order to clone DNA sequences into yeast/bacterial plasmids, the quantity of purified DNA 
fragments digested with restriction endonucleases was measured by UV spectroscopy          
(see section 5.2.3.3). A fourfold molar excess of insert DNA compared to the plasmid DNA 
fragment was incubated in a 20 µl ligase reaction (50 mM Tris-HCl pH 7.5, 10 mM MgCl2,             
1 mM ATP, 10 mM DTT, 400 U T4 DNA Ligase) for 1 h at RT or overnight at 16°C. Up to 3 µl of 
the ligation reaction were used for transformation of competent bacterial cells                         
(see section 5.2.2.3).  
 
5.2.3.13 DNA sequencing and oligonucleotide synthesis 
DNA sequencing was performed by GENEART and the service of primer synthesis was provided 
by Eurofins MWG Operon. Oligonucleotides used in this work are listed in section 5.1.4.  
 
5.2.4 Work with RNA 
5.2.4.1 Analysis of neo-synthesized RNA 
For each sample 1 OD600 of cells was centrifuged for 1 min at 10000 rpm and RT before the cell 
pellets were resuspended in 100 µl buffer R, respectively. Depending on the experiment 60 µCi 
or 20 µCi of 5',6'-[3H]-uracil were added and the cells were incubated for 5 min at 30°C        
(pulse prior to chase) or 20 min at 30°C (pulse), before one volume of YPUD was added and 
cells were incubated either for additional 4 min, 8 min, and 16 min at 30°C (chase). Immediately 
after the treatment, the samples were chilled on ice and centrifuged for 1 min at 13000 rpm 
and 4°C. The supernatants were discarded and the cell pellets were stored at -20°C. Total RNA 
was extracted as described (see section 5.2.4.2), same amounts of samples were separated by 
denaturing agarose gel electrophoresis as described (see section 5.2.4.3), transferred to a 
membrane as described (see section 5.2.4.4), and analysed as described (see section 5.2.4.5).  
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5.2.4.2 RNA extraction 
RNA extractions were essentially performed as described previously (Schmitt et al., 1990). Cell 
pellets were resuspended in 500 µl AE buffer and mixed with 500 µl phenol equilibrated in AE 
buffer and 50 µl of 10% (w/v) SDS. The samples were incubated in a thermomixer for 5 min at 
1400 rpm and 65°C and afterwards chilled on ice for 2 min. After centrifugation for 2 min at 
13000 rpm and RT, 3x 150 µl of the aqueous phase was collected and mixed with 500 µl phenol 
equilibrated in AE buffer by vortexing. The samples were again centrifuged and 3x 120 µl of 
the supernatant were mixed with 500 µl chloroform by vortexing. Phases were separated by 
centrifugation and the RNA in 3x 100 µl of the supernatant was precipitated by addition of 
1/10 volume of 3 M NaOAc pH 5.3 and 2.5 volumes of ethanol and incubation for 30 min at        
-20°C. The precipitated RNA, when used for denaturing agarose gel electrophoresis, was 
solubilized in RNA solubilization buffer, denatured by incubation for 15 min at 65°C and stored 
at -20°C.  
 
5.2.4.3 Denaturing agarose gel electrophoresis 
Denaturing agarose gel electrophoresis was used to separate longer RNA species. 
Electrophoresis was performed routinely with gels composed of 1.3% (w/v) agarose, 2% (v/v) 
formaldehyde and 1x MOPS containing 0.5 µg/ml ethidium bromide. The electrophoresis 
buffer was composed of 1x MOPS and 2% (v/v) formaldehyde. Gels were run for 14-16 h at      
40 V.  
 
5.2.4.4 Northern blot (passiv capillary transfer) 
Separated [3H]-labeled RNAs were transferred and immobilized on a positively charged 
membrane using the passive capillary transfer method. Prior to the transfer, the agarose gel 
was washed for 5 min in H2O, for 30 min in 50 mM NaOH to hydrolyze the RNAs and facilitate 
the transfer of larger RNAs, and was further equilibrated for 2x 20 min in 10x SSC. Transfer of 
the RNA fragments from the agarose gel to the membrane was achieved overnight by drawing 
the transfer buffer (10x SSC) from the reservoir through the gel and the membrane into a stack 
of paper towels. The RNA fragments were deposited onto the positively charged membrane. 
After the transfer, the RNAs were crosslinked to the dried membrane by exposition for 1 min to 
UV light (254 nm/312 nm).  
 
5.2.4.5 Radioactive probe labelling and detection 
Different RNA species immobilised on solid supports can be detected using specific DNA 
probes. Probes used in this work are listed in 5.1.6. 5’ ends of all oligo-probes were labelled 
with [32P]. Ten pmol of oligo-probe were incubated with 50mCi of γ-[32P]-ATP (Amersham), in 
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1xPNK buffer (70mM Tris-HCl, 10mM MgCl2, 5mM DTT) and 10 U of T4 polynucleotide kinase 
(NEB) for 30-45min at 37°C. Reactions were stopped by addition of 1ml of 0.5M EDTA pH 8. 
Labelled probes were purified from the non-incorporated nucleotides by gel exclusion column 
(Spin6-Biorad). Incorporated radioactivity was estimated by counting 1μl of purified-labelled 
probes using a scintillation counter (1600TR-Packard). Membranes were prehybridised at least 
1 h at 30°C in RNA hybridisation buffer. Membranes were then incubated at 30°C over-night 
after addition of 1-2x106 cpm of radiolabelled oligo-probe per blot. The membranes were 
washed twice 15 min in 2xSSC at 30°C. Signals were acquired exposing the membrane to a 
Phosphoimager screen and / or BioMax MS/MR film (Fujifilm). 
 
5.2.4.6 Detection of [3H]-labeled RNAs 
The membrane was covered with an erased tritium-imaging plate (TIP) in a cassette. The time 
of exposure depended on the intensity of the radioactive signal. The TIP was scanned with a 
resolution of 100 µm by a FLA-3000 phosphor imager using Image Reader FLA-3000 V1.8 
followed by quantitative analysis using Multi Gauge V3.0.  
Alternatively or subsequently, the membrane was sprayed with EN3HANCE solution and 
subjected to autoradiography.  
 
5.2.5 Work with proteins 
5.2.5.1 Preparation of yeast whole cell extract (WCE) 
For whole cell extract preparation, logarithmically growing cells from 50 ml liquid culture of 
OD600 ∼ 0.8 were harvested by centrifugation in a 50 ml tube for 3 min at 3000 rpm and 4°C. 
The cells were washed with 1 ml cold H2O and transferred to a 1.5 ml tube. After resuspending 
the cell pellet in an equal volume of high-salt extraction buffer [150 mM HEPES pH 7.6,           
400 mM (NH4)2SO4, 10 mM MgCl2, 20% (v/v) glycerol, 5 mM β-mercaptoethanol,                              
2 mM benzamidine, 1 mM PMSF], an equal volume of cold glass beads (∅ 0.75-1 mm) was 
added to the suspension and the tube was vigorously shaken either on an IKA-Vibrax VXR for 
3x 15 min at 2200 rpm and 4°C or in a FastPrep Instrument for 2x 40 sec at 5.5 m/s and 4°C. The 
tube was pierced on the bottom and on the lid with a hot needle and placed in a 15 ml tube to 
remove the glass beads from the cell extract by centrifugation for 2 min at 2000 rpm and 4°C. 
The cell extract was transferred to a 1.5 ml tube and centrifuged again for 1 min at 13000 rpm 
and 4°C to remove cell debris. The cleared supernatant (WCE) was transferred to a 1.5 ml tube 
and appropriate amounts were supplemented with 4x SDS sample buffer, incubated for 5 min 
at 99°C and analysed as described (see sections 5.2.5.6, 5.2.5.7, and 5.2.5.8) or if required frozen 
in liquid nitrogen before storage at -80°C. Protein concentration was determined using the 
Bradford assay (Bradford, 1976).  
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5.2.5.2 Determination of protein concentration 
Protein concentrations were determined using the Bio-Rad Protein Assay which is based on 
the method by Bradford (Bradford, 1976). 1-5 µl of the protein solution to be tested were 
mixed with 1 ml protein assay dye after diluting the reagent to the working concentration 
according to the instructions of the manufacturer. The approximate protein concentrations     
in µg/µl were calculated by dividing the absorbance at 595 nm by the sample volume and 
multiplying with the factor 23 which was determined using a BSA standard curve.  
 
5.2.5.3 TCA precipitation 
The volume of the protein sample to be analysed was adjusted to 100 µl with cold H2O prior to 
mixing with 10 µl cold 100% (w/v) TCA and 2 µl 2% (w/v) DOC (Bensadoun and Weinstein, 
1976). After incubation for 30 min at 4°C, the precipitated proteins were pelleted by 
centrifugation for 15 min at 13000 rpm and 4°C. The supernatant was discarded and the pellet 
was solubilized in an adequate volume of SDS sample buffer. The pH of the sample was 
neutralized using NH3 gas if necessary. Proteins were denatured by incubating the sample for  
5 min at 99°C for subsequent separation by SDS-PAGE.  
 
5.2.5.4 Methanol-chloroform precipitation 
Protein precipitation for subsequent mass spectrometric analyses was performed using the 
methanol-chloroform precipitation method (Wessel and Flügge, 1984). The volume of the 
sample was adjusted to 150 µl with H2O, followed by the addition of four volumes of methanol 
(600 µl), one volume of chloroform (150 µl), and three volumes of H2O (450 µl). After each of 
these steps the sample was mixed well by vortexing. After incubation for 5 min at 4°C, the 
sample was centrifuged for 5 min at 13000 rpm and 4°C. The supernatant was discarded 
without disturbing the interphase which contains the precipitated proteins. Upon addition of 
another three volumes of methanol (450 µl) and vortexing, the sample was incubated for 5 min 
at 4°C before centrifugation for 5 min at 13000 rpm and 4°C. The supernatant was completely 
removed and the protein pellet dried for 10 min in a Speed Vac Concentrator.  
 
5.2.5.5 Denaturing protein extraction 
Cell pellets were resuspended in 1 ml cold H2O, mixed with 150 µl pre-treatment solution   
[1.85 M NaOH, 1 M β-mercaptoethanol] and incubated for 15 min at 4°C. Proteins were 
precipitated with 150 µl 55% (w/v) TCA for 15 min at 4°C and pelleted by centrifugation for     
10 min at 13000 rpm and 4°C. The supernatant was discarded and the pellet was resuspended 
in 50 µl HU buffer. The pH of the sample was neutralized using NH3 gas if necessary. Proteins 
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were denatured by incubating the sample for 10 min at 65°C for subsequent separation by 
SDS-PAGE.  
 
5.2.5.6 SDS-polyacrylamide gel electrophoresis (SDS-PAGE) 
Proteins were separated according to their molecular weight using the vertical discontinuous 
SDS-polyacrylamide gel electrophoresis method by Laemmli (Laemmli, 1970). The 
discontinuous system consists of a lower separating gel composed of 8-12% acrylamide,       
375 mM Tris-HCl pH 8.8 and 0.1% (w/v) SDS and an upper stacking gel composed of                 
4% acrylamide, 125 mM Tris-HCl pH 6.8 and 0.1% (w/v) SDS.  
Gels were run for 1.5-2.5 h at 50 mA and 180 V in 1x electrophoresis buffer. Molecular weights 
of the different proteins were estimated using protein markers of known molecular weight.  
 
5.2.5.7 Western Blot 
Separated proteins were transferred to a PVDF membrane using a Trans-Blot SD Semi-Dry 
Transfer Cell. The gel and the PVDF membrane, pretreated with methanol, were placed in the 
transfer cell between two piles of three blotting papers soaked with transfer buffer. Transfer 
was performed for 1 h at 24 V.  
To control the blotting of the proteins before immunodetection, the total protein content was 
reversibly stained with Ponceau S by incubating the membrane in ponceau staining solution 
for 2 min and subsequent destaining with H2O until the protein bands were visible.  
 
5.2.5.8 Detection of proteins by chemiluminescence 
Prior to specific immunodetection of defined proteins, the membrane was blocked with      
non-related proteins from bovine milk to avoid unspecific binding of the antibodies by 
incubating the membrane in 5% (w/v) milk powder in 1x PBS for 1 h at RT or overnight at 4°C 
on a shaker. The antibodies were diluted to an adequate working concentration in 5% (w/v) 
milk powder in 1x PBST. The incubations were performed in small bags made of sealed plastic 
foils on a turning wheel for 1 h (primary antibodies) or 30 min (secondary antibodies) at RT. The 
membrane was washed in 1x PBST for 3x 5 min on a shaker following each antibody 
incubation step.  
In order to detect the specifically bound antibodies, the membrane was incubated for 1 min at 
RT with 2-4 ml BM Chemiluminescence Blotting Substrate (POD) which was prepared 
according to the instructions of the manufacturer. This reagent contains hydrogen peroxide 
and luminol which is a substrate for the horseradish peroxidase conjugated to the secondary 
antibodies used in this work. The light, which is emitted during this reaction at the 
corresponding specific positions on the membrane, was detected with a LAS-3000 
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chemiluminescence imager using Image Reader LAS-3000 V2.2 followed by quantitative 
analysis using Multi Gauge V3.0.  
 
5.2.5.9 Coomassie staining 
The polyacrylamide gel was stained with Coomassie Brilliant Blue R-250 in order to visualize 
the total protein content.  
The gel was stained in coomassie staining solution for 30 min on a shaker at RT. Destaining was 
performed by incubating the gel in destaining solution for 3-4x 30 min until protein bands 
showed up significantly over the background staining. Optionally, the gel could be dried in a 
vacuum gel dryer system for 2 h at 80°C or bands could be excised for subsequent protein 
identification using mass spectrometry.  
 
5.2.5.10 Analysis of neo-synthezised protein 
Cells were grown in SCD medium depleted of methionine and cysteine at 30°C and further 
cultivated either in the absence or in the presence of rapamycin or cycloheximide, respectively.  
For each sample 2 OD600 of cells were centrifuged for 1 min at 10000 rpm and RT before the cell 
pellets were resuspended in 200 µl SCD-met-cys. 15 µCi of [35S]-met/cys were added and the 
cells were incubated for 5 min at 30°C (pulse). Immediately after the treatment, the samples 
were centrifuged for 1 min at 13000 rpm and 4°C. The supernatants were discarded and the 
cell pellets were stored at -20°C. Total protein was extracted as described (see section 5.2.5.5), 
same amounts of samples were separated by SDS-polyacrylamide gel electrophoresis as 
described (see section 5.2.5.6) and coomassie staining was performed as described (see section 
5.2.5.9). The dried gel was subjected to autoradiography.  
 
5.2.6 I-TRAQ analyses (semi-quantitative MALDI mass spectrometry) 
5.2.6.1 Trypsin digest and iTRAQ labelling 
The lyophilised protein samples were resuspended in 20 μl dissolution buffer (iTRAQTM 
labelling kit, Invitrogen) and reduced with 5 mM Tris-(2-carboxyethyl)-phosphine at 60°C for    
1 h. Cysteins were blocked with 10 mM methyl-methanethiosulfonate (MMTS) at room 
temperature for 10 min. After trypsin digest for 20 h at 37°C, tryptic peptides of the 
purifications of interest were labelled with different combinations of the four iTRAQTM reagents 
according to the manufacturer (Invitrogen). The differentially labelled peptides were 
combined and lyophilised (Ross et al., 2004). 
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5.2.6.2 Peptide separation and automated spotting of the peptide fractions 
The combined differently labelled peptides were dissolved for 2 h in 0.1% TFA and loaded on a 
nano-flow HPLC-system (Dionex) harbouring a C18-Pep-Mep column (LC-Packings). The 
peptides were separated by a gradient of 5% to 95% of buffer B (80% acetonitrile/0.05% TFA) 
and fractions were mixed with 5 volumes of CHCA (alpha-cyano-4-hydroxy cinnamic acid; 
Sigma) matrix (2 mg/ml in 70% acetonitrile/0.1% TFA) and spotted online via the Probot 
system (Dionex) on a MALDI-target. 
 
5.2.6.3 MALDI TOF/TOF analysis 
MS/MS analyses were performed on an Applied Biosystems 4700 or 4800 Proteomics Analyser 
MALDI-TOF/TOF mass spectrometer operated in positive ion reflector mode and evaluated by 
searching the NCBInr protein sequence database with the Mascot search engine                
(Matrix Science) implemented in the GPS Explorer software (Applied Biosystems). Laser 
intensity was adjusted due to laser condition and sample concentration. The eight most 
intense peptide peaks per spot detected in the MS mode were further fragmented yielding the 
respective MS/MS spectra. 
 
5.2.6.4 iTRAQ data evaluation 
Only proteins identified by at least two nonredundant peptides with a Confidence Interval 
>95% were included in the analysis. The peak area for iTRAQTM reporter ions were interpreted 
and corrected by the GPS-Explorer software (Applied Biosystems) and Excel (Microsoft). An 
iTRAQ ratio average of all peptides of a given protein was calculated and outliers were deleted 
by manual evaluation. The iTRAQ ratios of the co-purifying proteins were normalised to the 
ratio of the bait protein. 
 
5.2.7 Additional biochemical methods 
5.2.7.1 Chromatin immunoprecipitation (ChIP) 
Chromatin immunoprecipitation was performed in three independent experiments for each 
protein mainly as described (Hecht and Grunstein, 1999). Cells from 50 ml liquid culture were 
crosslinked with formaldehyde as described (see section 5.2.1.4), washed with 500 µl cold ChIP 
lysis buffer [50 mM HEPES pH 7.5, 140 mM NaCl, 5 mM EDTA pH 8.0, 5 mM EGTA pH 8.0,          
1% (v/v) Triton X-100, 0.1% (w/v) DOC] and resuspended in an equal volume of cold ChIP lysis 
buffer. An equal volume of cold glass beads (∅ 0.75-1 mm) was added to the suspension and 
the tube was vigorously shaken on an IKA-Vibrax VXR for 3x 15 min at 2200 rpm and 4°C. The 
tube was pierced on the bottom and on the lid with a hot needle and placed in a 15 ml tube to 
remove the glass beads from the cell extract by centrifugation for 1 min at 1000 rpm and 4°C. 
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Cold ChIP lysis buffer was added to a final volume of 1 ml and the DNA in the suspension was 
sonicated using a Sonifier 250 to obtain an average DNA fragment size of 500-1000 bp. Cell 
debris were removed by centrifugation for 20 min at 13000 rpm and 4°C. The chromatin 
extracts were split into three aliquots. 40 µl of each aliquot served as an input control. 200 µl of 
each aliquot were incubated either with 3 µg of a monoclonal α-HA antibody (3F10) and 50 µl 
equilibrated Protein G Sepharose or with 50 µl equilibrated IgG Sepharose for 2 h at 4°C to 
enrich either HA3-tagged proteins or Prot.A-tagged proteins. After immunoprecipitation, the 
beads were washed 3x with cold ChIP lysis buffer, 2x with cold ChIP washing buffer I                
[50 mM HEPES pH 7.5, 500 mM NaCl, 2 mM EDTA pH 8.0, 1% (v/v) Triton X-100,                        
0.1% (w/v) DOC], and 2x with cold ChIP washing buffer II [10 mM Tris-HCl pH 8.0, 250 mM LiCl, 
2 mM EDTA pH 8.0, 0.5% (v/v) Nonidet P40, 0.5% (w/v) DOC] followed by a final washing step 
with TE buffer [10 mM Tris-HCl pH 8.0, 1 mM EDTA pH 8.0]. 250 µl IRN buffer [50 mM Tris-HCl 
pH 8.0, 20 mM EDTA pH 8.0, 500 mM NaCl] were added to the input (IN) and to the beads (IP) 
samples. RNA in the samples was digested with 2 µl RNase A (20 mg/ml) for 1 h at 37°C. 
Afterwards, 0.5% (w/v) SDS and 2 µl Proteinase K (20 mg/ml) were added to the samples 
followed by incubation for 1 h at 56°C. The formaldehyde crosslink was reversed overnight by 
incubation at 65°C. DNA was isolated by phenol-chloroform extraction as described               
(see section 5.2.3.1), precipitated with ethanol as described (see section 5.2.3.2) and 
resuspended in 50 µl sterile water.  
DNA amounts present in IN and IP samples were determined by quantitative real-time PCR as 
described (see section 5.2.3.8). Primer pairs for amplification used in this work are listed in 
section 5.1.4. IN DNA was diluted 1:1000 and IP DNA was diluted 1:200 prior to analysis. 
Retention of specific DNA fragments was calculated as the fraction of the total input DNA. The 
mean values and error bars were derived from independent ChIP experiments analysed in 
triplicate quantitative real-time PCR reactions.  
 
5.2.7.2 Chromatin endogenous cleavage (ChEC) 
Chromatin endogenous cleavage was performed mainly as described (Schmid et al., 2004). 
Cells from 50 ml liquid culture were crosslinked with formaldehyde as described (see section 
5.2.1.4), washed 3x with 500 µl cold ChEC buffer A (+ 1x PIs) and resuspended in 350 µl cold 
ChEC buffer A (+ 1x PIs). An equal volume of cold glass beads (∅ 0.75-1 mm) was added to the 
suspension and the tube was vigorously shaken on an IKA-Vibrax VXR for 10 min at 2200 rpm 
and 4°C. The tube was pierced on the bottom and on the lid with a hot needle and placed in a 
15 ml tube to remove the glass beads from the cell extract by centrifugation for 1 min at     
1000 rpm and 4°C. The cell lysate was transferred to a 1.5 ml tube and centrifuged again for      
2 min at 13000 rpm and 4°C. The supernatant was discarded. The lysate pellet containing intact 
nuclei was washed with 500 µl cold ChEC buffer A (+ 1x PIs) and resuspended in 350 µl cold 
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ChEC buffer Ag (+ 1x PIs). The sample was incubated in a thermomixer at 700 rpm and 30°C. 
One aliquot (0 min, untreated) of the well-mixed sample was taken (80 µl). MNase digestion 
was started by adding 10 µl 100 mM (w/v) CaCl2. Aliquots were taken at the chosen time points     
(80 µl). The digestion reaction was immediately stopped by pipetting the aliquot into 100 µl 
IRN buffer [50 mM Tris-HCl pH 8.0, 20 mM EDTA pH 8.0, 500 mM NaCl]. Before taking an aliquot, 
the sample should be mixed at higher rotation rates since nuclei sediment. Stopped aliquots 
could be kept at RT. When the time course was complete, 100 µl IRN buffer was added to the   
0 min aliquots. RNA in the aliquots was digested with 2 µl RNase A (20 mg/ml) for 1 h at 37°C. 
Afterwards, 0.5% (w/v) SDS and 2 µl Proteinase K (20 mg/ml) were added to the aliquots 
followed by incubation for 1 h at 56°C. The formaldehyde crosslink was reversed overnight by 
incubation at 65°C. DNA was isolated by phenol-chloroform extraction as described               
(see section 5.2.3.1), precipitated with ethanol as described (see section 5.2.3.2), and 
resuspended in 30 µl sterile water.  
10 µl of the DNA sample were digested with the appropriate restriction endonuclease for the 
experiment in a 20 µl reaction overnight at 37°C. Total DNA of the digestion reaction was 
separated by native agarose gel electrophoresis as described (see section 5.2.3.4), transferred 
to a membrane as described (see section 5.2.3.5), and analysed as described                              
(see section 5.2.3.6). 
 
5.2.7.3 Psoralen treatment  
Psoralen crosslinking was performed on nuclei. Nuclei were suspended in 1 ml                      
buffer Ag/IRN (1:1). 200 μl of this suspension were incubated with psoralen and another 200 μl 
were treated with ethanol as a control. The remaining nuclei were pelleted, frozen in liquid 
nitrogen and stored at -80°C. All samples were pipetted into the wells of a 24 tissue culture 
plate (for suspension cells). To each sample 10 μl of trimethylpsoralen (TMP, 0.2 mg/ml in 
ethanol) or ethanol was added, mixed and stored on ice in the dark for 5 minutes. Then, 
samples were irradiated with long-wavelength UV light (288 nm) for 5 minutes. The addition of 
psoralen and irradiation was repeated four times in total. Tissue plates were kept on a metal 
plate on ice during the irradiation. During irradiation it was important to remove the plastic 
cover of the 24 well plates. Then, samples were transferred to reaction tubes and subjected to 
further DNA workup. For this the RNA was digested with 2 μl RNAseA (20 mg/ml) for 1 h at 
37°C. Afterwards, SDS (final concentration 0.5%) was added together with 2 μl of proteinase K 
(20 mg/ml stock) and incubated for 1 h at 56°C. The formaldehyde crosslink was reversed by 
incubation at 65°C overnight or for at least 8 h. DNA was isolated by phenol-chloroform 
extraction, precipitated with ethanol and resuspended in 30 μl sterile water. 
To obtain slow-migrating band (s-band) or fast-migrating band (f-band) profiles from psoralen 
analyses, signal intensities in each lane were normalized to the respective peak values and 
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plotted against the distance of migration in the gel. Raw data were processed with the PeakFit 
software (Systat Software Inc.) using a Gaussian basis function (r2 values fit ≥0.98). 
 
5.2.7.4 Miller chromatin spreads 
Chromatin spreading was performed as described in (Osheim et al., 2009) with minor 
modifications. Carbon-coated grids were made hydrophilic by glow discharge instead of 
ethanol treatment. Depending on the contrast of the spread chromatin, counterstaining with 
heavy metal can be avoided. Negatively stained chromatin was obtained by short incubation 
with heavy metal followed by quick drying of the sample. 
 
5.2.7.5 Affinity purification using IgG coupled magnetic beads 
The cell pellet corresponding to 1 L yeast culture with OD600=0.8-1.0 was resuspended in 1.5 ml 
of cold buffer MB with 1 mM DTT and 0.04 U/μl RNasin per 1 g cell pellet. 800 μl of this cell 
suspension was added to 1.4 ml glass beads (Ø 0.75 – 1mm) and divided into 2 ml reaction 
tubes. A cell lysate was prepared by vigorous shaking of the cell suspension in a Vibrax shaker 
for 20 min, followed by 2 min on ice. This procedure was repeated twice. The cell lysate was 
cleared from cell debris by two centrifugation steps, 1x 5 min at 14000 rpm and 1x 10 min at 
14000 rpm. The protein concentration of the cleared lysate was determined using the Bradford 
assay. Triton X-100 (0.5%) and Tween 20 (0.1%) was added to the cell lysate. The whole amount 
of cell lysate (typically 2.0-2.4 ml with 120 – 180 mg of total protein) was incubated with 250 μl 
of equilibrated (3x washing with buffer A200 with 1x protease inhibitors) IgG coupled 
magnetic beads slurry and rotated for 1 h at 4°C. The beads were washed 7 times (1x 1 ml,        
5x 2 ml and 1x 10 ml) with cold buffer MB with 0.5% Triton X-100 and 0.1% Tween 20 in a 
BioRad 10 ml column. Bound proteins were eluted 2x with 500 μl of freshly prepared 500 mM 
NH4OH solution and rotation for 20 min at RT. Both supernatants were pooled in an original 
Eppendorf 1.5 ml reaction tube and lyophilised over night and e.g. further used for iTRAQ 
analyses. 
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A ampere 
Å angstrom 
amp ampicillin 
A/C autonomous replication sequence/centromere (single copy) 
ATP adenosin triphosphate 
bp base pair(s) 
CE/Core core element 
CF core factor 
ChEC chromatin endogenous cleavage 
ChIP chromatin immunoprecipitation 
CHX cycloheximide 
CoIP co-immunoprecipitation 
CSM complete supplement mixture 
C-terminal carboxy-terminal 
Da dalton 
DNA desoxyribonucleic acid 
dNTP desoxyribonucleoside-5'-triphosphate 
dox doxycycline 
E. coli  Escherichia coli 
EDTA  ethylene diamine tetra acetate 
EGTA  ethylene glycol tetraacetic acid 
EtBr ethidium bromide 
ETS external transcribed spacer 
g gram(s) 
GAL galactose 
gen geneticin 
GLC glucose 
h hour(s) 
HA3 triple hemagglutinin 
HMG high mobility group 
hyg hygromycin B 
IGS intergenic spacer 
IN input 
IP immunoprecipitation 
iTRAQ isobaric tag for relative and absolute quantitation 
ABBREVIATIONS 
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ITS internal transcribed spacer 
kb kilo base pair(s) 
l liter(s) 
LB luria broth 
LSU large ribosomal subunit 
m milli / meter 
M molar (mol/l) 
MALDI matrix assisted laser desorption/ionization 
min minute(s) 
MNase micrococcal nuclease 
mRNA messenger RNA 
MS mass spectrometry 
MW  molecular weight 
n nano 
NTS non-transcribed spacer 
OD600 optical density at 600 nm 
PAGE polyacrylamide gel electrophoresis 
PCR polymerase chain reaction 
PEG poly ethylene glycol 
pGAL galactose-inducible promoter (in this work usually GAL1-promoter) 
pH negative decadic logarithm [H+] 
PIP phosphor-imaging plate 
PKA protein kinase A 
PMSF phenylmethylsulfonyl fluoride 
Pol I RNA polymerase I 
Pol II RNA polymerase II 
Pol III RNA polymerase III 
Prot.A protein A 
qPCR quantitative PCR 
rDNA ribosomal DNA 
RAPA rapamycin 
RNA ribonucleic acid 
RNP ribonucleoprotein particle 
r-protein/RPs ribosomal protein 
rpm rotations per minute 
rRNA ribosomal RNA 
RT room temperature 
S sedimentation coefficient 
ABBREVIATIONS 
155 
S. cerevisiae Saccharomyces cerevisiae 
SDC synthetic dextrose complete 
sec second(s) 
SGC synthetic galactose complete 
snoRNA small nucleolar RNA 
snoRNP small nucleolar RNP 
SOB super optimal broth  
SOE  splicing by overlap extension 
SRC synthetic raffinose complete 
SSU small ribosomal subunit 
Taq thermus aquaticus 
TAP tandem affinity tag 
TBP TATA-binding protein 
TCA  tri chloro acetic acid 
TEMED  tetramethylethylenediamine 
TIP tritium-imaging plate 
TOR target of rapamycin 
TORC target of rapamycin complex 
ts temperature sensitive 
U unit(s) 
UAF upstream activation factor 
UE upstream element 
V volt 
v/v volume/volume 
WCE whole cell extract 
WT wild type 
w/v weight/volume 
YNB yeast nitrogen base 
YPD yeast extract / peptone / dextrose 
YPG yeast extract / peptone / galactose 
µ micro 
2µ 2 micron (multi copy) 
5-FOA 5-fluoroorotic acid 
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